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Multicomponent reactions (MCRs) are processes that show high atom and step 
economy; two different parts of my thesis were linked by MCRs. 
In the first part, levulinic acid was converted into a variety of bicyclic nitrogen 
heterocycles passing by an Ugi reaction. The obtained intermediate was then converted in the 
final product via a simple SN2 cyclization. 
The second part, instead, was dedicated to the obtainment of organo-catalysts 
structurally based on secondary and tertiary amine groups. First attempts, to get the latter in 
bicyclic structures, involved a starting MCR with L-prolinol, but the reaction showed low 
diastereoselectivity and the cyclization failed. A different strategy was aimed to obtain 
secondary amines and resulted to be more efficient. The involvement of a seven-membered 
cyclic imine, with a chiral center in C-3, in a Ugi-Joullié reaction resulted in a very 
diastereoselective process. Using a silyl oxy derived carboxylic acid, an Ugi adduct with a 
protected alcohol is obtained. Thus, an intramolecular cyclization can be performed producing 
the final free amine group. The obtained amine was used to perform the first catalysis tests in 
Michael and aldol reactions. Although no catalytic activity was detected, different reaction 
conditions and structures have still to been tested.  
Finally, the reaction mechanism in self-promoted glycosylations was investigated. They 
involve a trichloroacetimidate as glycosyl donor which is activated by an acceptor that 
contains an acid sulfonamide portion. An alcoholic function was added to the acceptor with a 
consecutive possible production of both O- and N-glycosides. Dissociative mechanism favors 
the first while an associative mechanism brings to the second. The study showed the 
chemoselectivity and, to some extent, the stereoselectivity of the reaction to be controlled by 
tuning the parameters e.g. the polarity of the solvent, the concentration of donor and acceptor 
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My doctorate thesis has been devoted to three different projects, correlated only in part. 
Therefore, both the thesis and this introduction have been divided into three parts. The use of 
multicomponent reactions for a fast and diversity-oriented synthesis and the use of 
aminoalcohols or their derivatives in stereoselective synthesis are the main aspects in 
common among these three different parts. 
1.1 Use of biobased levulinic acid for a fast and efficient construction of 
bicyclic heterocycles 
Levulinic acid 1 (Scheme 1) is one of the most important building blocks derived for 
biomass.1 It is quoted in the list of 12 most important lignocellulosic-derived compounds.2 It 
can be easily obtained by acid treatment of hexoses.3 Production of levulinic acid on large 
scale is already a well assessed methodology. Its price is, at the moment, about 1 $/kg, but it 
is expected to go further down, using waste sugar sources. Thus, the main problem now is not 
how to get it, but how to valorize it. Some applications in the polymer field are under study.4 
Far less investigated are transformations into nitrogen derivatives.5 
The goal was to exploit multicomponent reactions, in particular the isocyanide-based 
Ugi reaction, in order to convert levulinic acid into a variety of bicyclic heterocycles 5 
(Scheme 1). The other key substrates for this approach are aminoalcohols 2, that are often 
obtainable as well from renewable sources, and can be accessed in a huge variety, including 
chiral ones. The strategy involves just two steps, namely an Ugi reaction followed by a 
Mitsunobu-type cyclization.  
A brief State-of-the-Art of multicomponent reactions (MCRs), including the Ugi 
reaction, and of the power of combining MCRs with post-MCR cyclizations is reported in 
chapter 2.1. 
 
Scheme 1. Proposed strategy to convert levulinic acid into bicyclic heterocycles. 
As thoroughly described in chapter 2.2, the approach turned out to be successful. We 
have indeed been able to synthesize the target bicyclic heterocycles in high overall yields, and 
with great operational simplicity. When using chiral aminoalcohols, the multicomponent 
reaction showed very low or no diastereoselectivity, but both diastereomers could be easily 
converted to the final product. After optimization of the second cyclization both six- and 
seven-membered rings were obtained.  
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1.2  Multicomponent synthesis of chiral amines to be exploited as new 
enantioselective organocatalysts 
Multicomponent synthesis of chiral amines and their evaluation as new potential 
enantioselective organocatalysts represented the main part of my thesis. 
Organocatalysis is a relatively new research area that has witnessed a dramatic growth 
in the last 20 years, since the pioneering work of Barbas and List in 2000.6 Among 
organocatalysts, tertiary and secondary amines play a paramount role. The former can be used 
for general basic catalysis or, after conversion to quaternary salts, as phase-transfer 
catalysts.7,8 The latter are even more important, since they can be involved in both enamine 
and iminium ion catalysis.9 
In most cases, the organocatalysts employed thus far are obtained by derivatization of 
natural chiral amines or aminoacids. For example, proline and its derivatives are definitely the 
most popular in this area.6,10 Also Cinchona alkaloids have been often used.7 However, this 
limits the exploration of chemical diversity to the derivatives easily obtainable starting from 
this "chiral pool" members. 
Multicomponent reactions are very well suited for the exploration of chemical diversity, 
since they allow to introduce at least 3 diversity inputs in a single step, and, for this reason, 
they have been extensively employed in the synthesis of libraries of potential drug 
candidates.11 Thus, during my thesis I followed two different approaches, thoroughly 
described in chapter 2.3, to exploit this kind of reactions for the synthesis of new potential 
organocatalysts. 
The first one was based on previous reports by Sheppard et al., and was aimed to 
tertiary amines derived from prolinol 6 or functionalized prolinols (Scheme 2).12,13 Reaction 
of these secondary aminoalcohols under Ugi conditions should lead to a deviation of the 
normal reactivity, affording -aminoamides 10, instead of -acylaminoamides, which are the 
typical Ugi products. These tertiary amines could be rigidified by cyclizations that exploit the 
alcoholic moiety. 
 
Scheme 2. Proposed synthetic path to obtain bicyclic compounds having tertiary amine groups. 
This approach proved to be problematic since the multicomponent reaction showed low 
yields and diastereoselectivity. Furthermore, the two diastereomers resulted difficult to 
separate and first attempts towards cyclization failed. Although we believe that probably, with 
further efforts, these drawbacks could be overcome; we preferred to move to the second 
strategy described in Scheme 3, which was aimed to the synthesis of secondary amines.  
Such approach was based on the synthetic strategy used by my research group for the 
synthesis of tetrahydrobenzoxazepines which exploits Ugi-Joullié reaction as multicomponent 
process.14 Boc-aminoalchols 15, obtained from α-Boc-amino-acids, were chosen as starting 
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materials in order to have a greater availability of substrates and to increase the steric 
induction of the final potential catalyst. The multicomponent reaction showed a very high 
diasteroselectivity as will be reported and the two diastereomers could be easily separated 
through a simple chromatographic column. The conversion of the amide to the amine group 
was not so trivial. The Ugi-Joullié product 20-21 showed, indeed, a great sensitivity to basic 
conditions, used into an attempt to hydrolyze the amide group, bringing an epimerization 
phenomenon. Post-MCR cyclization turned out to be useful for the scope. By insertion of a 
protected alcohol into the multicomponent adduct, an intramolecular cyclization can be 
performed after remotion of the protecting group. Thus, 20a and 21a can be converted into 
the desired products 22 and 23 under the appropriate conditions (Scheme 3).  
 
Scheme 3. Proposed synthetic path to obtain bicyclic compounds having secondary amine groups. 
The obtained amine (chapter 2.3) offered a chance to perform the first tests to study the 
catalytic activity of these compounds. Michael and aldol reactions were chosen with this 
purpose. Many reaction conditions have been tested, but unfortunately, no catalytic activity 
has been observed so far.  
1.3 Mechanistic studies of self-promoted glycosylations 
Finally, during my Erasmus project (chapter 3), in the laboratories of Prof. Pedersen in 
Copenhagen, I studied the reaction mechanism in self-promoted glycosylations,15 and how it 
is influenced by the reaction conditions.  
Previously, Prof. Pedersen has developed a new and efficient strategy to perform self-
promoted N-glycosylation (Scheme 4).15   
 
Scheme 4. Self-promoted N-glycosylation. 
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Self-promoted reactions are processes that can be activated by one of the involved 
reagents without using external catalysts or additives.16,17 The acidity of the sulfonamide 
functionality makes the glycosyl acceptor 26a able to activate the trichloroacetimidate (TCA) 
donors 25 with a subsequent nucleophilic attack to the glycosyl cation 28 i.e. it acts as both 
catalyst and nucleophile (Scheme 5).  
 
Scheme 5. Putative mechanism of self-promoted N-glycosylation. 
Associated ion pairs were proposed as favorite for the reaction mechanism starting from 
axial-TCA donors. Contact and solvent-separated ion pairs are on the borderline between a 
SN1 and a SN2 mechanism. Small changes in the reaction condition can therefore shift the 
balance to either site. Important parameters in this are e.g. the polarity of the solvent and its 
ability to promote a charge separation.18-20 The dissociative reaction path allows two 
competing reaction pathways resulting in low anomeric selectivity. 
To better understand the mechanism and the solvent influence on the self-promoted 
reaction, an alcoholic function was inserted in the acceptor (Scheme 6). The nucleophilic 
attack from this group would be favored only by the formation of dissociated ion pairs. On the 
other side N-glycosylation is favored with a more associative mechanism. Thus, simply 
valuing the N-glycoside: O-glycoside ratio it is possible to understand the favored mechanism 
involved in the reaction. 
As chiral compounds are produced, all these reactions have been studied also from a 
stereochemical point of view. 
 
Scheme 6. N- vs O-glycosylation in self-promoted processes. 
The study showed the chemoselectivity and, to some extent, the stereoselectivity of the 
reaction to be controlled by tuning the parameters e.g. the polarity of the solvent, the 
concentration of donor and acceptor and using additives like lithium salts.  
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2. RESULTS AND DISCUSSION  
2.1 Multicomponent reactions 
Multicomponent reactions (MCRs) are defined as processes where three or more 
substrates are combined in a single step, to give a product which contains all the essential 
portions of the used species.21 Thus, based on the structure of the starting materials many 
products with different molecular complexity can be obtained with high step and atom 
economy making MCRs a sustainable strategy for the synthesis of highly diverse compound 
libraries. Furthermore, the scaffold of the products with new chirality centers makes them 
suited for exploring biological targets and drug-like entities.  
Two of the most famous multicomponent processes are the Passerini and Ugi reactions. 
The first, introduced by the italian Mario Passerini in 1921 consists in the synthesis of an α-
acyloxycarboxamide by simply mixing a carbonylic compound, an isocyanide and a 
carboxylic acid.22 The activation of the carbonyl group by the acid allows the isocyanide to 
give rise to a nucleophilic attack to produce intermediate 37 (Scheme 7). An acyl migration 
(Mumm rearrangement) completes the reaction mechanism to generate the final product. 
 
Scheme 7. Mechanism of Passerini reaction. 
The one introduced by Ugi in 1959 adds the preformation of an imine, by interaction 
between a carbonylic compound and an amine, in the reaction mechanism (Scheme 8).23 
Isocyanides are suitable substrates for this kind of reactions being able to react with both 
electrophiles and nucleophiles at the same atom to form α-adducts. These species can be 
available in commercial form, but also many procedures, like the use of diphosgene and in 
situ reactions with Burgess reagent, have been proposed for their synthesis.24,25 The Ugi 
reaction occurs thanks to protonation of the pre-formed imine 41 by the weak acid followed 
by nucleophilic attack by the isocyanide 43 to the iminium ion 44. The resulting nitrilium ion 
46 is then attacked by the carboxylate ion 45 and the Mumm rearrangement completes the 




Scheme 8. Mechanism of Ugi reaction. 
As a new stereogenic center is created, stereochemical issues have be considered. If at 
least one reagent is chiral two different diastereomers will indeed be formed. However, when 
using chiral isocyanides, amines, carboxylic acids, or carbonyl compounds as the chirality 
inductive components, no respectable level of diastereoselectivity is achieved and most of α-
chiral isocyanides or α-chiral aldehydes undergo a racemization under the Ugi reaction 
conditions.26  
Different strategies have been developed to discover novel MCRs. Some of them are 
presented in this thesis. 
2.2 Synthesis of bicyclic compounds starting from levulinic acid 
A very effective strategy to increase scaffold diversity without developing new MCRs is 
the combination of existing MCRs with complexity-generating reactions. If a nucleophilic 
group is inserted in the multicomponent product, an intramolecular cyclization would be 
possible. This so-called post-MCR cyclization strategy (Figure 1) has been used in many 
works to achieve significant variation of the resulting 4-MCR scaffolds and some of them 
involve levulinic acid 1 (Scheme 9). 
 
Figure 1. The generation of scaffold diversity by combining MCRs with cyclization reactions 




It has been used, for example, by Ugi et al. to obtain compounds 49, but they are 
imides, and thus less interesting for their hydrolytical instability.27 On the other hand, 
ketopiperazines 50 and 51, synthesized by Hulme and Doemling respectively, are limited 
from the point of view of the introduction of diversity: in 50 the isocyanide group is lost upon 
cyclization,28 whereas the synthesis of 41 necessarily requires an indole containing 
isocyanide.29 Our approach, depicted in Scheme 9, seemed more flexible and diversity-
oriented. Based on the thorough experience of our group,30-32 and of other authors,33-36 in Ugi 
reactions followed by intramolecular aliphatic substitutions, we planned to employ amino 
alcohols as one of the two additional components in the Ugi reactions with levulinic acid 1. 
Then, the isocyanide derived secondary amide group can react with the alcoholic function 
through a Mitsunobu or Mitsunobu-like reaction to produce a cyclization process. Two of the 
three components could be modified and different sizes of the diazalactam 5 can be achieved 
by varying the length of the spacer between the amino and the hydroxy groups. An added 
advantage of this strategy is that several amino alcohols may be obtained from biomass as 
well, including chiral enantiopure ones. The products of this two-step approach are quite 
uncommon bicyclic systems that join two "privileged structures":37-39 the pyrrolidinone40 and 
the piperazine41 or diazepine.  
 
Scheme 9. Multicomponent synthesis of bicyclic heterocycles from levulinic acid. 
11 
 
The planned two-step procedure was first optimized using ethanolamine 2a and 
isocyanide 52 (Scheme 10). Using a 1.2:1.2:1.0 stoichiometry of levulinic acid, amino alcohol 
and isocyanide, an excellent yield of the Ugi reaction was achieved. After a quick liquid–
liquid extraction to remove the acid and the amine in excess, product 53a was obtained in 
nearly quantitative yield without the need to perform any further purification. Isocyanide 52 
was chosen because it is solid, highly stable, and odorless.42  
 
Scheme 10. Optimized synthesis of tetrahydropyrrolopirazinedione 55a. 
Methanol has been found to be the best solvent according to the mechanism 
hypothesized by Harriman43 and shown in Scheme 11. Such mechanism is quite similar to the 
classical process already described for Ugi reaction. However, after the formation of the 
cyclic intermediate 61, Mumm rearrangement is forbidden because of the unfavored 
formation of a bridging transition state. MeOH provides the ring opening to produce 62, 
where an intramolecular nucleophilic attack from the amine group generates the final product. 
When using a bulkier nucleophile like tBuOH no reaction occurs. This should confirm the 
proposed mechanism, although we cannot completely rule out direct rearrangement of 61 into 
4, although difficult for steric reasons. 
 
Scheme 11. Presumed mechanism of the Ugi reaction with levulinic acid and 1,2-amino alcohols.  
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Mitsunobu reaction did not seem to be the best procedure to use for the cyclization 
reaction because of its poor atom economy. A two-step procedure involving conversion of the 
alcohol into a sulfonate was even less attractive from the point of view of operational 
simplicity. Thus, we chose to employ the combination of sulfonyl diimidazole (SDI) with 
NaH. This is a methodology firstly introduced by Hanessian.44,45 Although it is, surprisingly, 
seldom employed, it was already demonstrated by my group31 to be an useful alternative to 
the classical Mitsunobu conditions. SDI is a relatively nontoxic and stable solid. The two 
reagents are simply added to the solution of the substrate at room temperature without special 
precautions.  
The putative mechanism of the cyclization reaction is shown in Scheme 12. The 
alkoxide formed by deprotonation with NaH reacts with SDI to form a sulfonate 64. The 
deprotonation of the amide by the imidazoline anion 63 promotes an SN2 displacement of the 
sulfonate with the consecutive formation of the final product. On aqueous work-up, the 
leaving group 66 is hydrolyzed to sulfate anion and imidazole. Both these side products are 
nontoxic and easily removable by liquid–liquid extraction. Imidazole can be recycled and 
converted back into SDI by reaction with sulfuryl chloride. 
 
Scheme 12. Presumed mechanism of the cyclization with SDI. 
Initially the cyclization of 53a to 55a was performed in DMF as the solvent. This 
solvent is typically removed by an extraction using aqueous solution of LiCl, but the polarity 
of the product and its relative solubility in water makes this procedure unsuitable. The desired 
specie was indeed partially lost in the aqueous phase during the work-up, lowering the yield. 
On the other side, extraction from saturated NH4Cl was quantitative, but the crude was 
contaminated by DMF, that was difficult to remove under high vacuum. Moreover, some of 
the excess of SDI used for the reaction was extracted into the organic phase, contaminating 
the product 55a. Although in this particular case a chromatography was able to separate 55a 
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from SDI, for other products 55 shown in Figure 2 this was not so easy. Trituration of crude 
55a was tested as an alternative method that could avoid chromatography, but it failed to 
removed SDI impurity. 
 
 
Figure 2. Tetrahydropyrrolopirazinediones prepared. For 55b, 55c, 55e: overall yields of two steps 
from the isocyanide are reported. For 55d, 55f and 55g: overall yields of three steps from the 
formamide (precursor of the isocyanide) are reported. For 55h–55j: Ugi product yields are from the 
chiral amino alcohol, after chromatography. For 55h and 55i: the two diastereomers were separated 
after the Ugi step. Cyclization yields are for the upper and lower diastereomer. (by TLC). In the case 
of 55j, the diastereomer. were separated only after cyclization. 
When using THF instead of DMF, it turned out to be equally effective to get the product 
and, more important, it didn’t present any problems for the solvent remotion. A different and 
easy procedure brought the quantitative destruction of the excess of SDI. It consists in adding 
0.5 equivalents of inexpensive tris(hydroxymethyl)aminomethane (TRIS) which, in the 
presence of excess NaH, reacts with SDI to form a water soluble cyclic sulfate. In this way, an 
extractive work-up became sufficient to obtain a pure product, making chromatography 
unnecessary. The presented procedure is advantageous from different point of view. The 
overall yield is indeed quite high and, moreover, both steps are performed at room 
temperature, without particular precautions to avoid humidity. Finally, all side products can 
be removed through a simple liquid-liquid extraction after the two single steps. The results 
obtained for other pyrrolopirazinediones with good to excellent yield (Figure 2) confirm the 
efficiency of this methodology. Compound 55b was previously reported by Hulme et al.28 
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using the approach depicted in Scheme 8 (R1 = H, R2 = Bn). In that case the benzyl group (R2) 
did not derive from the isocyanide, but from a Boc-protected amino alcohol instead, and the 
overall yields were lower. The overall yield shown for compound 55f has not to be confused 
with an unsatisfactory result because it was calculated on three steps, starting from the 
corresponding formamide. The latter was used to prepare the isocyanide in situ using the 
Burgess reagent.46 This procedure was chosen because of the known poor stability of aromatic 
isocyanide and, thus, in order to have a more operationally simple method. Actually, the 
cyclization itself was again very efficient, proceeding in 95 % yield. In the case of compounds 
55d and 55g, the required benzyl isocyanides were obtained from the corresponding 
formamides ad purified by chromatography. However, due to their partial volatility, we did 
not dry them exhaustively, and thus also in this case the yield was calculated from the 
formamide. Although this bicyclic system is still poorly explored in medicinal chemistry, a 
recent patent has shown activity of tetrahydro-pyrrolopiperazines as neurokinin 1 receptor 
antagonists.40 Moreover, some natural alkaloids (e.g. paraherquamides and aspergillimides), 
that contains this scaffold, have antihelmintic or neuroprotective activity.47 
Then, in order to further expand diversity, we explored the use of chiral 1,2-amino 
alcohols derived from α-amino acids. The ratio between reagents was varied using a slight 
excess of isocyanide because of the preciousness of the amino alcohol. The Ugi reaction 
suffered the change of the amino alcohol. The formation of a concurrent Passerini product 
was indeed observed. Trifluoroethanol typically favors the formation of Ugi product when it 
is used as solvent because its polarity produces a stabilization of the nitrilium ion which is 
formed during the reaction. In this particular case, however, its use brought the formation of 
only the Passerini product. This, again, confirms the role of MeOH in opening the 
intermediate 61 (Scheme 11). The formation of the concurrent product was completely 
suppressed by simply preforming the intermediate oxazolidine 56 (Scheme 11). Thus, 
equimolar quantities of the chiral amino alcohol and levulinic acid were mixed in methanol 
for 2 h in the presence of molecular sieves, before addition of the isocyanide. Using this 
modification, the Ugi product yields were again good. On the other hand, the 
diastereoselectivity, as it often happens in isocyanide-based MCRs, was very poor. However, 
the two Ugi diastereomers could be separated and submitted independently to the next step. 
Cyclization was slower and only low or moderate yields were obtained in THF. By 
shifting to DMF and, in some cases, by increasing the temperature, all reactions were brought 
to completion. Interestingly, the rate of cyclization was remarkably lower for one of the two 
diastereomers. This is reflected in the different cyclization yields for the two diastereomers of 
55h and 55i. In both cases the less polar diastereoisomer behaved poorly in this step.   
1-amino-2-propanol was also employed, in racemic form. In this case the two Ugi 
diastereomers could not be separated at this stage, but only after cyclization. The different 
yields measured shows that also in this case cyclization is favored for one of the two 
diastereomers.  
This protocol was then extended to the obtainment of the hexahydro 
pyrrolodiazepinediones 67 depicted in Figure 3. The Ugi reactions using propanolamine as 
component proceeded without particular problems, but also in this case premixing the amino 
alcohol and levulinic acid better yields were obtained. On the other side, the first test to 
produce 67a using THF as solvent produced only poor yield. Replacing the latter with DMF 
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the reaction worked better, even if the yield was lower than those obtained for six-membered 
adducts. In this case very polar side-products containing the imidazole ring were detected. It 
may indicate that the intermediate sulfonate 64 (see the mechanism depicted in Scheme 12) 
may also be displaced by the imidazolide anion 63. 
When starting from cyclohexyl isocyanide the use of SDI under the usual conditions 
with DMF produced only poor yield (27 % at room temperature and 28 % at 50 °C) and the 
polar side products became predominant, probably because of the higher steric bias of the 
nucleophilic nitrogen. Then, an alternative strategy was proposed. It consists in the formation 
of a methanesulfonate that can be submitted to cyclization using NaH in DMF (method B, 
Figure 3). A higher yield of 60% was achieved using this strategy. My own contribute was 




Figure 3. Hexahydropyrrolodiazepinediones prepared. Method A: SDI, NaH, DMF, 50 °C. Method B: 
1) MsCl, Et3N, CH2Cl2; 2) NaH, DMF, 50 °C. For 67c and 67d the Ugi yield is calculated from the 
formamide (precursor of the isocyanide). For 67e the Ugi yield is calculated from the amino alcohol. 
In the case of 67e the two diastereomers were separated after the Ugi step and cyclized independently. 
Cyclization yields are for the upper and lower diastereomer (by TLC). 
The synthesis of pyrrolodiazepinedione 67c had already been noted to be sensitive to 
the use of method A with the production of side-products formed by the nucleophilic attack of 
imidazole anion towards the sulfonate intermediate. Thus, method B was favored for this 
synthesis obtaining a yield of 74%. The only problem of this procedure is that during the 
aqueous work-up at pH = 5 among the two steps, a little percentage of the methanesulfonate 
intermediate is hydrolyzed and the Ugi product is again produced. From this point it won’t be 
no more converted in the final product. With the combination of SDI and NaH, instead, we 
need just to add other equivalents of these two species to go on with the reaction. When the 
nitrogen of the secondary amide is linked directly to the aromatic ring the sulfonate 
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intermediate will be less sensitive to the attack of the imidazole anion and the method with 
SDI and NaH becomes again efficient for the obtainment of product 67d. The two 
diastereomers which were obtained as Ugi adducts starting from a chiral enantiopure 
propanolamine showed a different reactivity in the cyclization reaction, but method A 
produced good results for the synthesis of both diastereomer of 67e.  
As it can be seen in Figure 2 and Figure 3, several of the adducts prepared contain a 
protected phenol. This follows recent interest of my research group in the synthesis of 
artificial phenols from natural phenolic building blocks.48 The allyl group was selected by us 
as an ideal protecting group for the phenolic moiety, since it can be deblocked under neutral 
conditions. As an example, previous work showed the high deprotection of compound 55d to 
give the free phenol 55k, Scheme 13.  
The pyrrolidinone ring had already been noted to be able to be further functionalized 
through enolate chemistry. Scheme 13 shows the α-alkylation of the lactam with two different 
electrophiles. These alkylations were found to be diastereoselective, especially in the case of 
methylation.  
 
Scheme 13. Further reactions performed on pyrrolopiperazinedione 55d. Yields for 55k and 55l 
are calculated from unrecovered 55d. 
In conclusion, an operationally simple and high yielding methodology to convert 
levulinic acid into tetrahydro pyrrolopiperazinediones was developed. The procedure is 
endowed with operational simplicity consisting in simply mixing the reagents at room 
temperature. Albeit the higher strain of the seven membered ring makes the cyclization less 
efficient, it is worth noting that this represents the first example of synthesis of seven-
membered rings through SN2 cyclization of an Ugi-derived secondary amide onto an alcohol 
(or halogen) leaving group.49 This bicyclic scaffold is nearly unexplored, but, due to its drug-
likeness, it is expected to be promising in medicinal chemistry as well.50  
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2.3 Synthesis of new potential organo-catalysts 
2.3.1. Chiral amines in organo-catalysis 
As introduced in chapter 1, the main part of my work regarded the synthesis of new 
potential organo-catalysts employing multicomponent reactions in the synthetic pathway. All 
strategies were aimed towards the obtainment of tertiary and secondary amines.  
The examples of processes which are catalyzed by secondary or tertiary amines are 
many in the literature. The first ones are involved in catalysis via enamine or iminium ion, 
whereas the second ones are employed as quaternary ammonium salts in phase transfer 
catalysis or as such in base-catalyzed processes. Corey and O’Donnell reported the viability 
of Cinchona alkaloids for the synthesis of β-hydroxy α-amino acids via aldol reactions,7 a 
topic first explored by Miller and Gasparski, and via alkylation of the benzophenone Schiff 
base of tert-butyl glycinate (Scheme 14).8  
 Scheme 14. Reactions catalyzed by Cinchona alkaloids 
The mechanistic reasons of the high enantioselectivity of these reactions are kept inside a 
specific three-dimensional arrangement of a contact ion pair in which a nucleophilic site of 
the substrate is proximate to the quaternary cationic center among which there is an optimum 
van der Waals attractive interaction.51 Direct asymmetric Mannich reactions of ketones,52 α-
amination,53 aldol reactions54 and α-halogenation55 (Scheme 15) are only few examples of 
reactions that can be catalyzed by chiral secondary amines through enamine catalysis. It is 
based on the reversible generation of enamines from a catalytic amount of an amine and a 
carbonyl compound. The highest occupied molecular orbital (HOMO) of the enamine is 
higher in energy than the HOMO of the carbonyl compound. Thus, it can more easily interact 
with the lowest unoccupied molecular orbital (LUMO) or singly occupied molecular orbital 
(SOMO) of an electrophile.9  
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The iminium ion catalysis is used for example in Michael56 and Diels-Alder10 reactions 
(Scheme 16) to activate α,β-unsaturated carbonyl compounds through their reversible 
condensation with chiral amines to form an iminium ion. Its LUMO is lower in energy and 
this results in an enhanced electrophilicity and therefore can more readily interact with 
nucleophiles.9 
 
Scheme 15. Enamine-catalysis examples. 
 
Scheme 16. Iminium ion-catalysis examples. 
The catalytic cycles of this kind of catalysis are reported in Scheme 17. The 
modification of these catalysts often requires target-oriented synthetic pathways (Scheme 
18).7,51 In spite of these structural modifications, they remain Cinchona and proline 
derivative. Thus, an alternative strategy to obtain new catalysts with new scaffolds would be 





Scheme 17. Catalytic cycles with secondary amines as catalysts. 
 





2.3.2 Multicomponent synthesis of chiral tertiary amines from prolinol 
Sheppard and coworkers reported that replacing the amine with an amino alcohol it is 
possible to shift from classical Ugi products towards new scaffolds having tertiary amine 
groups. They employed chiral secondary amino alcohols, including L-prolinol 6, and reported 
two different methods leading to tertiary amines. The first one involves prolinol 6, an 
aldehyde, an isocyanide and thiophenol (Scheme 19, method A).12 In the second strategy 
thiophenol is replaced with a carboxylic acid (Scheme19, method B).13  
 
Scheme 19. Multicomponent reactions involving L-Prolinol 6. 
These reactions proceed with excellent diastereoselectivity. A single diastereoisomer is 
indeed formed and this is unusual for Ugi and Ugi-type reactions. Based on the type of acid 
the reaction mechanism can follow two paths. One follows the classical steps of Ugi reaction 
(path A, Scheme 20), but the acyl group migrates on the hydroxyl function instead of the 
amine function. This is because the intermediate B contains a tertiary amine where the acyl 
group is not able to migrate. When the carboxylic acid is replaced with thiophenol the softer 
nucleophilic character of this specie allows the nitrilium ion to rearrange and produce the 
cyclic intermediate D which is then involved in the production of the final product 73 (path B, 




Scheme 20. Proposed mechanism with amino alcohols. 
On these bases my work was initially aimed to the synthesis of tertiary amines starting 
from L-Prolinol 6.  A thiol and a carboxylic acid were chosen as nucleophile species in order 
to employ the methodologies reported by Sheppard to expand the reaction scope with the use 
of other aldehydes and isocyanides, also studying the change in the diasteroselectivity.  
Looking again at the mechanism, if no nucleophile is present, or if it reacts only slowly, 
the reaction should stop at the level of cyclic intermediate D (Scheme 20). Then, during work-
up, it would be hydrolized to give the truncated product 10 (Scheme 21). It can be interesting 
because the alcoholic group could be employed for further functionalization. Mitsunobu or 
Mitsunobu-like reactions are suitable for the scope. First, an intermolecular interaction with a 
sulfonamide could be tested as first approach to the study on the potentiality of the truncated 
product 10. Intramolecular cyclization could be then explored to obtain bicyclic and, thus, 
more rigid structures like 11. Following this approach, other prolinol derived compounds like 
78 should give the chance to go on in the exploration of chemical diversity to obtain even 




Scheme 21. Synthetic project for the synthesis of tertiary amines. 
Initially, my work was dedicated to the multicomponent synthesis of compound 70a 
(Scheme 22). tButyl isocyanide was chosen being commercially available and giving the 
chance to avoid the synthesis of other potentially unstable isocyanides. Pentanal 79, as 
aliphatic aldehyde, allowed us to adhere more closely to the methodologies described above 
(actually, Sheppard et al. used aliphatic aldehydes like heptanal and butanal instead of 
pentanal).  
 
Scheme 22. Synthesis of compound 70a starting from L-Prolinol. 
Surprisingly, perfectly reproducing the reported reaction conditions, no reaction 
occurred (entry 1, Table 1). Thus, different reaction conditions were tested. All tests were 
performed with molecular sieves to favor the formation of oxazolidine. In most cases it was 
preformed by simply mixing the aldehyde and prolinol in the solvent. MeOH resulted to be 
the best solvent producing better results than trifluoroethanol (entry 2 and 4, Table 1), which 
should stabilize the nitrilium intermediate thanks to its higher polarity. An increasing of 
temperature up to 100 °C was required to obtain the best results (entry 5, Table 1), probably 
indicating the thermodynamic push required to allow the opening of the intermediate D 
(Scheme 20). This intermediate also requires a sufficient amount of thiophenate to be opened. 
Thus, Et3N was used to guarantee the formation of sufficient amount of thiophenate but it 
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brought the reaction to be less clean and various not easily recognizable side product were 
detected (entry 6, Table 1). 
Table 1. Optimization for the synthesis of 70a. 
Entry Solvent Additives Molecular 
sieves 
t T (°C)  Yield (%) 
1 MeOH / / 20 min Microwave (60 W, 60 
°C) 
/ 
2a MeOH / 100 mg 4 h r.t. 33 
3a MeOH / 100 mg overnight reflux 32 
4a CF3CH2OH / 100 mg overnight reflux 2 
5a MeOH / 100 mg overnight 100  50 
6b  MeOH Et3N 100 mg overnight 100 8 
7a MeOH / 100 mg overnight 120 16 
The reaction progress was followed through TLC. aFirst only 79 and 6 were added in the solvent and 
the reaction was stirred for 2h at r.t. to favor the formation of oxazolidine. Then 78 and 69 were added. 
bFirst only 79 and 6 were added in the solvent and the reaction was stirred for 2h at r.t. to favor the 
formation of oxazolidine. Then 80, 69 and Et3N (0.170 µL, 1.22 mmol) were added.   
Again, based on the conditions reported by Sheppard (method B, Scheme 19), I tried to 
preform the oxazolidine using Et2O as solvent and MgSO4 to eliminate water and move the 
equilibrium of the reaction towards the product. At this stage we decided to shift to an 
aromatic aldehyde, which offers the chance to better follow the reaction though TLC. Thus, I 
chose to use a meta substituted methoxybenzaldehyde, because previous work in my lab has 
shown that para or ortho substituted alkoxybenzaldehyde tend to be less reactive in Ugi 
reactions (Scheme 23). The problem was that, in the first step, I got less product than the 
expected quantity, although the formation of the oxazolidine was almost complete. The reason 
could be that being MgSO4 a Lewis acid it could hold back the product during the filtration of 
the mixture reaction, so we couldn’t get the product with good yields. With DCM, instead, the 
reaction was complete and I got the expected quantity of oxazolidine.  
 




Thus, from the point of view of the yield, we were satisfied by these optimized 
conditions. The nature of the aldehyde slightly influences the diasteroselectivity of the 
reaction. While I noted the formation of one diastereomer with the aliphatic aldehyde 79, we 
got a d.r. = 9:1 with compound 72.  
As introduced at the beginning of this chapter, truncated Ugi specie 10 shows a free 
alcohol group that makes it desirable as product. Thus, I looked for a method to get it 
efficiently. First, I tried its synthesis performing the multicomponent reaction with the 
preformed oxazolidine and the isocyanide, using pyridinium p-toluenesulfonate to favor the 
opening of the cyclic intermediate D (Scheme 20).  
 
Scheme 24. Proposed synthetic pathway for the obtainment of 10a. 
Unfortunately, this test produced only unidentified side-products. A two-step procedure 
was, then, planned. First, a multicomponent reaction with acetic acid was performed (Scheme 
25) to obtain an ester function. Isocyanide 82 was used to follow more easily the formation of 
side products. Even in this case a complete diastereoselectivity was not detected. Moreover, 
the two diastereomers were not able to be separated by chromatography. As it can be 
observed, the product contains an ester function. It offers the chance to obtain the final 
desired product 10b with a very simple hydrolysis reaction under basic conditions.  
 
Scheme 25. Synthesis of truncated Ugi-product 10b. 
In order to explore the real potentiality of the linear compounds synthesized through 
multicomponent reaction, we studied the susceptibility of the hydroxylic group to a 
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functionalization with an intermolecular Mitsunobu reaction (Scheme 26). The reaction 
indeed worked in good yield and the two diastereomers could be separated. 
 
Scheme 26. Mitsunobu reaction. 
Thus, we investigated the possible cyclization by a nucleophilic substitution involving 
the isocyanide derived secondary amide as nucleophile and the primary alcohol as 
electrophile. This reaction has been often studied in my group, but never on a substrate 
containing a tertiary amine. SDI and NaH were employed (Scheme 27).  
 
Scheme 27. Proposed strategy for the synthesis of bicyclic products. 
Unfortunately, I did not get the hoped results, but just products with an unidentified 
structure. I tried to exploit a cyclization going through a methansulfonate intermediate 85 
(Scheme 28), but without better results. 
 
Scheme 28. Proposed strategy via methansulfonate for the synthesis of bicyclic products. 
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The intermediate 85 resulted very fleeting and its instability brought to the formation of 
other products, always not so easily identifiable.  
Briefly resuming, the synthesis of tertiary amines starting from L-prolinol showed 
different problematics, starting from their synthesis, where many side products tend to form. 
However, the synthetic strategy to get them is almost optimized. The truncated product was 
difficult to be obtained through a direct multicomponent reaction. Anyway, I showed that it 
can be prepared also through two very simple steps. Moreover, it is sensitive to a further 
functionalization. The diasteroselectivity of this kind of Ugi reaction is quite high and 
substrate dependent. When two diastereomers are formed they result separable by 
chromatography just after intermolecular Mitsunobu reaction, and this hamper their utilization 
as organocatalysts.  
Before studying other strategies to get intramolecular-functionalizations, the work was 
shifted towards the obtainment of secondary amines. As it has been widely discussed, Ugi-
type reactions produces peptide-like products. Thus, I moved towards the research of a 
method that would employ a multicomponent process with high degree of diastereoselectivity 
and, more important, allow to convert the amide of the multicomponent adduct into a 
secondary amine group. 
2.3.3. Synthesis of chiral seven-membered amines through diastereoselective Ugi-
Joullié reaction 
 Recently, my research group was involved in the synthesis of 
tetrahydrobenzoxazepines (Scheme 29).14 The methodology involves a starting Mitsunobu 
reaction between the protected form of salicyl aldehyde 87 and a Boc-amino alcohol 88. The 
treatment of the product with acid conditions produces in sequence the deprotection of the 
aldehyde and the amine group and a final basic work-up brings the spontaneous cyclization 
reaction to form 90. This cyclic imine is then involved in an Ugi-Jollié type reaction. Ugi-
Joullié reaction is one more example of MCR which brings to not classical Ugi-products. It 
involves a cyclic imine, an isocyanide and a carboxylic acid (Scheme 29).57 Most examples of 
this reaction regard five membered rings such as pyrrolines and thiazolines. Good 
diastereoselectivity have been obtained only in a few cases. Most of them involves five-
membered imines with a stereogenic center α to the imine carbon.58-60  Only moderate 
diastereoselectivity is achieved with cyclic imines having the stereogenic center α to the 
nitrogen.61,62 
 
Scheme 29. Synthesis of tetrahydrobenzoxazepines 93. 
27 
 
Using seven-membered cyclic imine 90 the multicomponent reaction afforded a good 
diastereoselectivity (up to 90:10 in favor of cis diastereomer). The mechanism depicted in 
Scheme 30 was used to explain this degree of stereoselectivity. Starting cyclic imine 90 is 
expected to prefer a half-chair conformation with the R1 substituent in an equatorial position. 
Attack from the upper face leads to axial ion 94, whereas attack from the lower face leads to 
equatorial ion 95. Here the α-addition requires a prior conformational rearrangement which 
gives twist conformation 96, in order to place the nitrilium ion in an axial position and avoid 
peri interactions. In 94, there is not this problem, because the nitrilium ion is already in an 
axial position, and thus 97 is readily (and irreversibly) formed. Finally, O→N acyl migration 
gives the final cis adduct 93. From an enthalpic point of view, both processes are feasible, but 
the need for a conformational rearrangement makes the route that leads to 93 trans less 
entropically favorable. 
 
Scheme 30. Rationalization of observed diastereoselectivity. 
Having in hand an already optimized procedure including a very diastereoselective 
multicomponent process producing a specie with a tertiary amide that could be converted into 
a secondary amine giving a compound structurally far from classical proline-derived catalysts, 
the described method was chosen as starting point for my purpose. 
Since it is also possible to obtain imines 90 in enantiomerically pure form, but the 
scarce availability of enantiopure amino-alcohols limits the generality, employing Boc-amino 
alcohols deriving from reduction of α-Boc-amino-acids 100 or protection of commercially 
available amino alcohols 101 was preferred (Scheme 31). As introduced in chapter 1, this 
strategy would increase the steric induction of the final potential catalyst producing two 




Scheme 31. Proposed strategy to obtain secondary amines. 
The reduction of Boc-α-amino acids proceeds through the formation of a mixed 
anhydride 103 which is then reduced with NaBH4 in the presence of water (Scheme 32, A). 
Alternatively, the product can be obtained by a simple introduction of the Boc-protecting 
group on the amino alcohol (Scheme 32, B).63  
 
Scheme 32. Synthesis of Boc-amino-alcohols. 
The Boc-amino-alcohol is then involved in a Mitsunobu reaction with the protected 
form of the salicyl aldehyde 12a (Scheme 33), which has to be used as crude product because 
of its instability through chromatographic column. The reaction was immediately noted to be 
critical because of the tendency of 104 to give intramolecular cyclization. The known 
aziridine 10664 (Scheme 33) was indeed detected since the first test with TBAD as 




Scheme 33. Synthesis of Mitsunobu product 16a. 
An optimization of this reaction was thus necessary testing different aza-dicarboxylate 
compounds, such as DEAD and DIAD, but the yield remained unsatisfactory, due to the 
formation of substantial amounts of 106 (entries 2-3, Table 2). This result was not completely 
unexpected, taking into account some literature precedents on Mitsunobu reactions of phenols 
with this type of Boc-amino alcohols, where yields are often low and strongly depend on the 
nature of the starting phenol.65,66 The intramolecular cyclization was mostly suppressed using 
ADDP. 
Table 2. Optimization of Mitsunobu reaction. 
Entry Azodicarboxylate Isolated yield (%) of 
16a (from 14a) 
Isolated yield (%) of 




2 Diethyl azodicarboxylate 
(DEAD) 
45 31 








As described above, the Mitsunobu product can be very easily converted in the cyclic 
imine by acid catalyzed cleavage of Boc group and the acetal. The latter has to be used as 
crude product because of its instability on silica gel. Thus, all presented yields for the 
multicomponent reaction have been calculated on two steps. Cyclic imine 17a was used to 





Scheme 34. Two step-procedure for the synthesis of 20b and 21b. 
Different reaction conditions have been tested, but the best result was obtained in 
MeOH at room temperature for 45h (entry 1, Table 3). 
Table 3. Optimization of Ugi-Joullié reaction. 
Entry Solvent Additive t T (°C) Yield (%)a d.r.b 
1 MeOH none 45 h r.t. 80 96 : 4 
2 CH2Cl2 none 38 h r.t. 74 90.5 : 9.5 
3 CH2Cl2 ZnBr2 (0.5 equiv.) 45 h r.t. 69 94 : 6 
4 CH2Cl2 ZnBr2 (1.0 equiv.) 48 h (incomplete) r.t. 51 89:11 
5 MeOH ZnBr2 (0.5 equiv.) 48 h (incomplete) r.t. 49 96 : 4 
6 CH2Cl2 Zn(OAc)2 (1.2 equiv.)c 48 h (largely 
incomplete) 
r.t. 9 95 : 5 
7 THF none 48 h (incomplete) r.t. 29 88 : 12 
8 THF ZnBr2 (0.5 equiv.) 48 h (incomplete) r.t. 34 95 : 5 
9 THF Zn(OAc)2 (1.2 equiv.)c 48 h (no reaction) r.t. - - 
10 EtOH none 48 h (incomplete) r.t. 62 92 : 8 
aIsolated yield of major diastereomer only. bDetermined by HPLC on the crude product. cZn(OAc)2 
was used instead of AcOH. 
Moreover, the reaction showed a very high diastereoselectivity. The same result was 
obtained for all the reaction that I performed with different substrates (Scheme 35), so it 
demonstrates a high versatility of the reaction from this point of view. These results show also 
the wide range of enantiopure products that can be obtained simply varying the nature of the 
salicyladehyde, the amino alcohol, the carboxylic acid and the isocyanide. Finally, both 
enantiomeric series of tetrahydrobenzoxazepines are accessible, thanks to the easy availability 





Scheme 35. Reaction scope.  
At the beginning of the work, we thought that a truncated Ugi reaction was sufficient to 
get the free amine group. So, I performed the reaction involving the cyclic imine 17a, tert-
butyl isocyanide both with boric acid and zinc bromide, but in both cases I did not get any 
result. One more chance was to get the free amine through a hydrolysis reaction of the tertiary 
amide group. I involved the product 20b in this test under basic conditions with KOH in 
MeOH. I did not get the desired product. What I obtained is an epimerization phenomenon 
giving a d.r. of 32:68. This is not what we expected to get, but it is a very important result. 
From this data we can understand that the major product of the multicomponent reaction is 
the kinetic diastereoisomer and not the thermodynamic one.  
 
Scheme 36. Epimerization reaction. 
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Moreover, the diastereomeric ratio is the same also after 25h. This means that this is the 
value that we find when the equilibrium is established. If the chiral center where the 
epimerization occurs is (1) the cis diastereomer 21b will be formed. If the epimerization 
occurs at the center (2) its enantiomeric form 21b-ent will be produced (Scheme 36). The 
problem is that we are not able to understand which is the real product through a simple 
NMR. Obtaining the two couples of enantiomers, one for each diastereomer, was necessary. 
Two multicomponent reactions were, thus, performed (Scheme 37). 
  
 
Scheme 37. Products of M.C.R. a and b. 
We did not focus our attention on the yield of the reaction b because our interest was 
directed simply in the obtainment of products 20k-ent and 21k-ent to use them as reference 
on chiral HPLC analysis. A preparative TLC on part of the crude was sufficient to get them. I 
involved compound 20k in the epimerization reaction (reaction c, Scheme 38) which 
produced a cis: trans ratio of 68:32 and comparing the analysis on chiral stationary phase of 
the two crudes (reactions a and c) showed that both 20k and 21k were enantiomerically pure 
and different from 20k-ent and 21k-ent. This fact clearly demonstrates that epimerization 
occurs at center (1). 
 
Scheme 38. Epimerization reaction. 
If we obtain a Ugi-Joullié product endowed with an additional nucleophilic group, we 
will be able to look for the best reaction conditions useful to promote an intramolecular 




Scheme 39. Intramolecular cyclization reaction. 
I started from the synthesis of the carboxylic acid 109 (Scheme 40). It is a three step 
procedure67 that begins with the solvolysis of γ-butyrolactone 24 to form the sodium salt 107. 
It is directly involved in the production of disilylate compound 108. This step is quite critical 
due to the volatility of the product. An ice bath for evaporation of solvents under reduced 
pressure is required. Finally, the last step generates the desired acid which can be used as 
crude product since its NMR is quite clean.   
 
Scheme 40. Synthesis of carboxylic acid 109 
It was involved it in the Ugi-Jolullié reaction obtaining product 20q-21q with high 
yields and high diastereoselectivity (Scheme 41).  
 
Scheme 41. Synthesis of the Ugi-Joullié product 20q-21q.  
I isolated the kinetic diastereomer and involved it in the classical conditions in order to 
promote the remotion of the silyl protecting group and the spontaneous intramolecular 
cyclization. I simply obtained the free alcohol group and, despite of the mild basic conditions, 




Scheme 42. Deprotection of the alcohol group. 
By treatment of 20i with camphorsulphonic acid in MeOH the desilylation reaction 
takes place quickly without epimerization at r.t. Then, by raising the temperature to 40 °C the 
intramolecular nucleophilic attack leads to the release of γ-butyrolactone and to the formation 
of the diasteromerically pure 22b (Scheme 43). 
 
Scheme 43. Synthesis of the new potential organo-catalysts. 
The same conditions convert cis alcohol 111i to diastereomerically pure amine 23b. 
Thus, thanks to the TBAF promoted epimerization, it is possible to stereodivergentely convert 
trans 20i into both trans and cis amines 22b and 23b, depending on reaction conditions. Since 
both enantiomers of amino alcohols 104 are available, this means that all four stereoisomers 
of these secondary amines are easily accessible. This fact is quite useful in view of 
investigation of these secondary amines as organocatalysts: we can explore both decoration 
diversity (up to 3 diversity inputs) and stereochemical diversity. It is worth noting that amines 
22b and 23b are completely stable against epimerization under basic conditions (TBAF or 
KOH), indicating that only N-acylated compounds are prone to epimerization. 
The analysis of Ugi-Joullié products 20 is not so easy from the practical point of view 
because they give rotamers and this makes an analysis in DMSO-d6 at high temperature 
necessary. With the products 22 and 23 the analysis is easier. Indeed, using CDCl3 and room 
temperature is sufficient to have a clear spectrum. This is the reason why we waited for 
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obtaining the free amine to do NMR analysis to understand the relative configuration of these 
compounds. Through a NOESY-2D of product 23b I observed the spatial correlation between 
H-5 and H-3, which can be present only in the cis compound. This correlation was not found 
in 22b. We performed the following study using the commercial software ChemBio3D Ultra 
and the MOPAC (PM3) interface to have a conformational analysis of compounds 22b and 
23b and confirm our hypothesis. 
First, we have searched for all the local minima of the parent compound (Figure 4). This 
parent compound gives rise to three conformations with similar energy (Table 4). One of 
them resembles a chair, while the second one resembles a twist and the third one a boat. Thus, 
here we conventionally adopt these three terms. Obviously, each of these three conformations 
exist in two possible enantiomeric forms, which are in equilibrium. A notable difference 
between them is that in the chair and twist conformations the axial hydrogen at C-5 is located 
on the same side of the median plane than C-2 and C-3. On the contrary, in the boat, they are 
opposite. 
 
Figure 4.  Parent compound used for conformational analysis. 
Table 4. Conformational analysis of parent compound. 





When passing to the real compound, the two conformations of each type become 
diastereomeric. Thus, we must consider 6 different conformations for each diastereomer. We 
have searched for the absolute minimum for each of them. According to the heat of formation 
found, the ones evidenced in yellow are more likely. 
From these results, it is clear that in general, as expected, conformations that place H-3 
and/or H-5 in axial position are favored. Obviously, this means that the substituents at C-5 
and/or at C-3 are equatorial. Therefore, the lower energy is obtained for the chair 
conformation of the cis compound, where both hydrogens are axial (entry 2, Table 5). 
In any case, the differences in heat of formation among the best three conformations of 
both isomers is too scarce to allow us to draw conclusion on the preferred one. 
However, from the data in the tables, it is evident that no conformation of trans isomer 
may be able to give a NOE between H-3 and H-5 (Table 6). On the other side, the best three 
Axial hydrogen  
Axial hydrogen  Axial hydrogen  
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conformations of cis compound can give it. We thus think that this is a proof of the 
stereochemical assignment. 
Unfortunately, we are not able to measure precisely both J between H-3 and H-2, 
because one of the diastereotopic H-2 falls very near to H-3 in both isomers. These coupling 
constants could have given an useful information regarding the stereochemical equilibria, 
because, as can be seen from the tables, the dihedral angles are quite different among them. 
Table 5. Conformational analysis of cis 21. 
. 













2 and H-3 
1 Chair -60.49 axial axial 2.31 178, 61 
2 Twist -59.48 axial axial 2.45 91, 29 
3 Boat -59.39 equatorial axial 2.50 153, 32 
4 Chair -57.76 equatorial equatorial 4.09 68, 52 
5 Twist -57.15 equatorial equatorial 4.11 175, 55 
6 Boat is converted to 
other 
conformations 





Table 6. Conformational analysis of trans 20. 













2 and H-3 
1 Chair -60.06 equatorial axial 3.61 67, 53 
2 Chair -59.79 axial equatorial 3.68 174, 65 
3 Twist -59.55 axial equatorial 3.61 149, 28 
4 Twist -58.73 equatorial axial 3.73 97, 24 
5 Boat is converted to 
other 
conformations 
axial axial - - 
6 Boat is converted to 
other 
conformations 
equatorial equatorial - - 
 
On these bases, it can be noted that the kinetic diastereomer of the multicomponent 
reaction is the trans-specie. The diasteroselectivity of the reaction towards this diastereomer 
can be explained considering that imine 17 exists in just two half-chair conformations 
depicted in Figure 5. The one on the left has the methyl substituent in axial position. The 
conformation on the right is more stable by about 0.80 Kcal/mol, according to MOPAC–PM3. 
In both conformations the C=N bond is coplanar to the benzene ring, and the face trans to the 
substituent is less hindered.   
 
Figure 5. Conformations of cyclic imine. 
The less sterically hindered and structurally complex compound 22a was chosen as first 
potential organo-catalyst to be tested. It was prepared following the optimized procedure. The 
Ugi-Joullié reaction (Scheme 44, it has to be performed at to 40 °C in order to be complete 
after 72h) gave product 20a-21a as a mixture of diastereomers not easily separable through 
chromatographic column. Thus, they have been involved together in the final step to obtain 




Scheme 44. Synthetic strategy which was used to obtain a new potential chiral organo-catalyst. 
The first approach to the study of the catalytic activity of 22a regarded the asymmetric 
synthesis of product 114 through Michael reaction between diethylmalonate 112 and the α,β-
unsaturated ketone derived from vanillin, previously protected with TBDMSiCl (113, Scheme 
45). This, in order to use substrates derived from biomasses. 
 
Scheme 45. Michael reaction for catalysis’ tests. 113 and 112 (2.0 eq.) were dissolved in the solvent 
(0.25M), at r.t. and the reaction progress was followed by TLC.  
First, the reaction was performed without any kind of catalyst or additive to verify that 
it cannot occur spontaneously (entry 1, Table 7). The reaction proceeded slowly using 
pyrrolidine (Figure 6) as catalyst, but it produced 114 (entry 2, Table 7) in a sufficient amount 
to be used as reference for the determination of e.e. from chiral-HPLC analysis. The desired 
product was isolated through a preparative TLC on a small amount of the crude product 
without determining the yield of reaction. Et3N was used as reference to compare the time of 
reaction with 22a, involved in a parallel reaction (entry 3-4, Table 7). My compound did not 
show any catalytic activity and, although Et3N was expected to give base catalysis, it simply 
produced 115. The same result was obtained with DBU, which brought the reaction to 
completeness in four days (entry 7, Table 7) and also it was able to suppress the catalytic 
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effect of pyrrolidine when the two species have been combined to favor the deprotonation of 
112 and, thus, the catalytic activity of pyrrolidine (entry 8, Table 7). The absence of catalysis 
with 22a could be explained by a missing formation of the iminium ion which could be 
favored with an acid catalysis (Scheme 16) or base catalysis. The latter should promote the 
deprotonation of malonate and the release of the proton which is necessary for the iminium 
ion formation. Using AcOH (Figure 6) no results were obtained (entry 5, Table 7). When 
adding together 22a and DBU (Figure 6) the reaction produced 115 more slowly (entry 9, 
Table 7). This suggests some interaction between my compound and the base, but it was no 
longer investigated. Both Et3N and pyrrolidine have been investigated as bases when 
combined with 22a. While the first gave again the same result (entry 6, Table 7), increasing 
the amount of pyrrolidine simply favored its catalytic activity, as expected.  
 
Figure 6. Molecules tested as catalysts or additive in Michael reaction. 
Table 7. First approaches to the evaluation of catalytic activity of 22a in Michael reactions. 
Entry Catalyst (20 
mol%) 
Additive t (days) Product 
1 / / 10 / 
2 Pyrrolidine / 10 114 (reaction not complete) 
3 22a / 10 / 
4 Et3N / 10 115 (reaction not complete) 
5 22a AcOH (20 mol%) 1 / 
6 22a Et3N (20 mol%) 1 115 (reaction not complete) 
7 / DBU (1.1 eq.) 4 115 (reaction complete) 
8 Pyrrolidine DBU (1.1 eq.) 4 115 (reaction complete) 
9 22a DBU (1.1 eq.) 4 115 (reaction not complete) 
10 22a Pyrrolidine (1.1 eq.) 4 114 (reaction complete) 


















Du and co-workers reported the use of 116 as catalyst in Michael reactions, supposing a 
participation of the tosyl group in the activation of the malonate (Figure 7).68  
 
Figure 7. Du and co-worker’s catalyst (on the left) and the activation mode of Michael reaction (on 
the right). 
Inspired from this structure, Tosyl methyl isocyanide 117 was involved in the 
multicomponent reaction in order to obtain 20t-21t and convert them in the final product 22c-
23c (Scheme 46). The reaction was performed at 40 °C based on the results obtained for 
similar reactions. Unexpectedly it produced the van Leusen product 118 as major 
compound.69 How the reaction conditions influenced this outcome was no longer investigated.  
 
Scheme 46. Synthetic strategy which was used to obtain the potential chiral organo-catalyst 22c-23c. 
Thus, we decided to test the catalytic activity of 22a in aldol reactions. Cossìo and co-workers 
reported the use of compound 124 and several similar compounds as catalysts for the aldol 
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reaction between benzaldehyde 119 derivatives and cycloexanone 120 (Scheme 47).54 
Through a collaboration between Prof. Cossìo’s group and mine, we have been asked to test 
my compounds in the same reaction.  
 









Figure 8. Molecules tested as catalysts in aldol reaction. 
First, the reaction was performed only with TFA as additive to qualitatively value the rate of 
reaction without any catalyst (entry 1, Table 8). 
Table 8. First approaches to the evaluation of catalytic activity of 22a in aldol reaction. 
Entry Catalyst 
(30 mol%) 
Additive Solvent T (°C) t  Product 
1a / TFA (30 mol 
%) 
neat r.t. 8 
days 
121 and 122  
(reaction not complete) 
2a Pyrrolidine  TFA (30 mol 
%) 
neat r.t. 8 
days 
121and 122 
 (reaction not complete) 
3a 22a TFA (30 mol 
%) 
neat r.t. 8 
days 
/ 
4a 22a TFA (15 mol 
%) 
neat r.t. 8 
days 
/ 
5a 22a AcOH (30 
mol %) 
neat r.t. 8 
days 
/ 
6b Pyrrolidine  TFA (30 mol 
%) 
CH3CN r.t. 7 
days 
123 
 (reaction not complete) 
7b Pyrrolidine  TFA (15 mol 
%) 
CH3CN r.t. 7 
days 
123 
 (reaction not complete) 
8b Pyrrolidine  TFA (46 mol 
%) 
CH3CN r.t. 7 
days 
123 
 (reaction not complete) 
9b Pyrrolidine  TFA (30 mol 
%) 





 (reaction not complete) 
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10 Pyrrolidine  TFA (15 mol 
%) 





 (reaction not complete) 
11b Pyrrolidine  TFA (46 mol 
%) 





 (reaction not complete) 
12c 124 TFA (30 mol 
%) 
neat r.t. 20 h 121 and 122 
(reaction complete) 
13c Pyrrolidine  TFA (30 mol 
%) 
neat r.t. 20 h 121 and 122 
 (reaction not complete) 
14c 22a TFA (30 mol 
%) 




121 and 122 
(reaction not complete) 
15c 22a TFA (15 mol 
%) 
neat 60 °C 3 
days 
121 and 122 
 (reaction not complete) 




121, 122 and 123 
 (reaction not complete) 
aThe reaction was performed in neat 120 with a 120/119 ratio of 60:1. bThe reaction was performed in the 
solvent (0.5 M) with a 120/119 ratio of 2:1. cThe reaction was performed in neat 120 with a 120/119 (freshly 
distilled) ratio of 60:1. All the reactions progress were followed by TLC. 
 It proceeded effectively more slowly than the reaction performed with pyrrolidine 
(entry 2, Table 8), but in both cases the products were observed just in traces through TLC. 
Using 22a no product was observed (entry 3, Table 8), suggesting a protonation of the amine 
group by the acid. The same result was obtained with a lower concentration of TFA and a 
milder acid like AcOH (entry 4-5, Table 8). Thus, other reaction conditions were tested with 
pyrrolidine as catalyst. The reaction resulted to be sensitive to acetonitrile producing 123 as 
major product (entry 6-11, Table 8). It was partly isolated from other side products without 
determining the yield of reaction, since we were only interested to understand the type of 
molecule produced by the reaction. At this point we realized that these preliminary tests gave 
results not easily rationalized because of impurities contained in the reagents, mainly in 
cycloexanone that was used in excess. Thus, I performed the next tests on freshly distilled 
substrates. Reproducing Cossìo and co-workers’ reaction conditions with 124 (Figure 8) in its 
racemic form allowed me to obtain 121 and 122 (entry 12, Table 8). They were partly isolated 
from the other side products, in order to have the two NMR- and HPLC-references. 
Surprisingly pyrrolidine showed a much lower catalytic efficiency, compared with bulkier 
124. On the other hand our amine 22a was able to produce traces of the desired products 
(entry 14, Table 8). I tried to determinate the degree of conversion through an NMR analysis 
of the crude product, using tetrachloro-3-nitrobenzene as internal standard, but the conversion 
was too low to be determined. Proline benzyl-ester 125 (Figure 8) was tested as catalyst to 
compare qualitatively the rate of reaction with pyrrolidine and value the effect of an ester 
group on the catalytic activity. The only difference between the two catalysts regarded the 
obtainment of 123 as additional product, with the use of 125 (entry 16, Table 8). In this case, 
however the catalyst was poorly soluble. 
In conclusion, starting from enantiomerically pure Boc-amino alcohols chiral cyclic 
imines 17 can be obtained. This kind of substrates give rise to a very diastereoselective 
multicomponent reaction. The two diastereomers can be separated through a simple 
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chromatographic column, which is not common for this kind of reactions. More important, we 
showed that multicomponent processes can be involved in an efficient synthetic pathway to 
obtain new potential organo-catalysts, which can be obtained in both the diastereomeric forms 
despite of the high diastereoselectivity of the MCR and are stable against the epimerization 
phenomenon. First approaches to the study on the catalytic activity of secondary amines like 
22a in Michael and aldol reactions did not bring about the desired results. Different additives 
have been used, in order to favor the formation of enamine or iminium ion which were 
necessary for catalysis, but the reactions did not show improvements. More studies are 
necessary to understand the parameters that may favor the desired catalysis. Other reaction 
conditions and structures similar to 22a have to be tested.   
2.4. N- vs O-Glycosylations 
2.4.1 Erasmus+ Mobility for Traineeship 
At the beginning of my third year of Ph.D. I was involved in an Erasmus program that 
allowed me to spend six months at the University of Copenhagen under the supervision of 
prof. Christian Marcus Pedersen. His research is focused on carbohydrates chemistry and 
glycosylation reactions.  
2.4.2 Glycosylation reactions 
Glycosylation reactions are the most famous process in carbohydrate chemistry.18,70-72 
They involve a glycosyl donor (electrophile), which must be activated, and a glycosyl 
acceptor (nucleophile).73 Based on what type of acceptor is involved, different kind of 
glycosyl bond can be formed.74-79 Among them, the O- and N-glycosyl bonds are of particular 
interest and hence received much attention.80-82 O-glycosides are omnipresent with different 
functions and relevance from a biological point of view.73 N-glycosylation is crucial in post-
translational modifications, where monosaccharides are connected to proteins via a glycosyl 
amide bond linkage.81-83 Other biologically active N-glycosides, like N-glycosyl 
sulfonamides, have recently received attention. These can be obtained via an addition of 
sulfamides to acetyl-protected glycals (via Ferrier rearrangement) or from monosaccharides, 
both in the presence of boron trifluoride etherate.84,85 Some of these compounds have been 
found to be carbonic anhydrase (CA) inhibitors.15,85,86 The same biological activity has been 
shown by O-glycosides containing aromatic sulfonamide residues.87-89 A different synthetic 
pathway was developed for this type of compounds. Indeed, a 1,3-dipolar cycloaddition 
reaction was used in order to generate 1,4-disubstituted 1,2,3-triazole glycoconjugate 
sulfonamides from alkyne-substituted sugars and azido aromatic sulfonamides.87,88 Due to the 
importance of these kind of N- and O-glycosides, the development of a single simple method 
able to bring both N- and O-glycosyl bonds is highly important.  
Recently, the research group of prof. Pedersen reported that sulfonamides react with 
trichloroacetimidates (TCAs) in a stereospecific and self-promoted manner forming N-




Scheme 48. Self-promoted N-glycosylations.  
Self-promoted reactions are processes that can be activated by one of the involved 
reagents without using external catalysts or additives.16,17 The work reported by Pedersen is 
not the first example of self-promoted glycosylation. Shmidt et al. reported that in some cases 
carboxylic acids and phosphorous acid derivatives can activate the α-trichloroacetimidates to 
promote a glycosylation with inversion of stereochemistry (Scheme 49).90 This inversion was 
explained by pre-complexation of the TCA donor and acid, leading to a pseudo six-membered 
transition state91 and a concerted mechanism, without the formation of an oxocarbenium 
intermediate. The Miller group even showed that a wide range of carboxylic acids can act as 
catalytic activators of TCA donors and the catalytic efficiency of these catalysts is inversely 
proportional to their pKa-value. Carboxylic acids with higher pKa-values simply resulted in 
self-condensation of the catalyst and TCA donor, thus yielding undesired glycosyl esters. 
 
 




Even the N-glycosylation reported by the Pedersen group proceeds as a self-promoted 
process thanks to acidity of the acceptor that, in this case, is the sulfonamide specie 26. The 
acid character, which was noted in many species used as acceptors (Figure 9) makes the 
sulfonamide functionality able to activate TCA donors with a subsequent nucleophilic attack 
to the glycosyl cation (Scheme 50) i.e. they act as both catalysts and nucleophiles (glycosyl 
acceptors).  
 
Figure 9. Sulfonamides used in previous work. 
The reactions have been found to be highly stereospecific with inversion of 
configuration, which is very useful as TCAs often can be synthesized in a stereoselective 
manner.92 One can thereby determine the N-glycoside stereochemistry already when 
synthesizing the glycosyl donor. In the preceding work, it was also realized that the degree of 
stereospecificity was dependent on the anomeric configuration. Axial TCAs often resulted in 
high equatorial selectivity, whereas using equatorial TCA the same degree of stereoselectivity 
was not always observed. This difference in selectivity, when using the preferred solvent for 
glycosylation (DCM), was explained by two mechanistic pathways. The activation of the 
glycosyl donor can either lead to the formation of an associated or dissociated ion pair. When 
the TCA is axially oriented (Scheme 50), the donor exists as two different conformers, which 
25α.1 has previously been found to be energetically favorable.91 Upon activation an 
associated and a dissociated ion pair can be formed. In the first one the amide ion 29 is in 
close proximity to the glycosyl cation intermediate 28 and should thus react more readily to 
form the β-anomer of the product. On the other side, the nucleophile attack in the dissociated 
ion pair is blocked by the C-2 substituent. Also, the back reaction to form the TCA donor 
could be a competing reaction (orange dotted arrow). This can explain such a high preference 





Scheme 50. Proposed mechanism for self-promoted N-glycosylation reactions using axial TCAs. 
Even using manno-derived donors 1,2-trans-glycosides are obtained (Scheme 51), as 
the associated ion pair is obscured by the axial C-2 substituent. Thus, the dissociated ion pair 
is made the more favorable intermediate leading to the α-anomer of the product. 
 




With activated and substituted equatorial (β)-TCAs the associated ion pair is no more so 
favorable since the C-2 substituent of the pyranose ring will block the trajectory of the 
incoming nucleophile and, thus, a more dissociative reaction path is followed. The 
nucleophilic attack is however sterically hindered by the leaving group 30 (Scheme 52). 
Consequently, this can lead to in situ anomerisation (Scheme 52 in green and red), resulting in 
formation of the α-TCA, with a consecutive loss of stereochemical information from the 
glycosyl donor and hence a mixture of products.15 
 
Scheme 52. Proposed mechanism for self-promoted N-glycosylation reactions using equatorial TCAs. 
Contact and solvent-separated ion pairs are on the borderline between a SN1 and a SN2 
mechanism. Small changes in the reaction condition can therefore shift the balance to either 
site. Important parameters in this aren e.g. the polarity of the solvent and its ability to promote 
a charge separation (Scheme 53).18-20 The dissociative reaction path allows two competing 





Scheme 53. Contact and solvent-system separated ion pairs involved in a continuum glycosylation 
mechanism. 
My work was aimed to better understand the reaction mechanism that involves 
sulfonamides as acceptors and how it is influenced by the reaction conditions. An alcoholic 
function was inserted in the acceptor with this purpose (Scheme 54). The nucleophilic attack 
from this group would be favored only by the formation of dissociated ion pairs. On the other 
side N-glycosylation is favored with a more associative mechanism. Thus, simply valuing the 
N-glycoside: O-glycoside ratio it is possible to understand the favored mechanism involved in 
the reaction. 
 
Scheme 54. N- vs O-glycosylation in self-promoted processes. 
Trichloroacetimidates are one of the most used glycosyl donor types. They are prepared 
under basic conditions, starting from the hemiacetal. Depending on the conditions and the 
stereochemistry of the starting sugar, especially at C-2, mainly the α- or β-anomer can be 
obtained.15,92 My study primary involved the thermodynamically more stable axial TCA (α) as 
this gives raise to the equatorial product in the glycosylation and has a greater stability.  
The perbenzylated glucopyranosyl trichloroacetimidate 25a-α was synthesized as a 
glycosyl donor model and 2-hydroxyethyl tosylcarbamate 26b was used as a glycosyl 
acceptor model (Scheme54).15 This acceptor contains both a primary alcohol and a 
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sulfonamide, but only the latter can activate the TCA. As the reaction is self-promoted only 
the two reactants and solvent are present, hence ruling out effects of metals ions, counterions 
and consequently reduce the complexity significantly. 
Initially, the reactions were performed in DCM as this is the most commonly used 
solvent for glycosylations. Glycosylating 26b gave, as expected, a mixture of O- and N-
glycosides. The N-glycosylation was very selective towards the β-product 27b-β in line with 
earlier work (associative mechanism).15 The O-glycoside 31a on the other hand were found to 
be a 1:1 mixture suggesting a reaction presumably proceeding through a highly reactive 
glycosyl cation (dissociative mechanism). The products 27b-β and 31a have been isolated in 
order to be used as references for the determination of product ratios from crude-NMR. The 
isolated yields (34 % for N-glycoside and 40 % for O-glycoside) were found to be in 
accordance with the ratio obtained from crude NMR. With DCM as a reference point, other 
solvents were then used to study the effects of polarity and solvent properties. Interestingly, a 
change in the chemoselectivity was observed going from the least polar solvent in the study, 
toluene (entry 1, Table 9) to the most polar MeNO2 (entry 4, Table 9). The difference in ratio 
is going from very N-selective to O-selective, but without a change in the anomeric selectivity 
of the O-glycosides, which also seems unaffected when using a participating solvent like 
THF. 
Table 9. Effect of the increasing polarity of the solvent. 
Entry 25a-α [M] 26b [M] Solvent N- vs O-
glycosides 
1a 0.073 0.110 PhMe 87:13 
2 0.073 0.110 DCM 46:54 
3 0.073 0.110 THF 56:44 
4 0.073 0.110 MeNO2 0:100 
The donor and acceptor were dissolved in the solvent at r.t. and the reaction progress was followed by 
TLC. a Performed at 40˚C. The data reported were determined through 1H-NMR of the crude product. 
When increasing the charge separation by using more polar solvents, the hydroxy group 
competes with the amide being the negatively charged counterion. In more polar solvents, the 
reaction is consequently shifted towards the O-glycosylation (dissociative mechanism). In less 
polar solvent like DCM there is less charge separation and the reaction results in both N- and 
O-glycosides. With the reaction on the borderline between mechanistic pathways it was 
expected that the concentration would also influence the reaction outcome. Therefore, the 
change of concentration of the sulfonamide was studied in both toluene and DCM (Table 10).  
Increasing the concentration of the acceptor without changing the concentration of 25a-
α resulted in a decrease in N-selectivity in DCM (Table 10). This change in reaction outcome 
can be explained by a second molecule of 26b attacking the dissociated ion pair resulting in 
more O-glycoside. This also explains why only a small excess of 26b is sufficient to get a 







Table 10. Effect of changing the concentration of sulphonamide 26b. 
Entry 25a-α [M] 26b [M] Solvent N- vs O-
glycosides 
129 (%) 
1a 0.073 0.0146 PhMe 100:0 37 
2a 0.073 0.049 PhMe 85:15 14 
3a 0.073 0.110 PhMe 87:13 / 
4a 0.073 0.367 PhMe 47:53 34 
5 0.073 0.0146 DCM 70:30 30 
6 0.073 0.049 DCM 70:30 / 
7 0.073 0.091 DCM 60:40 / 
8 0.073 0.110 DCM 46:54 / 
9 0.073 0.367 DCM 14:86 19 
The donor and acceptor were dissolved in the solvent at r.t. and the reaction progress was followed by 
TLC. aPerformed at 40˚C. The data reported were determined through 1H-NMR of the crude product. 
A different trend was observed in toluene (entry 3, Table 10). The low polarity of the 
solvent resulted in a decrease of the rate of reaction and therefore the reaction temperature 
was increased to 40 °C in order to be complete within 48 hours. The increase of temperature 
has no effect on the ratio between N- and O-glycosylation. Because of the lower solvent 
polarity, the ion pairs are tighter and the reaction with the alcohol is less competitive. The 
slow conversion of the sulfonamide to its dissociated form combined with the activation 
mode, based on a pre-complexation, ensures the presence of 26b upon activation, with a 
consecutive intermolecular competition from the free alcohol giving the O-glycosylation 
(Scheme 55), even if it is not predominant (entry 2 and 3, Table 10). Sub-stoichiometric 
amounts of the acceptor are therefore required, in order to get a more selective N-
glycosylation as a bimolecular (H-bond complex) reaction is favored and a termolecular 
reaction unlikely (entry 1, Table 10). A rearrangement of α-TCA donor can compete in the 
reaction (Scheme 52), producing the glucosyl trichloroacetamide 25a-α as side product, both 
with high and low concentration of 26b (Table 10). The participation of a second molecule 
26b was also supported by the results obtained when increasing the concentration of the 
reaction both in toluene and DCM, where more of the O-glycoside formed. A different trend 
was found in toluene. Its low polarity makes the rate of dissociation depending on the 
concentration of reaction. Thus, the more the reaction is diluted the more the conversion of 
the acceptor to its dissociated form is underdog. This results in a major concentration of 26b 






Scheme 55. Proposed mechanisms for N- and O-glycosylation. 
Table 11. Effect of changing the concentration of the reaction keeping the ratios constant. 
Entry 25a-α [M] 26b [M] Solvent N- vs O-
glycosides 
1a 0.146 0.220 PhMe 83:17 
2a 0.073 0.110 PhMe 87:13 
3a 0.0146 0.022 PhMe 75:25 
4 0.146 0.220 DCM 27:73 
5 0.073 0.110 DCM 46:54 
6 0.0146 0.022 DCM 56:44 
The donor and acceptor were dissolved in the solvent at r.t. and the reaction progress was 
followed by TLC. aPerformed at 40˚C. The data reported were determined through 1H-
NMR of the crude product. 
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To study the effect of other counterions, in the self-promoted glycosylation, lithium 
salts were added. It has earlier been demonstrated that counterions influences the outcome of 
glycosylations and also that the Lewis acidity of Li+ is enough to activate a TCA.93,94Using 
25a-α, 20 mol% of TfOLi or Tf2NLi and 26b in DCM completely changed the 
chemoselectivity and only the O-glycoside was observed (Table 12). Thus, the salt can 
change the reaction course of the self-promoted chemoselective glycosylation resembling a 
common acid catalyzed O-glycosylation.93 The O-glycoside 31a was obtained as a 1:1 
mixture as the major product suggesting a dissociated mechanism. 
 
Table 12. Effect of adding lithium salts. 
Entry Catalyst Acceptor N- vs O-
glycosides 
1 TfOLi 24 0:100 
2 Tf2NLi 24 0:100 
 
The donor 1 (0.073 M) and acceptor (0.110 M) were dissolved in the solvent at r.t. and the reaction 
progress was followed by TLC. The data reported were determined through 1H-NMR of the crude 
product. 
When performing the same reaction, without sulfonamide present, but with EtOH as the 
glycosyl acceptor, a similar stereoselectivity was obtained, suggesting that the sulfonamide is 
not participating in the activation when lithium salts are present (Table 13). 
Table 13. Effect of adding lithium salts. 
Entry Catalyst Acceptor α : β 
product 
3 TfOLi EtOH 56:44 
4 Tf2NLi EtOH 25:75 
5 / EtOH / 
The donor 23 (0.073 M) and acceptor (0.110 M) were dissolved in the solvent at r.t. and the reaction 
progress was followed by TLC. The data reported were determined through 1H-NMR of the crude 
product. 
As described above, β-TCA donors often give rise to a mixture of anomers. When 
mixing 25a-β and 26b in DCM, a 40:60 mixture of α- and β-N-glycosides was obtained 
confirming that the reaction proceeds through a less associated reaction pathway and therefore 
gives lower selectivity (Scheme 56). Furthermore, it was noticed that the α-N-glycosides 
decomposed on the silica column biasing the product ratio (Table 14). 
 
Scheme 56.  Self-promoted glycosylation using the β-TCA 25a-β and 26b. A mixture of anomers of 
N-glycosides was obtained and the α-N-glycosides was found to be unstable upon purification. 
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The donor 25a-β (0.073 M) and acceptor (0.110 M) were dissolved in the solvent at r.t. and the 
reaction progress was followed by TLC. The data reported were determined through 1H-NMR 
 
Thus, we have demonstrated that the self-promoted N-glycosylation of sulfonamides 
takes place in a concerted manner and presumably through an activated H-bond complex. 
When increasing the amount of the sulfonamide a competing reaction pathway involving 
another molecule of the sulfonamide results in the formation of O-glycosides. The same effect 
can be obtained by adding lithium salts, which acts as both acid and nucleophilic catalysts, 
forming an intermediate glycosyl triflate. Consequently, all stereochemical information is 
lost. As the reaction is on the borderline between mechanisms, solvents influence the outcome 
dramatically. Apolar solvents favors tight ion pair leading to an associative mechanism, i.e. 
SN2-type, whereas polar solvents lead to a dissociative mechanism closer to the SN1 
mechanism. Chemoselectivity and to some extent the stereoselectivity can be controlled by 
tuning the parameters. 
  
Entry N- vs O-
glycosides 








60:40 70:30 3:1 
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3. EXPERIMENTAL PROCEDURES 
3.1 General experimental details 
NMR spectra were taken at the indicated temperature in CDCl3 or DMSO-d6 at 300 MHz 
(1H), and 75 MHz (13C), using, as internal standard, TMS (1H NMR: 0.000 ppm) or the 
central peak of CDCl3 (
13C: 77.02 ppm), or the central peak of DMSO (1H NMR DMSO-d6; 
2.506 ppm), or the central peak of DMSO (13C in DMSO-d6; 39.43 ppm). Chemical shifts are 
reported in ppm (δ scale). Peak assignments were made with the aid of gCOSY and gHSQC 
experiments. HRMS: samples were analysed with a Synapt G2 QToF mass spectrometer. MS 
signals were acquired from 50 to 1200 m/z in ESI positive ionization mode. TLC analyses 
were carried out on silica gel plates and viewed at UV (254 nm) and developed with 
Hanessian stain (dipping into a solution of (NH4)4MoO4•4 H2O (21 g) and Ce(SO4)2•4 H2O (1 
g) in H2SO4 (31 ml) and H2O (469 ml) and warming) or with ninhydrin. Rf were measured 
after an elution of 7-9 cm. Column chromatographies were done with the "flash" methodology 
using 220-400 mesh silica. Petroleum ether (40-60 °C) is abbreviated as PE. In extractive 
work-up, aqueous solutions were always reextracted three times with the appropriate organic 
solvent. Organic extracts were always dried over Na2SO4 and filtered, before evaporation of 
the solvent under reduced pressure. All reactions using dry solvents were carried out under a 
nitrogen atmosphere. 





A solution of Ugi adduct 53b (2.0622 g, 5.95 mmol) in dry CH2Cl2 (60 mL) was cooled to – 
15 °C, and treated with triethylamine.(1.82 mL, 13.1 mmol) and with methanesulfonyl 
chloride (552 μL, 7.14 mmol). After 2h Et3N (0.5 mL, 3.57mmol) and MsCl (0.14 mL, 1.7 
mmol) were added. After 1h the reaction was complete by TLC. The mixture was poured into 
a 3:1 mixture of saturated aqueous NH4Cl and 5 % aqueous (NH4)2PO4, and extracted with 
AcOEt (pH of aqueous phase = 4). After evaporation to dryness, the crude mesylate was taken 
up in dry DMF (2.5 mL), and treated with NaH (60 % in mineral oil, 358.9 mg, 5.95 mmol). 
The solution was stirred at 50 °C overnight. Then it was poured into saturated NH4Cl and 
extracted with AcOEt. Evaporation and chromatography (AcOET to AcOEt/MeOH, 95:5) 
gave pure 67c (1.3824 g, 71 %). Oil. Rf = 0.24 (AcOEt). 
1H NMR (300 MHz, CDCl3, 25 °C) δ  
7.13 (d, J= 8.6 Hz, H meta to OAll, 2 H) 6.86 (d, J= 8.6 Hz, H ortho to OAll, 2H), 6.05 (ddt, 
J= 5.3, 10.5, 17.2 Hz, CH=CH2, 1H), 5.41 (dq, J= 1.6, J= 17.2 Hz, CH=CHH, 1H), 5.28 (dq, 
J= 1.4, 10.5 Hz, CH=CHH, 1 H), 4.56 and 4.48 (AB syst, J= 14.4 Hz, ArCH2, 2H), 4.52 (dt, 
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J= 1.5, 5.3 Hz, CH2CH=CH2, 2H) 4.16 (dt, J= 6.8, 13.8 Hz, H-5, 1H), 3.32 and 3.23 [ABXY 
syst, J= 14.7, 6.4 (ax), 9.5 (bx), 2.4 (ay = by) Hz, H-3, 2H), 2.97–2.77 (m, 2 H, H-5 and H-9), 
2.39 (dd, J= 6.7, 8.7 Hz, H-8, 2H); 2.00–1.63 (m, H-9 and H-4, 3H), 1.59 (s, CH3, 3H) ppm. 
13C NMR (75 MHz, CDCl3, 25 °C)δ  174.7, 174.2 (C=O), 158.1, 129.4 (quat,), 133.1 
(CH=CH2), 129.2 (C meta to OAll), 117.7 (CH=CH2), 114.9 (C ortho to OAll), 68.8 (CCH3), 
67.6 (C-9a), 52.9 (N-CH2Ar), 46.1 (C-3), 36.6 (C-5), 33.7 (C-9) 29.6 (C-8), 26.9 (C-4), 23.3 
(CH3) ppm. GC–MS: Rt 11.08 min. M/z: 328 (M+. 10.6), 287 (5.7), 181 (100.0), 162 (6.4), 
147 (62.9), 138 (10.3), 124 (12.1), 111 (16.7), 110 (12.7), 107 (9.9), 98 (17.8), 82 (8.4), 78 
(5.7), 56 (42.3), 55 (23.2), 42 (17.3), 41 (65.2). HRMS (ESI+) m/z [M + H +]: Calcd. For 
C19H25N2O3 329.1865, found 329.1862. 





A solution of N-(4-allyloxyphenyl) formamide (417.8 mg, 2.36 mmol) in dry CH2Cl2 (3.5 
mL) was cooled to 0 °C, and treated with Burgess reagent 
[(Methoxycarbonylsulfamoyl)triethylammonium hydroxide, inner salt] (674.8 mg, 2.83 
mmol). After stirring for 3h at 0 °C, the crude isocyanide (as CH2Cl2) solution was treated 
with the premixed levulinic acid (210 μL, 2.05 mmol) and propanolamine (150 μL, 1.97 
mmol) in dry MeOH mixture (8.1 mL) with 3Å powdered molecular sieves (100 mg). The 
mixture was stirred at room temperature for 4 days. Then it was diluted with CH2Cl2, filtered 
and the solvents evaporated to dryness. It was taken up in AcOEt/MeOH, 95:5 and washed 
with saturated aqueous NaHCO3. The organic phases gave, upon evaporation, and 
chromatography (AcOEt: DCM 1: 1 + 10% of EtOH), the Ugi product 53c (318 mg, 50 % 
from formamide). Rf = 0.3 (AcOEt: DCM 1: 1 + 10% of EtOH). 
1H NMR (300 MHz, 
Chloroform-d) δ 8.40 (bs, NH), 7.51-7.45 (m, Ar, 2H), 6.90-6.84 (m, Ar, 2H), 6.10-5.97 (m, 
OCH2CH, 1H), 5.40 (dq, J= 17.3, 1.61 Hz, CH=CHH, 1H), 5.28 (dq, J= 10.5, 1.39 Hz, 
CH=CHH, 1H), 4.51 (dt, J= 5.28, 1.53 Hz, OCH2CH, 2H), 3.73-3.65 (m, NCH2, 2H), 3.55-
3.50 (m, HOCH2, 2H), 2.57-2.41 (m, CH2C=O, CHHCH2C=O, 3H), 2.09-1.65 (m, 
CHHCH2C=O, HOCH2CH2, 3H), 1.63 (s, CCH3, 3H).
 13C NMR (75 MHz, CDCl3, 25°C) δ 
177.8, 171.6 (C=O), 133.1, 130.6 (quat.), 121.9 (aromatic CH), 117.7 (OCH2CH), 115.0 
(aromatic CH), 69.0 (OCH2CH), 68.3 (CCH3), 60.2 (NCH2), 38.8 (HOCH2), 33.7 
(CHHCH2C=O), 30.6 (HOCH2CH2), 29.7 (CH2C=O), 22.7 (CCH3). This intermediate (112.0 
mg, 0.339 mmol) was taken up in dry DMF (1 mL) and treated with sulfonyl diimidazole 
(SDI) (102.4 mg, 517 µmol), and NaH (60 % suspension in mineral oil) (21.8 mg, 545 µmol). 
The mixture was stirred for overnight at 50°C. Then tris(hydroxymethyl)aminomethane 
(TRIS) (31.2 mg, 258 µmol) was added, followed by a spatula tip of NaH. After 1h, the 
mixture was poured into a mixture of (NH4)H2PO4 5 %: NH4Cl sat. 1:1 and extracted with 
AcOEt: Et2O 1: 1. The organic phases were washed with LiCl 5% and Brine. 
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Chromatography gave pure 67d as an oil (78.9 mg, 74 %). Rf: 0.37 (AcOEt/MeOH, 99:1). 
1H 
NMR (300 MHz, CDCl3, 25 °C) δ  7.01 (d, J= 8.8 Hz, H meta to OAll, 2H), 6.90 (d, J= 8.8 
Hz, H ortho to OAll, 2H), 6.03 (ddt, J= 5.0, 10.5, 17.2 Hz, CH=CH2, 1H), 5.40 (dq, J= 1.5, 
17.3 Hz, CH=CHH, 1H), 5.28 (dq, J= 1.4, 10.5 Hz, CH=CHH, 1H), 4.52 (dt, J= 1.5, J= 5.2Hz, 
CH2CH=CH2, 2H), 4.31 (dt, J= 6.4, 13.9 Hz, H-5, 1H), 3.74 and 3.65 (ABXY syst, 
2J= 14.8, 
3J= 6.6 (ax), 8.7 (bx), 3.0 (ay = by)Hz, H-3, 2H), 3.07 (dt, J= 6.7, J= 13.8 Hz, H-5, 1H), 2.88 
(ddd, J= 5.1, 7.7, 12.8 Hz, H-9, 1H), 2.55–2.35 (m, H-8, 2H), 2.18–1.93 (m, H-4, 2H), 1.92 
(dt, J= 9.0, J= 12.8 Hz, H-9, 1 H), 1.65 (s, CH3, 3 H,) ppm. 
13C NMR (75 MHz, CDCl3, 25 
°C) δ  174.8, 174.4 (C=O), 157.2, 138.9 (quat,), 133.0 (CH=CH2), 127.3 (C meta to OAll), 
117.7 (CH=CH2), 115.4 (C ortho to OAll), 69.0 (CCH3), 67.6 (C-9a), 50.9 (C-3), 36.9 (C-5), 
33.7 (C-9) 29.6 (C-8), 27.5 (C-4), 23.1 (CH3) ppm. HRMS (ESI
+) m/z [M + H +]: Calcd. For 
C18H23N2O3 315.1709, found 315.1715. 
 





Levulinic acid 1 (324 μL, 3.17 mmol) was dissolved in dry MeOH(17.6 mL), and treated with 
3 Å powdered molecular sieves (143 mg), and (R)-3-ammino-1-buthanol (248 μL, 2.64 mmol) 
was added. After 30 min., isocyanide 131 (854.7 mg, 3.43 mmol) was added, and the mixture 
stirred for 5 days at room temperature. Then it was diluted with CH2Cl2, filtered and the 
solvents evaporated to dryness. It was taken up in AcOEt/MeOH, 95:5 and washed with 
saturated aqueous NaHCO3. The organic phases gave, upon evaporation, and chromatography 
(AcOEt: DCM: MeOH 95: 95: 10) the pure Ugi adduct as a brown oil (347.5 mg, 37%). 
Separation of the two diastereomers was not complete. The diastereomeric ratio, determined 
by 1H NMR on the crude, was 50:50.  Upper: Rf = 0.50 (AcOEt: DCM: MeOH 95: 95: 10). 
1H NMR (300 MHz, Chloroform-d) δ 7.21-7.17 (m, Ar, 2H), 7.11 (bs, NH), 6.89-6.84 (m, Ar, 
2H), 6.04 (ddt, J= 17.2, 10.5, 5.28 Hz, OCH2CH, 1H), 5.40 (dq, J= 17.3, 1.34 Hz, CH=CHH, 
1H), 5.29 (dq, J= 10.4, 1.11 Hz, CH=CHH, 1H),  4.52 (dt, J= 5.27, 1.31 Hz, OCH2CH, 2H), 
4.42- 4.30 (m, NHCH2, 2H), 3.70-3.55 (m, NCH, HOCHH, 2H), 3.50-3.42 (m, HOCHH, 1H), 
2.77-2.75 (m, OH, 1H), 2.50-2.22 (m, CH2C=O, NCHCHH, CHHCH2C=O, 4H), 1.97-1.76 
(m, NCHCHH, CHHCH2C=O, 2H), 1.59 (s, CCH3, 3H), 1.30 (d, J= 6.80 Hz, CHCH3, 3H). 
13C NMR (75 MHz, CDCl3, 25°C) δ 177.1, 173.7 (C=O), 133.1, 130.3 (quat.), 129.3 
(aromatic CH), 117.7 (OCH2CH), 114.9 (aromatic CH), 68.8 (OCH2CH), 68.5 (CCH3), 59.7 
(HOCH2), 48.4 (NCH), 43.3 (NHCH2), 37.6 (NCHCH2), 33.8 (CH2CH2C=O), 30.2 
(CH2C=O), 23.6 (CCH3), 19.1 (CHCH3). Lower: Rf = 0.43 (AcOEt: DCM: MeOH 95: 95: 
10). 1H NMR (300 MHz, Chloroform-d) δ 7.18-7.13 (m, Ar, 2H), 6.87-6.82 (m, Ar, 2H), 6.40 
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(bs, NH), 6.02 (ddt, J= 17.2, 10.5, 5.27 Hz, OCH2CH, 1H), 5.39 (dq, J= 17.3, 1.55 Hz, 
CH=CHH, 1H), 5.27 (dq, J= 10.5, 1.32 Hz, CH=CHH, 1H),  4.50 (dt, J= 5.26, 1.46 Hz, 
OCH2CH, 2H), 4.35 (d, J= 5.60 Hz, NHCH2, 2H), 3.64-3.92 (m, NCH, HOCH2, 3H), 2.49-
2.19 (m, CH2C=O, NCHCHH, 3H), 2.08-1.84 (m, NCHCHH, HOCH2, 3H), 1.54 (s, CCH3, 
3H), 1.34 (d, J= 6.87 Hz, CHCH3, 3H).
 13C NMR (75 MHz, CDCl3, 25°C) δ 176.2, 177.3 
(C=O), 133.1, 129.9 (quat.), 129.2 (aromatic CH), 117.7 (OCH2CH), 115.0 (aromatic CH), 
68.8 (OCH2CH), 68.5 (CCH3), 59.5 (HOCH2), 47.7 (NCH), 43.5 (NHCH2), 37.0 (NCHCH2), 
33.2 (CH2CH2C=O), 30.3 (CH2C=O), 22.9 (CCH3), 17.7 (CHCH3). The two diastereomers 
were cyclized independently. Upper and lower refers to the TLC behavior of intermediate 
Ugi adducts, since, after cyclization, they had the same Rf. 
Upper (Method A): The Ugi adduct was taken up in dry DMF (1 mL) and treated with 
sulfonyl diimidazole (SDI) (132.5 mg, 668 µmol), and NaH (60 % suspension in mineral oil) 
(28.8 mg, 720 µmol). The mixture was stirred for overnight at 50°C. Then 
tris(hydroxymethyl)aminomethane (TRIS) (33.2 mg, 274 µmol) was added, followed by a 
spatula tip of NaH. After 1h, the mixture was poured into a mixture of (NH4)H2PO4 5 %: 
NH4Cl sat. 1:1 and extracted with AcOEt: Et2O 1: 1. The organic phases were washed with 
LiCl 5% and Brine. Chromatography (AcOEt) gave pure 67e as an oil (68.2 mg, 45 %). [α]D = 
–12.6 (c = 1, CHCl3). 
1H NMR (300 MHz CDCl3, 25 °C) δ 7.17 (d, J = 8.7 Hz, H meta to 
OAll, 2H,), 6.87 (d, J = 8.7 Hz, H ortho to OAll, 2H), 6.05 (ddt, J = 10.5, 17.2, 5.3 Hz, 
CH=CH2, 1H), 5.41 (dq, J = 1.6, 17.2 Hz, CH=CHH, 1 H), 5.29 (dq, J= 1.4, 10.5 Hz, 
CH=CHH, 1 H), 4.56 and 4.47 (AB syst, J= 14.3 Hz, ArCH2, 2 H), 4.52 (dt, J = 1.5, 5.4 Hz, 
CH2CH= CH2, 2H), 3.44 (ddd, J= 4.4, 12.4, 15.1 Hz, H-3, 1H), 3.26 (dquint, J= 6.7, 11.4 Hz, 
H-5, 1H), 3.14 (ddd, J= 1.2, 5.1, 5.1 Hz, H-3, 1H), 2.68–2.51 (m, H-9, 1H), 2.36–2.22 (m, 2 
H, H-8); 2.19–2.07 (m, H-9, 1H), 1.91 (1 H, dddd, J= 1.5, 4.5, 11.7, J= 13.2 Hz, 1 H, H-4); 
1.67–1.53 (m, H-4, 1H), 1.60 (d, J= 6.9 Hz, CH3CH, 3H), 1.59 (s, CH3C, 3H) ppm. 
13C NMR 
(75 MHz CDCl3, 25 °C) δ  174.9, 173.7 (C=O), 158.1, 129.7 (quat,), 133.1 (CH=CH2), 129.3 
(C meta to OAll), 117.7 (CH=CH2), 114.9 (C ortho to OAll), 69.3(CCH3), 68.8 (C-9a), 52.2 
(N-CH2Ar), 48.5 (C-5), 45.3 (C-3), 31.7 (C-9) 31.6 (C-4), 30.6 (C-8), 24.4 (C-CH3), 17.4 
(CHCH3) ppm. HRMS (ESI
+) m/z [M + H +]: Calcd. For C20H27N2O3 342.2022, found 
343.2019. 
Lower: It was prepared in 53% yield from the lower diastereomer of Ugi adduct following 
method A. [α]D = +136.2 (c = 1, CHCl3). 
1H NMR (300 MHz CDCl3, 25 °C) δ  7.13 (d, J= 8.6 
Hz, H meta to OAll, 2H), 6.86 (d, J= 8.6 Hz, 2H, H ortho to OAll) 6.05 (ddt, J= 10.5, 17.2, 
5.3 Hz, CH=CH2, 1 H), 5.41 (dq, J= 1.6, 17.3 Hz, CH=CHH, 1 H), 5.29 (dq, J= 1.5,10.5 Hz, 
CH=CHH, 1 H), 4.62 and 4.41 (AB syst, J= 14.4 Hz, ArCH2, 2H), 4.52 (dt, J= 1.5, 5.3 Hz, 
CH2CH=CH2, 2 H), 4.50–4.35 (m, H-5, 1H), 3.30–3.12 (m, H-3, 2H), 2.79 (ddd, J= 8.2, 4.7, 
12.9 Hz, H-9, 1H), 2.45–2.25 (m, H-8, 2H); 2.16–1.72 (m, H-9, H-4, 3H), 1.71 (s, CH3C, 3H), 
1.26 (d, J= 6.9 Hz, CH3CH, 3H) ppm. 
13C NMR (75 MHz CDCl3, 25 °C) δ  175.6, 174.8 
(C=O), 158.1, 129.3 (quat,), 133.2 (CH=CH2), 129.2 (C meta to OAll), 117.7 (CH=CH2), 
114.9 (C ortho to OAll), 68.8 (CCH3), 68.6 (C-9a), 53.0 (N-CH2Ar), 47.6 (C-5), 46.6 (C-3), 
35.6 (C-9) 34.0 (C-4), 29.4 (C-8), 28.0 (C-CH3), 20.5 (CHCH3) ppm. HRMS (ESI
+) m/z [M + 
















A 0.4 M solution of LDA was prepared at –20 °C by adding nBuLi (1.6 M in hexanes, 5.0 
mL, 8.0 mmol) to a solution of diisopropylamine (1.24 mL, 8.8 mmol) in dry THF (12.3 mL) 
containing few crystals of 2,2′-bipyridyl and stirring for 20 min. Part of this deep red solution 
(3.10 mL corresponding to 1.24 mmol) was transferred via syringe into another flask, again 
cooled to –20 °C. To this flask, a solution of compound 55d (257 mg, 818 μmol) dissolved in 
dry THF (2 mL + 0.5 mL + 0.5 mL for washing) was added. After 20 min (the solution lose 
its deep red color) the flask was cooled to –78°C, and methyl iodide(77μL,1.24mmol) was 
added. The temperature was allowed to rise slowly to –30 °C during 3 h. Then the reaction 
was quenched with saturated aqueous NH4Cl and extracted with AcOEt. Evaporation and 
chromatography (CH2Cl2/AcOEt, 1:1 + 1.5 % MeOH) gave pure 55l as a foam (180 mg, 67 
%). Also 40 mg of starting 55d were recovered. Thus, the yield from unrecovered substrate 
was 79 %. Rf = 0.56 (CH2Cl2/ AcOEt, 1:1 + 5 % MeOH). 
1H NMR (300 MHz, CDCl3, 25 °C) 
(note: two diastereomers, in a 91:9 ratio are detected). The diastereomeric ratio was calculated 
by integration of the CH3CH signals (minor diast. resonates at 1.27. Here, only the signals of 
major diastereomer are reported) δ  7.30–7.15 (m, H meta to Oallyl, 2H), 6.93 (dt, J= 0.9, 7.5 
Hz, H para to Oallyl, 1H), 6.87 (d, J= 8.2 Hz, H ortho to Oallyl, 1H), 6.04 (ddt, J= 10.4, 17.2, 
5.1 Hz, CH=CH2, 1 H), 5.40 (dq, J= 1.6, J= 17.3 Hz, CH=CHH, 1H), 5.28 (dq, J= 1.4, 10.5 
Hz, CH=CHH, 1 H), 4.73 and 4.60 (AB syst, J= 14.7 Hz, CH2Ar, 2H), 4.55 (dt, J= 1.5, J= 5.1 
Hz, CH2CH=, 2H], 4.09 (ddd, J= 1.4, 5.0, 13.4 Hz, H-4, 1H), 3.38 (dt, = 5.0, 11.7, 1.7 Hz, H-
3, 1H), 3.28–3.08 (m, H-3 and H-4, 2H), 2.69–2.52 (m, H-7, 1H), 2.44 (dd, J= 8.1, J= 12.9 
Hz, H-8, 1H), 1.82 (dd, J= 11.0, 12.9 Hz, H-8, 1H), 1.51 (s, CH3, 3H), 1.19 (d, J= 7.0 Hz, 
CH3CH, 3H) ppm. 
13C NMR (75 MHz, CDCl3, 25 °C) δ  174.7, 171.5 (C=O), 156.6, 124.6 
(quat,), 133.0 (CH=CH2), 129.7, 128.9 (C meta to Oallyl), 121.0 (C para to Oallyl), 117.5 
(CH=CH2), 111.6 (C ortho to Oallyl), 68.8 (OCH2), 60.5 (C-8a), 46.2 (C-3); 44.8 (CH2Ar), 
40.1 (C-8), 35.1 (C-7), 33.8 (C-4), 22.7 (CH3C), 15.3 ( CH3CH) ppm. HRMS (ESI
+) m/z [M + 











3.3 Synthesis of tertiary amines 
Synthesis of 1-(allyloxy)-4-isocyanobenzene (130) 
 
N-(4-(allyloxy)phenyl)formamide 133 (452.0 mg, 2.55 mmol) and Et3N (1.6 mL, 11.5 mmol) 
were dissolved in dry DCM (25 mL) and the solution was cooled at -30°C. POCl3 (0.350 mL, 
3.75 mmol) was dropped into the solution and the reaction mixture was stirred for 1.5 h. It 
was diluted with Et2O, washed with NaHCO3 and the solvent was removed under reduced 
pressure. The crude product was purified through chromatographic column and the desired 
product was obtained as a green oil (192.0 mg, 48%). 1H-NMR was in accordance with data 
reported in literature.48 
Synthesis of N-(tert-butyl)-2-(2-((phenylthio)methyl)pyrrolidin-1-yl)hexanamide (70a) 
 
Pentanal 79 (130 µL, 2.06 mmol), L-prolinol 6 (200 µL, 2.06 mmol) were added in dry 
MeOH (2 mL) and the reaction was stirred for 2h at room temperature. Then tButyl-
isocyanide 80 (280 µL, 2.47 mmol) and thiophenol 69 (250 µL, 2.44 mmol) were added and 
the reaction mixture was stirred at 100 °C overnight. The solvent was removed under reduced 
pressure and the crude product was purified through chromatographic column to afford the 
desired product as a yellow solid (363.0 mg, 1.00 mmol, 50%). Rf = 0.38 (PE: AcOEt 5:1 and 
1% EtOH). [α]D = -44.1 (c = 0.9, CHCl3). m.p. = 44.3-46.3 °C. 
1H NMR (300 MHz, 
Chloroform-d) δ 7.35-7.23 (m, Ar, 4H), 7.19-7.13 (m, Ar, 1H), 6.24 (s, NH, 1H), 3.20-3.12 
(m, NCHCH2, 1H), 3.08-2.94 (m, SCH2, NCH2, COCH, 3H), 2.86-2.71 (m, SCH2, NCH2, 
2H), 2.20-1.90 (m, NCHCH2, 1H), 1.83-1.69 (m, NCHCH2, NCH2CH2, 3H), 1.68-1.50 (m, 
COCHCH2, 2H), 1.34-1.24 (m, COCHCH2CH2CH2, COCHCH2CH2CH2, 
tButyl, 13H), 0.89-
0.84 (m, CH3, 3H). 
13C NMR (75 MHz, Chloroform-d) δ 172.7 (C=O), 136.7 (quat.) 129.1, 
128.9, 125.9 (aromatic CH), 67.0 (COCH), 58.3 (NCHCH2), 51.9 (NCH2), 39.8 (SCH2), 31.0 
(COCHCH2CH2), 30.9 (NCHCH2), 28.8 (COCHCH2CH2CH2), 28.7 (
tButyl), 23.3 
(NCH2CH2), 22.8 (COCHCH2CH2CH2), 14.0 (CH3). I.R. (ATR): νmax: 3269, 3074, 2965, 
2924, 2869, 2825, 1649, 1551, 1455, 1390, 1359, 1303, 1263, 1229, 1136, 1096, 1024, 908, 






Molecular sieves (206 mg) were added to a solution of m-methoxy-benzaldehyde 81 (0.156 
mL, 1.28 mmol) and L-prolinol 6 (0.130 mL, 1.34 mmol) in dry DCM (13 mL).  The 
reaction mixture was stirred at r.t. overnight. It was filtered and the solvent was removed to 
obtain the crude product (293.8 mg) as a red oil. This crude product (236.3 mg, theoretical 
1.07 mmol) was then dissolved in dry MeOH (1.1 mL) and tButyl isocyanide 80 and 
thiophenol 69 were then added. The reaction mixture was stirred at 100 °C overnight. After 
filtration, it was diluted in AcOEt, washed with a mixture of Na2CO3: Brine 1:1 and the 
solvent was removed under reduced pressure. The crude product was purified through 
chromatographic column (PE:AcOEt 6:1 up to 4:1 and 1% of EtOH) to obtain the desired 
product (yellow oil, 285.2 mg, 63%) as a mixture of diastereoisomers. The d.r. was = 90:10 
by HPLC of the obtained fractions. Conditions: column Gemini C6-Phenyl 150x3 mm, 3µ. 
Flow: 0.34 ml/min. Temp = 30°C. Eluent: H2O + 0.1% HCOOH: MeOH + 0.1% HCOOH 
90:10 up to 20 min. Then MeOH + 0.1% HCOOH 100%. Rf = 0.30 (PE: AcOEt 3:1). [α]D 
= -19.2 (c = 1.1, CHCl3). 
1H NMR (300 MHz, Chloroform-d) δ 7.24-7.05 (m, Ar diast. 
A+B, 5H), 6.98-6.93 (m, Ar diast. A+B, 3H), 6.86-6.83 (m, Ar diast. A+B, 1H), 4.22 (s, 
COCH diast. B, 1H), 3.93 (s, COCH diast. A, 1H), 3.77 (s, OCH3 diast. B, 3H), 3.76 (s, 
OCH3 diast. A, 3H), 3.16-3.02 (m, NCHCH2, SCHH diast. A+B, 2H), 2.81 (dd, NCHH 
diast. A+B, J= 12.7, 4.03 Hz, 1H), 2.69-2.61 (m, SCHH diast. A+B, 1H), 2.50 (dd, SCHH 
diast. A+B, J= 12.7, 8.56 Hz, 1H), 1.98-1.72 (m, NCHCH2, NCH2CH2 diast. A+B, 4H), 
1.38 (s, tButyl diast. A, 9H), 1.3 (s, tButyl diast. B, 9H). 13C NMR (75 MHz, Chloroform-
d) δ 170.9 (C=O diast. A), 159.6, 139.1, 136.7 (quat. diast. A), 129.5, 129.0, 128.7, 128.2, 
125.4, 121.4, 114.4, 114.1 (aromatic CH diast. A), 75.1 (COCH diast. A), 69.9 (COCH 
diast. B), 59.0 (NCH diast. A), 55.1 (CH3 diast. A), 54.8 (SCH2 diast. A), 39.5 (NCH2 
diast. A), 30.4 (NCHCH2 diast. A), 28.8 (
tButyl diast. A), 23.6 (NCHCH2CH2 diast. A). 
I.R. (ATR): νmax: 3323, 3058, 2963, 3871, 2835, 1662, 1584, 1511, 1481, 1452, 1437, 









oxoethyl)pyrrolidin-2-yl)methyl acetate (72a) 
 
Molecular sieves (159 mg) were added to a solution of m-methoxy-benzaldehyde 81 (0.120 
mL, 0.987 mmol) and L-prolinol 6 (0.100 mL, 1.03 mmol) in dry DCM (10 mL). The reaction 
mixture was stirred at r.t. overnight. It was filtered and the solvent was removed to obtain the 
crude product (226 mg, theoretical 0.987 mmol) as a red oil. It was dissolved in dry MeCN 
(2.5 mL) and 1-(benzyloxy)-4-(2-isocyanoethyl)benzene 77 (281.0 mg, 1.2 mmol), acetic acid 
83 (68.0 µL, 1.21 mmol), p-toluensulphonic acid (19.6 mg, 0.103 mmol) and molecular sieves 
(30 mg) were added. The reaction mixture was stirred under reflux overnight. After filtration, 
it was diluted in AcOEt, washed with NaHCO3 and Brine and the solvent was removed under 
reduced pressure. The crude product was purified through chromatographic column (PE: 
AcOEt 2:1 and 1% of EtOH) to obtain the desired product (yellow oil, 281.4 mg, 55%) as a 
mixture of diastereoisomers (d.r. = 91:9, determined through 1H-NMR of the obtained 
fractions). The d.r. was = 87:13 by HPLC of the crude product. Conditions: column Gemini 
C6-Phenyl 150x3 mm, 3µ. Flow: 0.34 ml/min. Temp = 30°C. Eluent: H2O + 0.1% HCOOH: 
MeOH + 0.1% HCOOH 70:30 up to 30 min. Then MeOH + 0.1% HCOOH 100%. Rf = 0.20 
(PE: AcOEt 2:1). [α]D = +24.7 (c = 1.1, CHCl3). 
1H NMR (300 MHz, Chloroform-d) δ 7.46-
7.30 (m, Ar diast. A+B, 5H), 7.23-7.18 (m, Ar diast. A+B, 1H), 7.11-7.08 (m, Ar diast. A+B, 
2H), 7.00-6.97 (t, J= 5.57 Hz, NH, 1H), 6.92-6.80 (m, Ar diast. A+B, 5H), 5.05 (s, PhCH2O 
diast. A, 2H), 4.41 (s, COCH diast. B), 1H), 4.08 (s, COCH diast. A, 1H), 3.78 (s, OCH3 diast. 
B, 3H), 3.77 (s, OCH3 diast. A, 3H), 3.69 (m, CHCH2O diast. A+B, 2H), 3.57-3.50 (m, 
NHCH2 diast. A+B, 2H), 3.03-2.97 (m, NCH diast. A+B, 1H), 2.91-2.83 (m, NCHH diast. 
A+B, 1H), 2.79 (t, J= 6.92 Hz, NHCH2CH2 diast. A+B, 2H), 2.63-2.55 (m, NCHH diast. 
A+B, 1H), 1.98 (s, COCH3 diast. A+B, 3H), 1.88-1.50 (m, NCHCH2, NCH2CH2 diast. A+B, 
4H). 13C NMR (75 MHz, Chloroform-d) δ 171.5, 170.9 (C=O), 159.6, 157.5, 139.0, 137.0, 
131.1 (quat.), 129.7, 129.5, 128.6, 127.9, 127.4, 121.1, 114.9, 114.8, 113.5 (aromatic CH), 
73.8 (COCH), 70.0 (PhCH2O), 66.6 (CHCH2O), 58.4 (NCH), 55.2 (OCH3), 53.7 (NCH), 40.3 
(NHCH2), 34.7 (NHCH2CH2), 28.0 (NCHCH2), 23.5 (NCHCH2CH2), 20.9 (COCH3). I.R. 













yl)methyl acetate 72a (168.7 mg, 0.326 mmol) was dissolved in MeOH (0.63 mL) and a 
solution of KOH in MeOH 1M (0.656 mL, 0.656 mmol) was added. The reaction mixture was 
stirred for 40 min. It was diluted with AcOEt and washed with a mixture of NH4Cl sat.: 
NaHCO3 sat.: NaCl sat. 10:5:40. After checking pH = 8 the solvent was removed under 
reduced pressure. The crude product was purified through chromatographic column (AcOEt: 
DCM 1:1 and 5% of MeOH) to obtain the desired product (yellow oil, 118 mg, 76%) as a 
mixture of diastereoisomers (d.r. = 89:11, determined through 1H-NMR of the obtained 
fractions). Rf = 0.3 (AcOEt: DCM 1:1 and 5% of MeOH). 
1H NMR (300 MHz, Chloroform-
d) δ 7.45-7.29 (m, Ar diast. A+B, 5H), 7.26-7.18 (m, Ar diast. A+B, 1H), 7.08-7.01 (m, Ar 
diast. A+B, 2H), 6.92-6.80 (m, Ar diast. A+B, 5H), 6.69 (t, J= 5.55 Hz, NH, 1H), 5.04 (s, 
PhCH2O diast. A+B, 2H), 4.22 (s, COCH diast. B, 1H), 4.11 (s, COCH diast. A, 1H), 3.78 (s, 
OCH3 diast. B, 3H), 3.77 (s, OCH3 diast. A, 3H), 3.52 (q, J= 6.74 Hz, NHCH2 diast. A+B, 
2H), 3.15 and 3.04 (ABX syst, J= 10.8 (ab), 4.75 (ax), 4.55 (bx) Hz, CH2OH diast. A+B, 2H), 
2.92 (m, NCH diast. A+B, NCHH, 2H), 2.76 (m, NHCH2CH2 diast. A+B, 2H), 2.70-2.61 (m, 
NCHH diast. A+B, 1H), 1.86-1.52 (m, NCHCH2, NCH2CH2 diast. A+B, 4H). 
13C NMR (75 
MHz, Chloroform-d) δ 170.2 (C=O), 159.6, 157.5, 138.9, 137.0 (quat.), 131.0, 129.7, 129.6, 
128.6, 127.9, 127.4, 121.0, 115.0, 114.7, 113.6 (aromatic CH), 73.1 (COCH diast. A), 70.7 
(COCH diast. B), 70.0 (PhCH2O), 64.1 (CH2OH), 61.7 (COCH), 55.2 (OCH3), 53.6 (NCH2), 
40.4 (NHCH2), 34.6 (NHCH2CH2), 28.0 (NCHCH2), 23.7 (NCHCH2CH2). 
Synthesis of Boc-p-toluensulphonamide (84)  
 
p-Toluensulfonamide 134 (501.0 mg, 2.92 mmol) was dissolved in dry DCM (6 mL). (Boc)2O 
(700.0 mg, 3.21 mmol), DMAP (70.0 mg, 0.58 mmol) and Et3N (0.49 mL, 3.50 mmol) were 
added and the reaction mixture was stirred at room temperature overnight. It was cooled at 
0°C and HCl 1M (5 mL) was added. The mixture was extracted with AcOEt and the organic 
phases were washed with NaHCO3, brine and the solvent was removed under reduced 
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pressure. The crude product was purified through chromatographic column (PE:AcOEt: 3:1) 





methoxyphenyl)acetamide 10b (71.4 mg, 0.150 mmol) was dissolved in dry DCM (1.5 mL). 
tButyl tosylcarbamate 84 (48.7 mg, 0.179 mmol) was added and the solution was cooled to 
0°C. TBAD (51.9 mg, 0.225 mmol) and Ph3P (59.6 mg, 0.227 mmol) were added and the 
reaction mixture was stirred at room temperature overnight. The solvent was removed under 
reduced pressure and the crude product was purified though chromatographic column (PE: 
AcOEt 2:1 and 1% of EtOH). to obtain the desired product (78.9 mg, 72%) as a colorless oil. 
The two diasteroisomers were not completely separated. Both the major (diast. A) and the 
minor (diast. B) were obtained as a mixture with the opposite diastereoisomer (d.r. = 97:3, 
determined through 1H-NMR of the obtained fractions). Rf  (A) = 0.25 (PE: AcOEt 2:1 and 
1% of EtOH), Rf  (B) = 0.30 (PE: AcOEt 2:1 and 1% of EtOH). Diast. A: [α]D = +30.2 (c = 
0.9, CHCl3). 
1H NMR (300 MHz, Chloroform-d) δ 7.92 (t, J= 5.87 Hz, NH, 1H), 7.76-7.70 
(m, Ar diast. A+B, 2H), 7.43-7.27 (m, Ar diast. A+B, 7H), 7.20-7.15 (m, Ar diast. A+B, 3H), 
7.04-7.02 (m, Ar diast. A+B, 1H), 7.98-6.96 (m, Ar diast. A+B, 1H), 6.91-6.87 (m, Ar diast. 
A+B, 2H), 6.80-6.75 (m, Ar diast. A+B, 1H), 5.05 (s, PhCH2O diast. B, 2H), 5.01 (s, PhCH2O 
diast. A, 2H), 4.02 (s, COCH diast. A, 1H), 3.90 (s, COCH diast. B, 1H), 3.80 (s, OCH3 diast. 
A, 3H), 3.77 (s, OCH3 diast. B, 3H), 3.75-3.67 (m, NCHCHHN diast. A+B, 1H), 3.60-3.52 
(m, NHCH2 diast. A+B, 2H), 3.42 (dd, J= 14.4, 4.59 Hz, NCHCHHN diast. A+B, 1H), 3.26-
3.12 (m, NCHH, NCH diast. A+B, 2H), 2.86 (t, J= 7.57 Hz, NHCH2CH2 diast. A+B, 2H), 
2.79-2.64 (m, NCHH diast. A+B, 1H), 2.43 (s, CH3 diast. A+B, 3H), 1.96-1.71 (m, NCHCH2, 
NCH2CHH diast. A+B, 3H), 1.60-1.41 (m, NCH2CHH diast. A+B, 1H), 1.31 (s, 
tButyl diast. 
B, 9H) 1.15 (s, tButyl diast. A, 9H). 13C NMR (75 MHz, Chloroform-d) δ 170.5 (C=O), 159.8, 
157.2, 150.5, 143.9, 139.2, 137.8, 137.2 (quat.), 131.6, 129.8, 129.6, 129.2, 128.5, 127.8, 
127.6, 127.4, 121.4, 114.7, 114.5, 113.4 (aromatic CH), 73.7 (COCH), 70.0 (PhCH2O), 59.4 
(NCH), 55.1 (OCH3), 51.5 (NCH2CH2), 49.8 (NCH2CHN), 40.6 (NHCH2), 34.8 
(NHCH2CH2), 27.8 (
tButyl diast. B), 27.7 (tButyl diast. A), 26.6 (NCHCH2), 22.2 
(NCHCH2CH2), 21.5 (CH3). I.R. (ATR): νmax (diast. A): 3351, 2972, 2933, 2873, 1752, 1665, 





3.4 Synthesis of secondary amines 
General procedure for the synthesis of Boc-protected amino alcohols 104a-d from the 
corresponding Boc-α-amino acids.  
 
Boc-amino acid was dissolved in dry THF (1 mL/mmol). This solution was cooled at -10 °C, 
and isobutyl chloroformate (1.2 eq.) and N,Ndiisopropylethylamine (1.5 eq.) were added in 
this order. The mixture was stirred at – 10 °C for 1h. Then it was filtered and the filtrate was 
cooled at -10 °C and treated with NaBH4 (1.5 eq.) and H2O (3 mL/mmol of NaBH4), in this 
sequence. After stirring at -10 °C for 30 min and at rt for 1h, the mixture was diluted with 
AcOEt and with saturated aqueous NH4Cl and 5% aqueous (NH4)H2PO4)NH4 (resulting pH = 
5). After phase separation, the organic phases were washed with brine, and evaporated to 
dryness. Chromatography afforded the pure products. 
104a. Chromatography: PE/AcOEt/CH2Cl2 2:1:2. Yield: 88%. Only (S)-compound was 
prepared and used. This compound is known.95  
104b. Chromatography: PE/AcOEt/CH2Cl2 1:1:1. Yield: 87%. Only (S)-compound was 
prepared and used. This compound is known.96  
104c. Chromatography: PE/AcOEt 3:1. Yield: 87%. Only (S)-compound was prepared and 
used. This compound is known.96 
Using the same procedure, both (R)- and (S)-104d were prepared. Chromatography with PE: 
AcOEt: CH2Cl2 2:1:1 afforded the products in 67% and 58% yield respectively from the 
corresponding amino alcohols. They are both known.96 
Synthesis of tert-butyl (R)-(2-hydroxy-1-phenylethyl)carbamate (104e) 
 
R-(-)-2-phenyl glycinol 105 (1.010 g, 7.36 mmol) was dissolved in dry CH2Cl2 (12.3 mL). 
Et3N (1.13 mL, 8.11 mmol) and (Boc)2O (1.771 g, 8.11 mmol) were added at this solution. 
The mixture was stirred overnight at room temperature, then it was diluted with CH2Cl2 and 
with HCl 1M. After phase separation, the organic phases were washed with saturated aqueous 
NaHCO3, and evaporated to dryness. The crude product was purified by chromatography 
using PE: AcOEt: CH2Cl2 2:1:1. The product (1.500 g, 6.32 mmol) was obtained as a white 
solid with a yield of 86,0%. This product is known.97 
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Optimization of the Mitsunobu reaction to give 16a  
The reaction was first optimized using stoichiometric quantities of the two reagents. Thus, all 
the following reactions were carried out in THF at 0°C for 3 h and then at rt overnight, using 
1 eq. each of 14a and 104a and 1.5 eq. of PPh3 and of azodicarboxylate. A main side-product 
was detected, corresponding to Boc-aziridine 106. 
 
Then, also taking into account the fact that the Boc-amino alcohol is more precious than the 
salicyladehyde, we decided to use a slight excess (1.2 equiv.) of salicylaldehyde. Finally, we 
noticed that a slight better yield was achieved by adding PPh3 and azodicarboxylate in three 
portions. 
Typical procedure for the Mitsunobu reaction: synthesis of (S)-tert-Butyl (1-(2-
(dimethoxymethyl)phenoxy)-3-phenylpropan-2-yl)carbamate (16a). 
 
A solution of salicylaldehyde (0.770 mL, 7.38 mmol) in dry MeOH (8.1 mL) was treated with 
trimethyl orthoformate (3.50 mL, 32.0 mmol) and Amberlyst 15 (100 mg). The resulting 
mixture was stirred at room temperature for 20 h, then diluted with CH2Cl2 and filtered. The 
filtrate was treated with solid NaHCO3 (25 mg) and filtered again. The filtrate was 
evaporated, and the residue was taken up in CH2Cl2/toluene, and again evaporated to 
azeothropically remove all methanol. The crude acetal 14a was obtained as a yellow oil 
(1.380 g). This acetal (301.7 mg, theoretical 1.61 mmol) was dissolved in dry THF (2.60 mL), 
cooled to 0°C, and treated sequentially with Boc-amino alcohol 7a (330.5 mg, 1.31 mmol), 
PPh3 (171.8 mg, 0.655 mmol) and 1,1'-(Azodicarbonyl)dipiperidine (ADDP) (165.5 mg, 
0.656 mmol). After stirring at 0°C for 60 min, further PPh3 (171,8 mg, 0,655 mmol) and 
ADDP (165,5 mg, 0,656 mmol) were added. Finally, after 60 minutes, an identical amount of 
both reagents was added. The mixture was further stirred overnight at rt and evaporated to 
dryness. The crude was taken up in Et2O and washed with NaOH 1M, to remove excess of 
14a. The organic phase was washed with aqueous saturated NH4Cl, evaporated and purified 
by chromatography (PE: AcOEt 11:1) to give pure 16a as an oil (411.4 mg, 78% from 104a). 
Rf = 0.20 (PE / AcOEt 10:1). [α]D = −15.1 (c 1.1, CHCl3). 
1H NMR (300 MHz, CDCl3, 20 °C) 
δ 7.54 (dd, J = 7.6, 1.6 Hz, Ar, 1H), 7.34-7.14 (m, Ar, 6H), 6.98 (t, J = 7.5 Hz, Ar, 1 H), 6.76 
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(d, J = 8.2 Hz, Ar, 1H), 5.73 (1 H, s, CH(OCH3)2), 5.63 (broad d, J = 8.1 Hz, NH, 1H), 4.21-
4.05 (broad m, CHN, 1H), 3.98 (dd, J = 9.3, 2.6 Hz, CHHO, 1H), 3.84 (dd, J = 9.3, 3.8 Hz, 
CHHO, 1H), 3.47 (s, OCH3, 3H), 3.29 (s, OCH3, 3H), 3.10-2.94 (m, CH2Ph, 2H), 1.43 (s, 
C(CH3)3, 9H). 
13C NMR (75 MHz, CDCl3, 20 °C): δ 156.5, 155.5 (C=O and C-O), 138.1, 
126.1 (quat.), 129.8, 129.5 (x2), 128.5 (x2), 127.6, 126.5, 120.7, 112.3 (aromatic CH), 99.4 
(CH(OCH3)2), 79.3 (C(CH3)3), 68.6 (CH2O), 54.4 (OCH3), 51.7 (OCH3 and CHN), 38.2 
(CH2Ph), 28.4 (C(CH3)3). I.R. (ATR): νmax 3346, 2978, 2930, 2897, 2827, 1700, 1606, 1590, 
1522, 1494, 1455, 1442, 1388, 1365, 1337, 1284, 1244, 1203, 1164, 1125, 1096, 1047, 1033, 
987, 973, 960, 921, 901, 881, 866, 850, 822, 780, 763, 742, 698, 670, 641, 623, 608 cm−1. 
HRMS (ESI+): found 402.2287 [Calcd for C23H32NO5
+ (M + H)+ 402.2280]. 
(S)-tert-Butyl 2-benzylaziridine-1-carboxylate 106. 
 
Oil. Rf = 0.49 (PE: AcOEt 10:1). 
1H NMR (300 MHz, CDCl3, 20 °C): δ 7.35-7.20 (m, 5H), 
3.02-2.89 (m, CHN, 1H), 2.71-2.57 (m, CH2N, 2H), 2.31 (d, J = 6.0 Hz, CHHPh, 1H), 2.03 
(d, J = 3.6 Hz, CHHPh, 1H), 1.44 (s, C(CH3)3, 9H). This compound is known.
98 
Synthesis of (S)-tert-Butyl (1-(2-(dimethoxymethyl)phenoxy)-4-methylbutan-2-
yl)carbamate 16b.  
 
It was prepared from salicylaldehyde and Boc-amino alcohol 104b following the same 
procedure described for 16a, but using stoichiometric quantities of 14a and Boc-amino 
alcohol 104b. The isolated yield of 16b was 65% from salicylaldehyde. Chromatography was 
carried out with PE: AcOEt 30:1 →10:1. Oil. Rf = 0.34 (PE: AcOEt 30:1). [α]D = + 50.3 (c 
1.0, CHCl3). 
1H NMR (300 MHz, CDCl3, 20 °C) δ 7.52 (dd, J = 7.5, 1.5 Hz, Ar, 1H), 7.29 (td, 
J = 7.8, 1.5 Hz, Ar, 1H), 6.97 (td, J = 7.5, 1.2 Hz, Ar, 1H), 6.85 (dd, J = 8.1, 0.6 Hz, 1H), 5.65 
(s, CH(OCH3)2, 1H), 5.29 (broad d, J = 8.1 Hz, NH, 1H), 4.10-3.91 (m, CHN, CHHO, 3H), 
3.43 (s, OCH3, 3H), 3.28 (s, OCH3, 3H), 1.80-1.45 (m, CH2CH(CH3)2, 2H), 1.43 (s, C(CH3)3, 
9H), 0.97 (d, J = 6.6 Hz, (CH3)2CH, 6H). 
13C NMR (75 MHz, CDCl3, 20 °C) δ 156.6, 155.6 
(C=O and C-O), 129.8, 127.5, 120.6, 112.2 (aromatic CH), 126.2 (quat.), 99.3 (CH(OCH3)2), 
79.1 (C(CH3)3), 71.0 (CH2O), 54.5 (OCH3), 52.0 (OCH3), 48.4 (CHN), 41.4 (CH2iPr), 28.4 
(C(CH3)3), 24.9 (CH(CH3)2), 22.9, 22.5 (CH(CH3)3. I.R. (ATR): νmax 3349, 2956, 2933, 2871, 
2830, 1697, 1604, 1516, 1491, 1455, 1391, 1366, 1329, 1285, 1241, 1163, 1118, 1091, 1047, 
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977, 910, 872, 847, 811, 754, 731, 672, 647, 610 cm−1. HRMS (ESI+): found 368.2429 [Calcd 
for C20H34NO5
+ (M + H)+ 368.2437].  
Synthesis of (S)-tert-Butyl (1-(2-(dimethoxymethyl)phenoxy)-3-methylpropan-2-
yl)carbamate (16c). 
 
It was prepared from salicylaldehyde and Boc-amino alcohol 104c following the same 
procedure described for 16a, but using 1.1 equiv. of 14a relative to Boc-amino alcohol 104c. 
The isolated yield of 16c was 55% from 104c. Chromatography was carried out with PE: 
AcOEt 16:1 →10:1. Oil. Rf = 0.25 (PE: AcOEt 16:1). [α]D = −56.2 (c 1.0, CHCl3). 
1H NMR 
(300 MHz, CDCl3, 20 °C) δ 7.52 (dd, J = 7.6, 1.6 Hz, Ar, 1H), 7.29 (td, J = 7.5, 1.5 Hz, Ar, 
1H), 6.98 (t, J = 7.5 Hz, Ar, 1H), 6.85 (d, J = 8.1 Hz, Ar, 1H), 5.64 (s, CH(OCH3)2, 1H), 5.43 
(broad d, J = 9.0 Hz, NH, 1H), 4.21 (dd, J = 9.3, 2.8 Hz, CHHO, 1H), 3.92 (dd, J = 9.3, 3.8 
Hz, CHHO, 1H), 3.73-3.60 (m, CHN, 1H,), 3.43 (s, OCH3, 3H), 3.26 (s, OCH3, 3H), 2.02 
(octuplet, J = 7.1 Hz, CH(CH3)2, 1H), 1.43 (s, C(CH3)3, 9H), 1.02 (d, J = 6.9 Hz, (CH3)CH, 
3H), 1.00 (d, J = 6.9 Hz, (CH3)CH, 3H). 
13C NMR (75 MHz, CDCl3, 20 °C) δ 156.7, 155.9 
(C=O and C-O), 129.8, 127.5, 120.5, 112.1 (aromatic CH), 126.2 (quat.), 99.3 (CH(OCH3)2), 
79.0 (C(CH3)3), 69.1 (CH2O), 55.6 (CHN), 54.5 (OCH3), 51.7 (OCH3), 30.2 (CH(CH3)2), 28.4 
(C(CH3)3), 19.6, 19.3 (CH(CH3)3. I.R. (ATR): νmax 3348, 2962, 2934, 2829, 1711, 1604, 
1591, 1516, 1491, 1456, 1390, 1365, 1286, 1240, 1170, 1121, 1092, 1073, 1045, 1028, 979, 
946, 911, 883, 867, 807, 755, 737, 703, 675, 650, 620, 610 cm−1. HRMS (ESI+): found 
354.2284 [Calcd for C19H32NO5
+ (M + H)+ 354.2280].  
Synthesis of (S)-tert-Butyl (1-(2-(dimethoxymethyl)phenoxy)-propane-2-yl)carbamate 
(16d).  
 
It was prepared from 4-bromosalicylaldehyde and Boc-amino alcohol (S)-104d following the 
same procedure described for 16a, but using 1.1 equiv. of 14b relative to Boc-amino alcohol 
(S)-104d. The isolated yield of 16d was 60% from 104d. Chromatography was carried out 
with PE: AcOEt: CH2Cl2 8:1:1 →6:1:1. Oil. Rf = 0.37 (PE: AcOEt: CH2Cl2 8:1:1). [α]D = 
−40.4 (c 1.0, CHCl3). 
1H NMR (300 MHz, CDCl3, 20 °C) δ 7.64 (d, J = 2.4 Hz, Ar, 1H), 7.38 
(dd, J = 8.7, 2.7 Hz, Ar, 1H), 6.74 (d, J = 8.7 Hz, 1H), 5.61 (s, CH(OCH3)2, 1H), 5.26 (broad 
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s, NH), 4.05 (broad s, CHNH, 1H), 4.01 (dd, J = 8.9, 2.8 Hz, CHHO, 1H), 3.90 (dd, J = 8.9, 
4.3 Hz, CHHO, 1H), 3.41 (s, OCH3, 3H), 3.28 (s, OCH3, 3H), 1.44 (s, C(CH3)3, 9H), 1.31 (d, 
J = 6.6 Hz, CH3CH, 3H). 
13C NMR (75 MHz, CDCl3, 20 °C) δ 155.6, 155.3 (C=O and C-O), 
132.4, 130.6, 114.0 (aromatic CH), 128.4, 113.3 (quat.), 98.5 (CH(OCH3)2), 79.3 (C(CH3)3), 
72.2 (CH2O), 54.3 (OCH3), 52.0 (OCH3), 45.9 (CHN), 28.4 (C(CH3)3), 18.2 (CH3CH). I.R. 
(ATR): νmax 3350, 2976, 2933, 2830, 1695, 1595, 1514, 1487, 1457, 1404, 1391, 1365, 1266, 
1242, 1164, 1133, 1099, 1053, 980, 912, 875, 854, 806, 781, 752, 734, 677, 657, 645, 616 
cm−1. HRMS (ESI+): found 404.1075 [Calcd for C17H27BrNO5
+ (M + H)+ 404.1073].  
 
Synthesis of (R)-tert-Butyl (1-(2-(dimethoxymethyl)phenoxy)-propane-2-yl)carbamate 
(ent-16d).  
 
It was prepared exactly as for 16d, but starting from (R)-104d. [α]D = +39.9 (c 1.0, CHCl3). 
The other spectroscopical data were identical to those of 16d.  
Synthesis of (R)-tert-Butyl (2-(2-(dimethoxymethyl)phenoxy)-1-phenylethan-1-
yl)carbamate (16e).  
 
It was prepared from salicylaldehyde and Boc-amino alcohol 104e following the same 
procedure described for 16a, but using 1.1 equiv. of 14a relative to Boc-amino alcohol 104e. 
The isolated yield of 16e was 42% from 104e. Chromatography was carried out with PE: 
AcOEt 8:1 →6:1. Oil. Rf = 0.20 (PE: AcOEt 8:1). [α]D = −33.5 (c 1.2, CHCl3). 
1H NMR (300 
MHz, CDCl3, 20 °C) δ 7.49 (dd, J = 7.6, 1.6 Hz, Ar, 1H), 7.46-7.22 (m, Ar, 6H), 6.97 (t, J = 
7.5 Hz, Ar, 1H), 6.82 (d, J = 8.4 Hz, Ar, 1H), 6.12 (broad s, NH), 5.54 (s, CH(OCH3)2, 1H), 
5.09 (broad s, CHNH, 1H), 4.32-4.15 (m, CH2O, 2H), 3.40 (s, OCH3, 3H), 3.28 (s, OCH3, 
3H), 1.43 (s, C(CH3)3, 9H). 
13C NMR (75 MHz, CDCl3, 20 °C) δ 156.3, 155.5 (C=O and C-
O), 140.2, 126.5 (quat.), 129.8, 128.5 (x2), 127.6, 127.4, 126.8 (x2), 120.9, 112.4 (aromatic 
CH), 99.6 (CH(OCH3)2), 79.5 (C(CH3)3), 72.0 (CH2O), 54.6 (OCH3), 54.1 (CHN), 52.0 
(OCH3), 28.4 (C(CH3)3). I.R. (ATR): νmax 3335, 2977, 2933, 2830, 1706, 1604, 1591, 1515, 
1491, 1454, 1391, 1366, 1284, 1239, 1164, 1121, 1092, 1070, 1047, 979, 947, 902, 867, 794, 
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751, 699, 666, 633 cm−1. HRMS (ESI+): found 388.2119 [Calcd for C22H30NO5
+ (M + H)+ 
388.2124].  
Synthesis of tert-butyl (R)-(1-(2-(dimethoxymethyl)phenoxy)propan-2-yl)carbamate (16f) 
 
It was prepared from salicylaldehyde and Boc-amino alcohol (R)-104d following the same 
procedure described for 16a, but using 1.1 equiv. of 14a relative to Boc-amino alcohol (R)-
104d. The isolated yield of X was 58% from 104d. Chromatography was carried out with PE: 
AcOEt: CH2Cl2 8:1:1. Colorless Oil. Rf = 0.30 (PE: AcOEt: CH2Cl2 8:1:1). [α]D = −42.7 (c 
1.0, CHCl3). 
1H NMR (300 MHz, Chloroform-d) δ 7.53- 7.28 (m, Ar, 1H), 7.27-7.26 (m, Ar, 
1H), 6.98-6.95 (m, Ar, 1H), 6.87-6.84 (m, Ar, 1H), 5.67 (s, CHOCH3,1H), 5.36 (bs, NH, 1H), 
4.10-4.00 (m, CHCH3, OCHH, 2H), 3.94 (dd, J= 9.07, 4.20 Hz, 3.43 (s, OCH3, 3H), 3.3 (s, 
OCH3, 3H), 1.44 (s,
 tButyl, 3H), 1.33 (d, J= 6.72 Hz, CHCH3, 3H).
13C NMR (75 MHz, 
Chloroform-d) δ 156.5, 155.4 (quat.), 129.8, 127.5, 126.2, 120.6, 112.19, 99.4 (aromatic CH), 
71.9 (OCH2), 54.3 (OCH3), 52.1 (OCH3), 46.0 (CHCH3), 28.4 (
tButyl), 18.2 (CHCH3). I.R. 
(ATR): νmax: 3343, 2976, 2933, 2829, 1694, 1603, 1491, 1454, 1365, 1285, 1240, 1162, 1121, 
1093, 1047, 977, 905, 752. 





Acetal 16a (312.4 mg, 778 µmol) was dissolved in CH2Cl2 (3.0 mL) and treated with 37% 
aqueous HCl (640 µL, 7.73 mmol). The mixture was stirred at rt for 5 h. Then it was diluted 
with CH2Cl2, and cautiously treated with 5% aqueous Na2CO3 (25 mL). After checking that 
pH > 9, the two phases were separated, washed with brine, and evaporated to dryness. The 
resulting crude imine 17a (oil) was taken up in dry methanol (3.90 mL), and treated with 
acetic acid (53 µL, 927 µmol), and tert-butyl isocyanide (106 µl, 937 µmol). The mixture was 
stirred at rt for 45 h and evaporated to dryness. It was taken up in AcOEt, washed with 
saturated aqueous NaHCO3 (to remove excess carboxylic acid), evaporated, and 
chromatographed (PE: AcOEt 2:1) to give pure 20b (237 mg, 80%). The ratio 20b: 21b was 
determined by HPLC on the crude product and resulted = 96:4. HPLC conditions: C6-Phenyl 
column 150 x 3 mm, 3 µm. Flow: 0.38 ml/min. Temp: 26°C. Eluent: H2O: CH3CN 55:45. 
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Detection: UV 220 nm. Rt of 20b: 13.62. Rt of 21b: 14.41. Minor diastereomer 21b was 
recognized using a MS (ESI) detector. White solid. Rf = 0.24 (PE: AcOEt 2:1) (Rf of 20b = 
0.31). [α]D = +10.0 (c 1.06, CHCl3). M.p. = 119.7-122.0 °C. 
1H NMR (300 MHz, DMSO-d6, 
90 °C) δ 7.57 (dd, J = 7.7, 1.6 Hz, Ar, 1H), 7.36-7.16 (m, Ar, 6H), 7.00 (t, J = 8.2 Hz, Ar, 
2H), 6.47 (broad s, NH, 1H), 5.66 (broad s, CHC=O, 1H), 4.77 (broad d, J = 11.1 Hz, CHHO, 
1H), 4.55 (broad s, CHN, 1H), 4.03 (dd, J = 13.2, 4.8 Hz, CHHO, 1H), 2.79 (dd, J = 13.4, 5.9 
Hz, CHHPh, 1H), 2.65-2.48 (m, CHHPh, 1H), 2.06 (s, CH3C=O, 3H),1.22 (s, C(CH3)3, 9H). 
13C NMR (75 MHz, DMSO-d6, 90 °C) δ 169.8, 168.8 (C=O), 155.6 (aromatic C-O), 137.6, 
121.4 (quat.), 132.1, 129.6, 128.4 (x2), 127.8 (x2), 125.8, 120.9, 118.8 (aromatic CH), 66.6 
(CH2O), 62.8 (broad) (CHC=O), 57.5 (broad) (CHN), 50.2 (C(CH3)3), 36.4 (CH2Ph), 27.8 
(C(CH3)3), 21.2 (CH3C=O). I.R. (ATR): νmax 3410, 3314, 3067, 3034, 2966, 2928, 2870, 
1671, 1639, 1607, 1580, 1563, 1509, 1494, 1453, 1416, 1391, 1366, 1352, 1332, 1305, 1288, 
1267, 1249, 1224, 1193, 1172, 1157, 1125, 1115, 1086, 1052, 1028, 1007, 973, 937, 908, 885, 
871, 862, 827, 802, 752, 731, 719, 700, 665, 644, 631, 616, 603 cm−1. HRMS (ESI+): found 
381.2171 [Calcd for C23H29N2O3
+ (M + H)+ 381.2178].  
Synthesis of (3S,5R)-3-Benzyl-N-(cyclohexyl)-4-phenylacetyl-2,3,4,5-




It was prepared in 65% overall yield from (S)-16a, phenylacetic acid and cyclohexyl 
isocyanide, following the typical procedure described for 20b. Chromatography was carried 
out with PE: AcOEt: CH2Cl2 5: 1: 1. Separation of the two diastereomers was not complete. 
We obtained fractions with pure 20c plus some fractions contaminated with little 21c. The 
overall yield was 65%. The calculated yield of 20c is therefore 62%. The d.r. was = 94: 6 by 
HPLC of the crude product. Conditions: column Luna C8 150 x 4.6 mm, 5 µ. Flow: 0.8 
ml/min. Temp: 25°C. Eluent: H2O: MeOH 30:70. Detection: UV 220 nm. Rt of 20c: 21.25. Rt 
of 21c: 20.43. Minor diastereomer 21c was recognized using a MS (ESI) detector. White 
solid. Rf = 0.21 (PE: AcOEt: CH2Cl2 5 : 1 : 1) (Rf of 21c = 0.24). [α]D = +9.0 (c 1.0, CHCl3). 
M.p. = 157.8-159.9 °C. 1H NMR (300 MHz, DMSO-d6, 90 °C) δ 7.42 (broad s, Ar, 1H), 7.36-
7.15 (m, Ar, 11H), 7.05-6.95 (m, Ar, 2H), 6.80 (broad d, J = 6.6 Hz, NH, 1H), 5.72 (s, 
CHC=O, 1H), 4.75 (broad d, J = 12.3 Hz, CHHO, 1H), 4.61 (broad s, CHN, 1H), 4.02 (dd, J = 
13.3, 4.6 Hz, CHHO, 1H), 3.84 (d, J = 15.6 Hz, CHHC=O, 1H), 3.67-3.50 (m, CHC=O, 
CHNH, 2H), 2.80 (dd, J = 13.2, 6.0 Hz, CHHPh, 1H), 2.65-2.48 (m, CHHPh, 1H), 1.80-1.45 
(m, CH2 cyclohexyl, 5H), 1.35-1.05 (m, CH2 cyclohexyl, 5H). 
13C NMR (75 MHz, DMSO-d6, 
90 °C) δ 170.2 168.4 (C=O), 155.6 (broad) (aromatic C-O), 137.5, 135.1, 121.3 (quat.), 132.1, 
129.6 (x2), 128.5 (x2), 128.4 (x2), 127.8 (x2), 127.6, 125.83, 125.76, 121.0, 118.7 (aromatic 
CH), 66.7 (broad) (CH2O), 65.9 (broad) (CHC=O), 57.3 (broad) (CHN), 47.7 (CHNH), 39.4 
(CH2C=O, hidden by DMSO signal, visible at qHSQC), 36.3 (broad) (CH2Ph), 31.2 (x2), 
24.6, 23.7, 23.6 (CH2 cyclohexyl). I.R. (ATR): νmax 3271, 3023, 2977, 2940, 2920, 2855, 
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1656, 1633, 1604, 1582, 1525, 1492, 1451, 1416, 1360, 1343, 1319, 1306, 1289, 1270, 1250, 
1222, 1193, 1150, 1115, 1094, 1076, 1060, 1029, 1012, 981, 968, 957, 935, 907, 893, 884, 
875, 853, 826, 809, 781, 762, 749, 720, 696, 640, 619 cm−1. HRMS (ESI+): found 483.2654 
[Calcd for C31H35N2O3
+ (M + H)+ 483.2648]. 
Synthesis of (3S,5R)-3-Benzyl-4-(2-((benzyloxycarbonyl)amino)acetyl)-N-(isopropyl)-




It was prepared in 80% overall yield from (S)-16a, N-benzyloxycarbonyl glycine and 
isopropyl isocyanide, following the typical procedure described for 20b. Chromatography was 
carried out with PE: AcOEt 2: 1. Separation of the two diastereomers was not complete. We 
obtained fractions with pure 20d plus some fractions contaminated with little 21d. The overall 
yield was 80%. The calculated yield of 20d is therefore 74.4%. The d.r. was = 94: 6 by HPLC 
of the crude product. Conditions: column Luna C8 150 x 4.6 mm, 5 µ. Flow: 1 ml/min. Temp: 
26°C. Eluent: H2O: CH3CN 50:50. Detection: UV 220 nm. Rt of 20d: 20.55. Rt of 21d: 21.68. 
Minor diastereomer 21d was recognized using a MS (ESI) detector. White solid. Rf = 0.12 
(PE / AcOEt 2: 1) (Rf of 21d = 0.17). [α]D = −19.7 (c 1.0, CHCl3). M.p. = 70.0-72.2 °C. 
1H 
NMR (300 MHz, DMSO-d6, 90 °C) δ 7.56 (d, J = 7.5 Hz, Ar, 1H), 7.40-7.17 (m, Ar, 11H), 
7.01 (t, J = 7.5 Hz, Ar, 2H), 7.00-6.90 (m, NHCH2, 1H), 6.89 (broad d, J = 7.2 Hz, NHCH, 
1H), 5.66 (s, CHC=O, 1H), 5.08 (s, PhCH2O, 2H), 4.76 (broad d, J = 12.9 Hz, CHHO, 1H), 
4.54 (broad s, CHN, 1H), 4.16 (dd, J = 16.6, 5.6 Hz, CHHNH, 1H), 4.01 (dd, J = 13.2, 4.5 Hz, 
CHHO, 1H), 3.93-3.77 (m, CHNH, CHHNH, 2H), 2.82 (dd, J = 13.4, 5.1 Hz, CHHPh, 1H), 
2.62-2.48 (m, CHHPh, 1H), 1.08 (d, J = 6.6 Hz, CH3, 3H), 1.00 (d, J = 6.6 Hz, CH3, 3H). 
13C 
NMR (75 MHz, DMSO-d6, 90 °C) δ 168.6 168.2 (C=O), 155.7, 155.5 (C=O urethane and 
aromatic CO), 137.4, 136.6, 121.1 (quat.), 132.4, 129.6, 128.4 (x2), 127.8 (x2), 127.7 (x2), 
127.1, 126.9 (x2), 125.9, 120.9, 118.7 (aromatic CH), 66.0 (broad) (CH2O), 65.1 (PhCH2O), 
61.6 (broad) (CHC=O), 57.2 (CHN), 42.3 (CH2NH), 40.8 (CHNH), 36.3 (broad) (CH2Ph), 
21.3 (CH3). I.R. (ATR): νmax 3410, 3321, 3064, 3031, 2971, 2935, 1715, 1648, 1606, 1581, 
1510, 1493, 1453, 1424, 1387, 1366, 1347, 1241, 1220, 1156, 1115, 1084, 1049, 1030, 1010, 
929, 912, 892, 871, 826, 797, 749, 697, 658, 638 cm−1. HRMS (ESI+): found 516.2490 [Calcd 
for C30H34N3O5











tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (20e).  
 
 
A solution of N-(4-(allyloxy)phenyl)formamide (100 mg, 564 µmol)99 in dry CH2Cl2 (0,84 
mL) was cooled at 0°C and treated with Burgess reagent (Methyl N-
(triethylammoniosulfonyl)carbamate inner salt161.2, mg (676 µmol). The mixture was stirred 
at 0°C for 3h, then further 66.0 mg (276 µmol) of Burgess Reagent were added to the mixture. 
After 10 min. the mixture was allowed to reach room temperature and stirred for 2h. This 
mixture was then added to a solution of imine 17a (400 µmol) in MeOH (1.5 mL), prepared 
as described above for the synthesis of 20b. Finally, 3-bromobenzoic acid (112 mg, 557 µmol 
mmol) was added at this mixture. The mixture was stirred at room temperature for 48h and 
then 30 °C overnight. The solvent was evaporated under reduced pressure and the crude 
product was purified by chromatography (PE: AcOEt 5:1) to give pure 20e (128.8 mg, 54%). 
The d.r. was = 93: 7 by HPLC of the crude product. HPLC conditions: C6-Phenyl column 150 
x 3 mm, 3 µm. Flow: 0.34 ml/min. Temp: 25°C. Eluent: H2O: CH3CN 40:60 + 1% CF3CO2H. 
Detection: UV 220 nm. Rt of 20e: 13.33. Rt of 21e: 14.00. Minor diastereomer 21e was 
recognized using a MS (ESI) detector. The overall yield, calculated from the d.r., was 58%. 
White solid. Rf = 0.13 (PE / AcOEt 2: 1). [α]D = +57.0 (c 1.0, CHCl3). M.p. = 148.6-150.7 °C. 
1H NMR (300 MHz, DMSO-d6, 90 °C) δ 9.17 (s, NH, 1H), 7.64 (ddd, J = 8.1, 1.8, 1.0 Hz, Ar, 
2H), 7.44-7.18 (m, Ar,  9H), 7.10 (td, J = 7.5, 1.2 Hz, Ar, 1H), 7.05 (dd, J = 8.1, 0.9 Hz, Ar, 
1H), 7.01-6.92 (m, Ar, 2H), 6.88 (d, J = 9.0 Hz, Ar, 2H), 6.02 (ddt, J = 17.2, 10.5, 5.2 Hz, 
CH=CH2, 1H), 5.81 (broad s, CHC=O, 1H), 5.37 (dq, J = 17.2, 1.6 Hz, CH=CHH, 1H), 5.23 
(dq, J = 10.5, 1.5 Hz, CH=CHH, 1H), 4.95 (dd, J = 12.3, 1.8 Hz, CHHO, 1H), 4.53 (dt, J = 
5.4, 1.5 Hz, CH2CH=CH2, 2H), 4.44 (broad s, CHN, 1H), 4.13 (dd, J = 13.0, 4.0 Hz, CHHO, 
1H), 2.73 (dd, J = 13.2, 7.3 Hz, CHPh, 1H), 2.62 (dd, J = 13.2, 8.4 Hz, CHHPh, 1H). 13C 
NMR (75 MHz, DMSO-d6, 90 °C) δ169.1 167.4 (C=O), 155.6, 154.4, 138.0, 137.2, 131.2, 
121.7, 121.2 (quat.), 133.3 (CH=CH2), 131.9, 131.7, 130.1, 130.0, 128.5 (x2), 128.3, 127.8 
(x2), 125.9, 124.6, 121.8, 121.4 (x2), 119.6, 114.4 (x2) (aromatic CH), 116.5 (CH=CH2), 68.2 
(CH2CH=CH2), 68.1 (broad) (CH2O), 63.4 (broad) (CHC=O), 58.4 (broad) (CHN), 37.0 
(broad) (CH2Ph). I.R. (ATR): νmax 3314, 3062, 2945, 2906, 2026, 1672, 1646, 1606, 1578, 
1563, 1509, 1488, 1446, 1414, 1386, 1353, 1330, 1305, 1278, 1256, 1211, 1171, 1148, 1114, 
1094, 1085, 1069, 1061, 1027, 1007, 967, 934, 914, 897, 887, 864, 824, 807, 752, 730, 709, 
703, 682, 665, 649, 637, 605 cm−1. HRMS (ESI+): found 597.1396 [Calcd for C33H30BrN2O4
+ 





tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (20f).  
 
 
It was prepared in 53% yield from (S)-16c, methoxyacetic acid and benzyl isocyanide, 
following the typical procedure described for 20b. However, in this case, the Ugi-Joullié step 
reaction was carred out at 40°C. Chromatography was carried out with PE: AcOEt 1: 1, 
affording a complete separation of the two diastereomers. The overall yield was 56%. The d.r. 
was = 94: 6 by HPLC of the crude product. Conditions: column Luna C8 150 x 4.6 mm, 5 µ. 
Flow: 0.8 ml/min. Temp: 25°C. Eluent: H2O: MeOH 30:70 + 1% TFA. Detection: UV 220 
nm. Rt of 20f: 6.02. Rt of 21f: 5.49. Minor diastereomer 21f was recognized using a MS (ESI) 
detector. Oil. Rf = 0.35 (PE: AcOEt 1: 1) (Rf of 21f = 0.46). [α]D = −42.4 (c 1.0, CHCl3). 
1H 
NMR (300 MHz, DMSO-d6, 90 °C) δ 7.80 (s, NH, 1H), 7.48 (d, J = 6.6 Hz, Ar, 1H), 7.31-
7.14 (m, Ar, 6H), 6.99 (td, J = 7.5, 1.2 Hz, Ar, 1H), 6.91 (dd, J = 8.1, 1.1 Hz, Ar, 1H), 5.62 (s, 
CHC=O, 1H), 4.76 (broad d, J = 12.3 Hz, CHHO, 1H), 4.37 (dd, J = 13.2, 4.8 Hz, CHHO, 
1H), 4.31 (broad t, J = 5.4 Hz, CH2NH, 2H), 4.29 (J = 14.2 Hz, CHHOMe, 1H), 4.11 (broad s, 
CHN, 1H), 4.01 (J = 14.2 Hz, CHHOMe, 1H), 3.31 (s, CH3O, 3H), 1.59 (d of heptuplets, J = 
9.9, 6.6 Hz, CH(CH3)3, 1H), 0.88 (d, J = 6.6 Hz, CH3CHCH3, 3H), 0.75 (d, J = 6.8 Hz, 
CH3CHCH3, 3H). 
13C NMR (75 MHz, DMSO-d6, 90 °C) δ 169.3 (x2) (C=O), 156.0, 138.7, 
122.3 (quat.), 131.6, 129.5, 127.5 (x2), 126.4 (x2), 126.0, 121.3, 119.1 (aromatic CH), 70.6 
(CH2OMe), 68.1 (broad) (CH2O), 62.0 (CHC=O), 59.8 (broad) (CHN), 57.8 (OCH3), 42.3 
(CH2NH), 28.5 (CH(CH3)2), 19.3, 18.8 (CH3). I.R. (ATR): νmax 3314, 3062, 3031, 2964, 
2931, 2873, 2825, 1653, 1605, 1580, 1516, 1493, 1453, 1424, 1390, 1367, 1320, 1248, 1218, 
1198, 1156, 1124, 1107, 1080, 1028, 965, 948, 860, 838, 750, 731, 698, 640, 605 cm−1. 
HRMS (ESI+): found 397.2135 [Calcd for C23H29N2O4
+ (M + H)+ 397.2127].  
Synthesis of (3S,5R)-4-(Acetyl)-N-(tert-butyl)-3-iso-propyl-2,3,4,5-
tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (20g).  
 
 
It was prepared in 52% yield from (S)-16c, acetic acid and tert-butyl isocyanide, following the 
typical procedure described for 20b. The reaction was in this case incomplete and also 6% of 
starting material was recovered. Chromatography was carried out with CH2Cl2: AcOEt 4: 1, 
affording a complete separation of the two diastereomers. The minor diastereomer 21g was 
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not detected by HPLC-MS or NMR. The d.r. was thus supposed to be > 97: 3. HPLC 
conditions: C6-Phenyl column 150 x 3 mm, 3 µm. Flow: 0.38 ml/min. Temp: 26°C. Eluent: 
H2O: CH3CN 60:40. Detection: UV 220 nm. Rt of 20g: 11.66. White solid. Rf = 0.28 (CH2Cl2: 
AcOEt 4: 1). [α]D = −9.4 (c 0.9, CHCl3). M.p: 104.5-107.8 °C. 
1H NMR (300 MHz, DMSO-
d6, 120 °C) δ 7.46 (dd, J = 7.6, 1.4 Hz, Ar, 1H), 7.25 (td, J = 8.0, 1.6, Ar, 1H), 6.98 (td, J = 
7.5, 1.1 Hz, Ar, 1H), 6.90 (dd, J = 8.1, 1.0, Ar, 1H), 6.62 (broad s, NH, 1H), 5.49 (s, CHC=O, 
1H), 4.68 (dd, J = 12.5, 3.7 Hz, CHHO, 1H), 4.35 (dd, J = 12.5, 5.8 Hz, CHHO, 1H), 4.12 
(broad s, CHN, 1H), 2.10 (s, CH3C=O, 3H), 1.71 (d of heptuplets, J = 9.9, 6.6 Hz, CH(CH3)3, 
1H), 1.26 (s, C(CH3)3, 9H), 0.90 (d, J = 6.6 Hz, CH3CHCH3, 3H), 0.79 (d, J = 6.8 Hz, 
CH3CHCH3, 3H). 
13C NMR (75 MHz, DMSO-d6, 90 °C) δ 170.3, 168.4 (C=O), 155.9, 123.3 
(quat.), 130.7, 129.1, 121.2, 119.2 (aromatic CH), 68.4 (CH2O), 63.3 (broad) (CHC=O), 59.9 
(very broad, barely visible) (CHN), 50.1 (CNH), 28.4 (CH(CH3)2), 27.8 (C(CH3)3), 21.7 
(CH3C=O), 19.3, 18.9 (CH3). I.R. (ATR): νmax 3332, 2965, 2933, 2874, 1980, 1668, 1640, 
1607, 1583, 1529, 1496, 1451, 1413, 1392, 1365, 1346, 1331, 1303, 1289, 1266, 1250, 1218, 
1116, 1088, 1041, 979, 945, 900, 890, 858, 841, 812, 755, 746, 689, 654, 631, 621 cm−1. 
HRMS (ESI+): found 333.2176 [Calcd for C19H29N2O3
+ (M + H)+ 333.2178]. 
Synthesis of (3S,5R)-N-(Cyclohexyl)-3-iso-propyl-4-(phenylacetyl)-2,3,4,5-
tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (20h).  
 
  
It was prepared in 79% yield from (S)-16c, phenylacetic acid and cyclohexyl isocyanide, 
following the typical procedure described for 20b. However, in this case, the Ugi-Joullié step 
reaction was carried out at rt for 64 h. Chromatography was carried out with PE: CH2Cl2: 
AcOEt 3: 1: 1, affording a complete separation of the two diastereomers. The overall yield 
was 82%. The d.r. was = 96: 4 by HPLC of the crude product. Conditions: column Luna C8 
150 x 4.6 mm, 5 µ. Flow: 0.8 ml/min. Temp: 25°C. Eluent: H2O: MeOH 30:70. Detection: 
UV 220 nm. Rt of 20h: 15.14. Rt of 21h: 13.89. Minor diastereomer 21h was recognized 
using a MS (ESI) detector. White solid. Rf = 0.42 (PE: CH2Cl2: AcOEt 3: 1: 1). [α]D = −72.8 
(c 1.0, CHCl3). M.p.: 65.0-67.2 °C. 
1H NMR (300 MHz, DMSO-d6, 120 °C) δ 7.39 (d, J = 7.8 
Hz, Ar, 1H), 7.33-7.19 (m, Ar, 6H), 6.98 (t, J = 7.5 Hz, Ar, 1H), 6.89 (d, J = 8.1, Ar, 1H), 
6.78 (broad s, NH, 1H), 5.61 (s, CHC=O, 1H), 4.63 (dd, J = 12.5, 3.0 Hz, CHHO, 1H), 4.35 
(dd, J = 12.5, 5.5 Hz, CHHO, 1H), 4.20 (broad s, CHN, 1H), 3.86 (d, J = 15.6 Hz, CHHPh, 
1H), 3.71 (d, J = 15.6 Hz, CHHPh, 1H), 3.63 (broad m, CHNH, 1H), 1.83-1.48 (m, CH(CH3)2 
and CH2 cyclohexyl, 6H), 1.38-1.10 (m, CH2 cyclohexyl, 5H), 0.89 (d, J = 6.6 Hz, 
CH3CHCH3, 3H), 0.75 (d, J = 6.8 Hz, CH3CHCH3, 3H). 
13C NMR (75 MHz, DMSO-d6, 90 
°C) δ 171.3, 168.1 (C=O), 156.0, 135.4, 123.3 (quat.), 130.8, 129.3, 128.7 (x2), 127.6 (x2), 
125.8, 121.4, 119.3 (aromatic CH), 68.6 (CH2O), 62.5 (broad) (CHC=O), 60.4 (very broad) 
(CHN), 47.6 (CHNH), 39.9 (CH2Ph), 31.43, 31.37, 24.6, 23.7, 23.6 (CH2 cyclohexyl), 28.5 
(CH(CH3)2), 19.3, 18.8 (CH3). I.R. (ATR): νmax 3418, 3320, 3064, 3031, 2930, 2854, 1647, 
1604, 1581, 1510, 1493, 1450, 1408, 1387, 1367, 1348, 1319, 1248, 1217, 1153, 1113, 1080, 
75 
 
1031, 949, 891, 855, 810, 795, 757, 747, 719, 696, 641 cm−1. HRMS (ESI+): found 435.2639 
[Calcd for C27H35N2O3
+ (M + H)+ 435.2648].  
Synthesis of (3S,5R)-3-iso-Butyl-N-(tert-butyl)-4-(phenylacetyl)-2,3,4,5-
tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (20j).  
 
 
It was prepared in 57% overall yield from (S)-16b, phenylacetic acid and tert-butyl 
isocyanide, following the typical procedure described for 20b. The reaction under these 
conditions was not complete. Chromatography was carried out with PE: AcOEt 5: 1. 
Separation of the two diastereomers was not complete. We obtained fractions with pure 20j 
plus some fractions contaminated with little 21j. The overall yield was 57%. The calculated 
yield of 20j is therefore 54%. The d.r. was 96: 4 by HPLC of the crude product. Conditions: 
column Luna C8 150 x 4.6 mm, 5 µ. Flow: 0.8 ml/min. Temp: 25°C. Eluent: H2O: MeOH 
30:70 + 1% CF3CO2H. Detection: UV 220 nm. Rt of 20j: 18.25. Rt of 21j: 16.23. Minor 
diastereomer 26e was recognized using a MS (ESI) detector. Oil. Rf = 0.22 (PE: AcOEt 5: 1) 
(Rf of 21j = 0.25). [α]D = +12.2 (c 1.0, CHCl3). 
1H NMR (300 MHz, DMSO-d6, 90 °C) δ 
7.26-7.07 (m, Ar, 7H), 6.32 (s, NH, 1H), 5.52 (s, CHC=O, 1H), 4.59 (d, J = 12.9 Hz, CHHO, 
1H), 4.36 (broad s, CHN, 1H), 4.12 (dd, J = 13.2, 5.2 Hz, CHHO, 1H), 3.74 (d, J = 15.6 Hz, 
CHHPh, 1H), 3.57 (d, J = 15.6 Hz, CHHPh, 1H), 1.51 (nonuplet, J = 6.6 Hz, CH(CH3)2, 1H), 
1.17 (t, J = 6.9 Hz, CH2iPr, 2H), 1.11 (s, C(CH3)3, 9H), 0.74 (d, J = 6.6 Hz, CH3CHCH3, 3H), 
0.67 (d, J = 6.6 Hz, CH3CHCH3, 3H). 
13C NMR (75 MHz, DMSO-d6, 90 °C) δ 170.3 168.7 
(C=O), 155.7, 135.2, 121.6 (quat.), 131.6, 129.3, 128.5 (x2), 127.6 (x2), 125.8, 120.8, 118.6 
(aromatic CH), 67.6 (CH2O), 62.3 (broad) (CHC=O), 54.0 (broad) (CHN), 50.2 (CH2iPr), 
39.6 (CH2Ph), 27.7 (C(CH3)3), 24.3 (CH(CH3)2), 22.7, 21.2 (CH3). I.R. (ATR): νmax 3413, 
3331, 3063, 3030, 2959, 2930, 2870, 1683, 1644, 1604, 1580, 1508, 1492, 1452, 1411, 1393, 
1365, 1348, 1309, 1264, 1248, 1219, 1168, 1144, 1115, 1096, 1076, 1057, 1030, 1004, 957, 
869, 823, 804, 758, 721, 695, 634 cm−1. HRMS (ESI+): found 423.2641 [Calcd for 
C26H36N2O3







It was prepared in 68% yield from (S)-16d, acetic acid and tert-butyl isocyanide, following 
the typical procedure described for 20b. However, in this case, during Ugi-Joullié reaction, 
after 24 h, additional 0.2 equivalents of isocyanide were added. Chromatography was carried 
out with PE: AcOEt 2:1→1:1, affording a complete separation of the two diastereomers. The 
minor diastereomer 21k was not isolated. An overall yield 71% was calculated on the basis of 
d.r. The d.r. was = 95: 5 by HPLC of the crude product. Conditions: column Luna C8 150 x 
4.6 mm, 5 µ. Flow: 0.8 ml/min. Temp: 25°C. Eluent: H2O: MeOH 50:50 + 1% CF3CO2H. 
Detection: UV 220 nm. Rt of 20k: 13.59. Rt of 21k: 12.51. Minor diastereomer 21k was 
recognized using a MS (ESI) detector. White solid. Rf = 0.30 (PE/AcOEt 2 : 1). Rf of 21k = 
0.42. [α]D = −46.2 (c 1.0, CHCl3). M.p.: 180.3-181.8 °C. 
1H NMR (300 MHz, DMSO-d6, 90 
°C) δ 7.74 (d, J = 2.1 Hz, Ar, 1H), 7.39 (dd, J = 8.7, 2.5 Hz, Ar, 1H), 6.85 (d, J = 8.7 Hz, 1H), 
6.62 (broad s, NH, 1H), 5.62 (broad s, CHC=O, 1H), 4.85 (d, J = 13.0 Hz, CHHO, 1H), 4.45 
(broad quintuplet, J = 5.9 Hz, CHCH3, 1H), 4.18 (dd, J = 13.0, 4.9 Hz, CHHO, 1H), 2.12 (s, 
CH3C=O, 3H), 1.25 (s, C(CH3)3, 9H), 1.10 (d, J = 6.9 Hz, CH3CH, 3H). 
13C NMR (75 MHz, 
DMSO-d6, 90 °C): δ 169.4, 168.6 (C=O), 154.9, 123.3, 111.6 (quat.), 134.3, 131.9, 120.7 
(aromatic CH), 69.5 (CH2O), 61.6 (broad) (CHC=O), 51.4 (broad) (CHN), 50.3 (CNH), 27.8 
(C(CH3)3, 21.1 (CH3=O), 16.2 (CH3CH). I.R. (ATR): νmax 3413, 3336, 2969, 2930, 1685, 
1630, 1570, 1514, 1487, 1449, 1418, 1389, 1369, 1335, 1319, 1299, 1281, 1267, 1254, 1221, 
1179, 1146, 1125, 1106, 1090, 1066, 1042, 1000, 962, 929, 903, 877, 823, 766, 740, 709, 689, 
659, 624 cm−1.HRMS (ESI+): found 383.0974 [Calcd for C17H24BrN2O3




It was prepared exactly as for the enantiomer 20k.  [α]D = +44.9 (c 1.0, CHCl3). All the other 
data were identical to those of the enantiomer.  
Synthesis of (3S,5R)-7-Bromo-4-(5-chlorothiophene-2-carbonyl)-N-isopropyl-3-methyl-
2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (20i).  
 
Acetal 16d (395.4 mg, 976 µmol) was dissolved in CH2Cl2 (3.7 mL) and treated with 37% 
aqueous HCl (808 µL, 9.67 mmol). The mixture was stirred at rt for 5 h. Then it was diluted 
with CH2Cl2, and cautiously treated with a solution of Na2CO3 (765 mg, 7.21 mmol) in water 
(16.0 mL). After checking that pH > 9, the two phases were separated, washed with brine, and 
evaporated to dryness. The resulting crude imine 17d (yellow oil)(197.5 mg) was taken up in 
dry methanol (4.75 mL), and treated with tert-butyl isocyanide (131 µl, 1.15 mmol) and with 
3-((tert-butyldimethylsilyl)oxy)propanoic acid (252 mg, 1.15 mmol). The mixture was stirred 
at rt for 24 h. Then further tert-butyl isocyanide (21 µL, 0.25 mmol) were added. After strring 
for 24 h more, the mixture was evaporated to dryness and chromatographed (PE: AcOEt 5:1) 
to give pure 20i (284 mg, 54%). The minor diastereome 21i was not isolated. The ratio 20i: 
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21i was determined by HPLC on the crude product and resulted = 95:5. HPLC conditions: 
column Luna C8 150 x 4.6 mm, 5 µ. Flow: 0.8 ml/min. Temp: 25°C. Eluent: H2O: MeOH 
50:50 + 1% CF3CO2H up to 20 minutes. Then 100% MeOH + 1% CF3CO2H. Detection: UV 
220 nm. Rt of 20i: 20.82. Rt of 21i: 20.45. Minor diastereomer 20i was recognized using a MS 
(ESI) detector. The overall yield was calculated to be 57% on the basis of d.r. Oil. Rf = 0.33 
(PE: AcOEt 5: 1). [α]D = −23.0 (c 1.0, CHCl3). 
1H NMR (300 MHz, DMSO-d6, 90 °C) δ 7.72 
(d, J = 2.5 Hz, Ar, 1H), 7.39 (dd, J = 8.7, 2.5 Hz, 1H), 6.85 (d, J = 8.7 Hz, 1H), 6.57 (broad s, 
NH, 1H), 5.64 (broad s, CHC=O, 1H), 4.82 (d, J = 13.1 Hz, CHHO, 1H), 4.47 (broad 
quintuplet, J = 6.1 Hz, CHCH3, 1H), 4.18 (dd, J = 13.1, 4.9 Hz, CHHO, 1H), 3.64 (t, J = 6.4 
Hz, CH2OSi, 2H), 2.55 (dt, J = 15.6, 7.2 Hz, CHHC=O, 1H), 2.37 (dt, J = 15.6, 7.2 Hz, 
CHHC=O, 1H), 1.77 (quintuplet, J = 6.9 Hz, CH2CH2OSi, 2H), 1.25 (s, C(CH3)3, 9H), 1.11 
(d, J = 6.8 Hz, CH3CH, 3H), 0.89 (s, SiC(CH3)3, 9H), 0.05 (s, (CH3)2Si, 6H). 
13C NMR (75 
MHz, DMSO-d6, 90 °C) δ 171.7, 168.6 (C=O), 155.0, 123.4, 111.6 (quat.), 134.2, 131.9, 
120.6 (aromatic CH), 69.4 (CH2O), 61.4 (CH2OSi), 61.2 (broad) (CHC=O), 51.1 (CHN), 50.2 
(CNH), 28.4 (CH2C=O), 27.8 (C(CH3)3, CH2CH2OSi), 25.3 (SiC(CH3)3), 17.3 (SiC(CH3)3)), 
16.2 (CH3CH), −5.9 ((CH3)2Si). I.R. (ATR): νmax 3418, 3344, 2956, 2929, 2857, 1686, 1625, 
1538, 1507, 1486, 1472, 1462, 1454, 1412, 1393, 1365, 1323, 1273, 1250, 1235, 1181, 1124, 
1100, 1060, 1005, 968, 939, 834, 775, 752, 679, 664, 626, 612 cm−1.HRMS (ESI+): found 
541.2103 [Calcd for C25H42BrN2O4Si
+ (M + H)+ 541.2097]. 
Synthesis of (3R,5S)-4-(3-Bromobenzoyl)-N-(cyclohexyl)-3-phenyl-2,3,4,5-
tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (20l).  
 
It was prepared in 86% yield from (R)-16e, 3-bromoacetic acid and cyclohexyl isocyanide, 
following the typical procedure described for 20b. However, in this case, 1.3 equivalents of 
isocyanide were used. Chromatography was carried out with PE: AcOEt 3:1→AcOEt: MeOH 
95:5, affording a complete separation of the two diastereomers. The minor diastereomer 21l 
was not isolated. An overall yield 89% was calculated on the basis of d.r. The d.r. was = 97: 3 
by HPLC of the crude product. Conditions: column Luna C8 150 x 4.6 mm, 5 µ. Flow: 0.8 
ml/min. Temp: 25°C. Eluent: H2O: MeOH 30:70 + 1% TFA. Detection: UV 220 nm. Rt of 
20l: 10.93. Rt of 21l: 11.72. Minor diastereomer 21l was recognized using a MS (ESI) 
detector. White solid. Rf = 0.36 (PE: AcOEt 3: 1). [α]D = −98.5 (c 1.0, CHCl3). M.p: 229.0-
231.5 °C. 1H NMR (300 MHz, DMSO-d6, 90 °C) δ 7.61 (d, J = 7.8 Hz, Ar, 1H), 7.41-7.22 (m, 
Ar, 4H), 7.21-7.05 (m, Ar, 6H), 6.95 (td, J = 7.4, 0.9 Hz, Ar, 1H), 6.71 (d, J = 8.1, Ar, 1H), 
6.65 (broad d, J = 6.6 Hz, NH, 1 H), 5.78 (broad s, CHC=O, 1H), 5.44 (broad s, CHPh, 1H), 
5.03 (dd, J = 13.6, 1.4 Hz, CHHO, 1H), 4.53 (dd, J = 13.6, 4.0 Hz, CHHO, 1H), 3.70-3.55 
(broad m, CHNH, 1H), 1.82-1.47 (m, CH2 cyclohexyl, 5H), 1.40-1.05 (m, CH2 cyclohexyl, 
5H). 13C NMR (75 MHz, DMSO-d6, 90 °C) δ 169.7, 168.5 (C=O), 155.3, 138.8, 138.1, 121.0, 
120.3 (quat.), 132.1, 131.8, 130.0, 129.4, 128.4, 127.2 (x2), 125.9, 125.6 (x2), 124.6, 120.9, 
118.9 (aromatic CH), 68.5 (CH2O), 64.1 (broad) (CHC=O), 60.5 (broad) (CHN), 48.1 
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(CHNH), 31.1 (x2), 24.5, 23.8, 23.7 (CH2 cyclohexyl). I.R. (ATR): νmax 3320, 3063, 3028, 
2924, 2850, 1663, 1650, 1610, 1581, 1563, 1512, 1490, 1464, 1449, 1414, 1389, 1352, 1332, 
1311, 1275, 1249, 1219, 1178, 1148, 1115, 1080, 1046, 1027, 998, 977, 956, 917, 903, 894, 
879, 866, 854, 823, 798, 777, 753, 741, 731, 691, 647 cm−1. HRMS (ESI+): found 533.1429 
[Calcd for C29H30BrN2O3







It was prepared in 60% yield from (S)-16d, 5-chloro-2-thienoic acid and isopropyl isocyanide, 
following the typical procedure described for 20b. However, in this case, for the Ugi-Joullié 
reaction, 1.4 equivalents of isocyanide were used. Chromatography was carried out with PE: 
AcOEt 4:1→3:1. The minor diastereomer 21m was not isolated. The overall yield was 
calculated to be 63% on the basis of d.r. The d.r. was = 95: 5 by HPLC of the crude product. 
Conditions: column Luna C8 150 x 4.6 mm, 5 µ. Flow: 0.8 ml/min. Temp: 25°C. Eluent: 
H2O: MeOH 50:50. Detection: UV 220 nm. Rt of 20m: 16.27. Rt of 21m: 15.68. Minor 
diastereomer 21m was recognized using a MS (ESI) detector. White solid. Rf = 0.33 (PE: 
AcOEt 4: 1). [α]D = −71.3 (c 1.0, CHCl3). M.p.: 166.8-169.0 °C. 
1H NMR (300 MHz, CDCl3, 
20 °C) δ 7.41 (dd, J = 8.7, 2.4 Hz, Ar, 1H), 7.22 (d, J = 2.3 Hz, Ar, 1H), 7.17 (d, J = 3.9 Hz, 
Ar, 1H), 6.90-6.85 (m, Ar, 2H), 5.63 (broad s, CHC=O, 1H), 5.49 (broad s, NH, 1H), 4.63 (d, 
J = 13.5 Hz, CHHO, 1H), 4.70-4.58 (m, CHCH3, 1H), 1.31 (d, J = 6.8 Hz, CH3CH, 3H), 1.12 
(d, J = 6.6 Hz, CH3CHCH3, 3H), 1.10 (d, J = 6.6 Hz, CH3CHCH3, 3H). 
13C NMR (75 MHz, 
CDCl3, 20 °C) δ 168.8, 164.6 (C=O), 155.5, 135.7, 134.6, 122.1, 113.7 (quat.), 134.1, 133.8, 
128.6, 126.2, 121.9 (aromatic CH), 70.2 (CH2O), 64.4 (CHC=O), 53.9 (CHN), 42.5 (CHNH), 
22.4, 22.3 (CH3)2CH, 16.8 (CH3CH). I.R. (ATR): νmax 3283, 3094, 2977, 2933, 2876, 1657, 
1623, 1514, 1486, 1434, 1386, 1344, 1316, 1277, 1251, 1220, 1186, 1145, 1129, 1107, 1059, 
998, 951, 933, 874, 859, 840, 771, 743, 688 cm−1.HRMS (ESI+): found 471.0156 [Calcd for 
C19H21BrClN2O3S






    
Acetal 16d (1.3681 g, 4.20 mmol) was dissolved in CH2Cl2 (15 mL) and treated with 37% 
aqueous HCl (3.48 mL, 41.7 mmol). The mixture was stirred at rt for 5 h. Then it was diluted 
with CH2Cl2, and cautiously treated with a solution of Na2CO3 (3.793 g, 35.7 mmol) in water 
(65 mL). After checking that pH > 9, the two phases were separated, washed with brine, and 
evaporated to dryness. The resulting crude imine 17d (yellow oil)(611.1 mg) was taken up in 
dry methanol (21.0 mL), and treated with methyl isocyanide (300 µl, 5.04 mmol) and with 3-
((tert-butyldimethylsilyl)oxy)propanoic acid (1.2836 g, 5.88 mmol). The mixture was stirred 
at rt for 24 h. Then further methyl isocyanide (100 µL, 1.68 mmol) was added. After stirring 
for 24 h more, the reaction mixture was heated up to 40°C. After 24h it was evaporated to 
dryness and chromatographed (PE: AcOEt 1:1) to give the final product (1.0886 g, 62%) as a 
mixture of diastereoisomers not separable. The ratio 20a: 21a was determined by HPLC both 
on the crude and pure product and resulted = 96:4. HPLC conditions: column DAICEL 
CHIRAL PAK AD 0.46 cm x 25cm. Flow: 0.8 ml/min. Temp: 25°C. Eluent: Exan: iPrOH 
90:10. Detection: UV 220 nm. Rt of 20a: 10.0. Rt of 21a: 8.7. Rf = 0.25 (PE/AcOEt 1:1). [α]D 
= −66.4 (c 1.0, CHCl3). 
1H NMR (300 MHz, DMSO-d6, 90 °C) δ 7.41-7.28 (m, Ar, 1H), 7.27-
7.25 (m, Ar, 1H), 7.10 (br, NH, 1H), 6.95-6.85 (m, Ar, 2H), 5.67 (s, COCHN, 1H), 4.77 (d, J= 
12.9 Hz, OCHH, 1H), 4.46 (bs, CHCH3, 1H), 4.14 (dd, J=, 13.21, 4.01 Hz, OCHH, 1H), 3.64 
(t, J= 6.39 Hz, COCHH, 1H), 3.46 (t, J= 6.28, COCHH, 1H), 2.62 (d, J= 4.50 Hz, NHCH3, 
3H), 2.57-2.55 (m, SiOCHH, 1H), 2.40-2.36 (m, SiOCHH, 1H), 1.81-1.72 (m, COCH2CH2, 
2H), 1.08 (d, J= 6.79 Hz, CHCH3, 3H), 0.87 (s, 
tButyl, 9H), 0.04 (s, SiCH3, 3H), -0.01 
(SiCH3, 3H). 
13C NMR (75 MHz, DMSO-d6, 90 °C) δ 172.8, 172.4, 171.3, 156.3 (quat.), 
133.7, 130.3, 121.5, 119.3 (aromatic CH), 69.9 (OCH2), 62.4 (COCH2), 60.8 (COCH2), 52.1 
(CHCH3), 30.0 (SiOCH2), 28.9 (COCH2CH2), 26.7 (NHCH3), 26.2 (
tButyl), 17.5 (CHCH3), -
2.8 (SiCH3), -4.86 (SiCH3). I.R. (ATR): νmax: 2435, 3345, 2955, 2930, 2857, 1669, 1634, 




Typical procedure for the synthesis of trans-secondary amines: (3S,5R)-7-Bromo-N-(tert-
butyl)-3-methyl-2,3,4,5tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (22b).  
 
Compound 20i (75.2 mg, 139 mmol) was dissolved in a 1.0 M solution of camphorsulfonic 
acid in dry MeOH (0.60 mL), and stirred overnight at 40 °C. Then it was diluted with AcOEt 
and washed with a 1: 1 mixture of saturated aqueous NaHCO3 and brine. The final pH of 
aqueous phase was 8. The phases were separated, and the organic one evaporated to dryness 
and chromatographed (PE: AcOEt 2: 1 + 1% EtOH up to PE: AcOEt 1: 1 + 1% EtOH) to give 
pure 22b as a white solid (29 mg, 62%). Rf = 0.55 (PE: AcOEt 2: 1). [a]D = +28.6 (c 0.6, 
CHCl3). Mp: 154.0– 156.2°C. 
1H NMR (300MHz,CDCl3,20°C): δ 7.34(dd,J=  8.4,2.4Hz, Ar, 
1H), 7.29 (d,J= 2.4Hz, Ar, 1H), 6.92 (d, J= 8.4Hz, Ar, 1H), 5.96 (broad s, NH, 1H), 4.40 (s, 
CHC=O, 1H), 4.12 (dd, J= 11.6, 2.0 Hz, CHHO, 1H), 3.50–3.31 (m, CHHO, CHN, 2H), 1.32 
(s, C(CH3)3, 9H), 1.07 (d, J = 6.3 Hz, CH3CH, 3H,). 
13C NMR (75 MHz, CDCl3, 25°C): δ 
169.3 (C=O), 157.7, 133.7, 116.2 (quat.), 133.6, 132.3, 123.4 (aromatic CH), 78.4 (CH2O), 
64.3 (CHC=O), 51.5 (CNH), 50.8 (CHN), 28.7 (C(CH3)3), 17.8 (CH3CH). IR (ATR): νmax 
3320, 3295, 2995, 2970, 2930, 2869, 1745, 1673, 1520, 1502, 1483, 1452, 1391, 1363, 1345, 
1298, 1268, 1243, 1222, 1194, 1166, 1114, 1080, 1045, 1016, 985, 941, 928, 907, 874, 819, 
786, 761, 726, 661 cm-1. HRMS (ESI+): found 341.0870 [calcd for C15H22BrN2O2





It was prepared from 20a-21a following the typical procedure described for 22a. The 
substrate was used as a mixture of diastereomers. Chromatography was carried out with PE: 
AcOEt 1:2 and 5% of MeOH. Separation of the two diastereomers was not complete. We 
obtained fractions with pure 22a plus some fractions contaminated with little 23a. The overall 
yield was 58%. Rf 22a = 0.21 (PE: AcOEt 1:2 and 5% of MeOH). [α]D = +13.2 (c 1.0, 
CHCl3). Mp: 154.9– 155.5°C. 
1H NMR (300 MHz, Chloroform-d) δ 7.31-7.25 (m, Ar, 1H), 
7.21-7.20 (m, Ar, 1H), 7.18-7.05 (m, Ar, 2H), 5.72 (bs, NH, 1H), 4.49 (s, COCH, 1H), 4.12 
(d, J= 9.76 Hz, OCHH, 1H), 3.50-3.39 (m, OCHH, CHCH3, 2H), 2.77 (d, J= 4.87 Hz, 
NHCH3, 3H), 1.06 (d, J= 6.19 Hz, CHCH3, 3H).
13C NMR (75 MHz, Chloroform-d) δ 171.9, 
158.6 (quat.), 131.4, 131.1, 129.9, 124.2, 122.1 (aromatic CH), 78.6 (OCH2), 65.1 (COCH), 
51.2 (CHCH3), 26.5 (NHCH3), 18.0 (CHCH3). I.R. (ATR): νmax: 3673, 3310, 2973, 2939, 
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2867, 1651, 1583, 1520, 1485, 1461, 1444, 1407, 1388, 1364, 1345, 1279, 1252, 1207, 1168, 
1120, 1032, 1005, 968, 945, 916, 885, 839, 804, 781, 754, 637, 616. 
Typical procedure for the synthesis of cis-secondary amines: (3S,5S)-7-Bromo-N-(tert-
butyl)-3-methyl-2,3,4,5tetrahydrobenzo[f][1,4]oxazepine-5-carboxamide (23b). 
 
Compound 20i (103.7 mg, 191 mmol) was dissolved in dry THF (1.22 mL) and treated with a 
1M solution of tetrabutylammonium fluoride (TBAF) in THF (230 mL, 230 mmol). The 
mixture was stirred at rt for 2 h. Then it was diluted with AcOEt and washed with a 1: 1 
mixture of brine and water. The organic phases were evaporated. HPLC analysis of this crude 
product indicated a d.r. of 90: 10 (see below for details). This crude product was 
chromatographed (PE/AcOEt 1: 2 + 1% EtOH) to give pure cis compound 111i as a colorless 
oil (58mg, 71%). The overall yield, calculated from d.r., was 79%. This intermediate was 
dissolved in a 1M solution of camphor sulfonic acid in dry MeOH (0.63 mL), and stirred 
overnight at 40 °C. Then it was diluted with AcOEt and washed with a 1: 1 mixture of 
saturated aqueous NaHCO3 and brine. The final pH of aqueous phase was 8. The phases were 
separated, and the organic one evaporated to dryness and chromatographed (PE: AcOEt 2: 1 + 
1% EtOH  up to PE: AcOEt 1 : 1 + 1% EtOH) to give pure 23b as a white solid (36 mg, 
77%). Rf = 0.55 (PE: AcOEt 2 : 1). [a]D = -57.0 (c 1.0, CHCl3). Mp: 107.6– 110.0 °C. 
1H 
NMR (300 MHz, CDCl3, 20°C) δ  7.39 (d, J= 2.4 Hz, Ar, 1H), 7.30 (dd, J= 8.4, 2.4 Hz, Ar, 
1H,), 7.10 (broad s, NH, 1H), 6.90 (d, J= 8.4 Hz, Ar, 1H), 4.53(s, CHC=O, 1H), 4.24 (d, J= 
9.0 Hz, CHHO, 1H), 3.32–3.18 (m, CHHO, CHN, 2H), 1.43 (s, C(CH3)3, 9H), 1.03 (d, J= 5.6 
Hz, CH3CH, 3H). 
13C NMR (75 MHz, CDCl3, 25°C): δ  169.6 (C=O), 158.0, 137.0, 116.8 
(quat.), 131.6, 130.4, 123.3 (aromatic CH), 78.6 (CH2O), 61.4 (CHC=O), 54.5 (CHNH), 51.1 
(CNH), 28.8 (C(CH3)3), 17.7 (CH3CH). IR (ATR): νmax 3338, 3286, 2965, 2931, 2875, 1661, 
1513, 1477, 1457, 1392, 1365, 1316, 1300, 1286, 1264, 1245, 1223, 1164, 1144, 1104, 1085, 
1047, 1009, 994, 939, 915, 903, 884, 874, 852, 829, 823, 805, 774, 751, 730, 675, 623cm-1. 
HRMS (ESI+): found 341.0866 [calcd for C15H22BrN2O2
+ (M + H)+ 341.0865]. 
HPLC conditions for analysis of the diastereomeric ratio of 111i-cis and 111i-trans.  
 
 
Column Luna C8 150 x 4.6 mm, 5 µ. Flow: 0.8 ml/min. Temp: 25°C. Eluent: H2O: MeOH 
90:10 + 1% CF3CO2H up to 20 minutes. Then 100% MeOH + 1% CF3CO2H. Detection: UV 







It was prepared from 20a-21a following the typical procedure described for 23b. The 
substrate was used as a mixture of diastereomers. HPLC analysis of the crude product (111h-
cis: 111h-trans) indicated a d.r. of 73: 27 (see below for details). This crude product was used 
without any further purification in the final step. Separation of the two diastereomers was not 
complete. We obtained fractions with pure 23a plus some fractions contaminated with little 
22a. The overall yield (calculated from 22a-23a) was 77%. Rf 23a = 0.26 (PE/AcOEt 1:2 and 
5% of MeOH), [α]D = -1.39 (c 1.0, CHCl3). Mp: 164.9– 166.3°C. 
1H NMR (300 MHz, 
Chloroform-d) δ 7.38 (s, bs, NH, 1H), 7.27-7.18 (m, Ar, 2H), 7.07-7.02 (m, Ar, 2H), 4.72 (s, 
COCH, 1H), 4.31-4.22 (m, OCHH, 1H), 3.34-3.14 (m, OCHH, CHCH3, 2H), 2.91 (d, J= 4.96 
Hz, NHCH3, 3H), 1.03 (d, J= 6.08 Hz, CHCH3, 3H). 
13C NMR (75 MHz, CDCl3, 25°C) δ  
171.8 (C=O), 159.0, 134.8 (quat.), 129.0, 127.3, 124.3, 121.7 (aromatic CH), 78.8 (CH2O), 
61.6 (CHC=O), 55.0 (CHNH), 26.1 (NHCH3), 17.8 (CH3CH). I.R. (ATR): νmax: 3368, 3264, 
2966, 2894, 2858, 1649, 1598, 1576, 1537, 1481, 1455, 1410, 1381, 1315, 1268, 1216, 1173, 
1143, 1117, 1088, 1038, 1008, 941, 893, 848, 800, 776, 752, 732, 661, 626. 
HPLC conditions for analysis of the diastereomeric ratio of 111h-cis and 111h-trans. 
 
 
Phenylic column C6 150 x 3 mm, 3µ. Flow: 0.34 ml/min. Temp: 25°C. Eluent: H2O: MeCN 
90:10 + 1% CF3CO2H up to 20 minutes. Then H2O: MeCN 40: 60 + 1% CF3CO2H. 
Detection: UV 220 nm. Rt of 111h-trans: 12.08 Rt of 111h-cis: 11.12. The ratio was 73:27 
(111h-cis: 111h-trans).  
Synthesis of 4-((tert-Butyldimethylsilyl)oxy)butanoic acid (109). 
γ-Butyrolactone (1.526 mL, 20.0 mmol) was dissolved in a solution of NaOH (901.2 mg, 22.5 
mmol) in MeOH (20.0 mL). The mixture was stirred at room temperature for 2 h. It was then 
evaporated and the crude product (2.7560 g) was taken up in dry DMF (40.0 mL). The 
mixture was cooled to 0°C and then tert-butyldimethylchlorosilane (6.5958 g, 43.8 mmol) and 
imidazole (4.5185 g, 66.3 mmol) were added. The mixture was stirred overnight at room 
temperature. It was diluted with PE / Et2O 1:1 and washed with water. The organic phases 
were dried over Na2SO4, filtered and evaporated under reduced pressure at low temperature 
(the rotavapor bath was kept near 0°C). The resulting colourless oil (9.1058 g) was taken up 
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with a mixture of water (60.0 mL), MeOH (20.0 mL), THF (20.0 mL), and treated with 
K2CO3 (5.5382 g, 40.0 mmol). The resulting mixture was stirred at room temperature 
overnight. It was then concentrated to remove most MeOH and THF, diluted with Et2O and 
extracted with water. The aqueous phase was acidified to pH = 2 with HCl 1M and extracted 
with Et2O. The organic phases were dries over Na2SO4, filtered and evaporated under reduced 
pressure. The desired product (3.7923 g, 87%) was obtained as a colorless oil and used as 
such without any purification.  
3.5 N- vs. O-Glycosylation 
General experimental details 
All chemicals used have been used in synthesis purchased at Sigma-Adrich, Fluka, TCI, 
ABCR, CarboSynth or Merck unless otherwise noted. All solvents used for synthesis were 
HPLC-grade and obtained dry from an Innovative Technology PS-MD-05 solvent drying 
system. ROTH silica gel 60 (40-63 mesh) has been used as stationary phase for column 
chromatography. Merck 60 F254-plates were used for TLC-analysis, visualized by UV and 
submerged in Ce/Mo-solution (Ce(IV)sulphate (10 g) and (NH4)2MO4 (15 g) in 1000 mL 10 
% aqueoussulphuric acid), 10 % H2SO4 in methanol or vanillin stain (10 g, in 1000 mL 10 % 
H2SO4 in MeOH) followed by heating. All reactions were carried out under an inert nitrogen 
atmosphere in flame-dried glassware unless otherwise stated. A Bruker 500 MHz Ultra Shield 
Plus spectrograph with a cryo probe has been used to obtain 1HNMR-, 13C-NMR-, COSY- 
(Correlation Spectroscopy) and HSQC-spectra (Heteronuclear Single Quantum Coherence). 
High-resolution mass spectrometry has been performed on a Bruker SolarX XR 7T 
E8I/MALDI-FTICR-MS instrument. 
Synthesis of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (25a-α) 
 
Trichloroacetonitrile (4.00 mL, 39.9 mmol) was added to a solution of 2,3,4,6-tetra-O-benzyl-
D-glucopyranose (4.0 g, 7.43 mmol) in dry DCM (40 mL). Then, DBU (115 µL, 0.768 mmol) 
was added slowly. The solution was stirred overnight at RT. Et3N (5.5 mL, 39.9 mmol) was 
added and the solution was stirred for 10 minutes at RT. The solvent was evaporated under 
reduced pressure and the crude product was purified through chromatographic column (EPT: 
AcOEt 3:1) to yield the desired product (4.34 g, 6.3 mmol, 85%) as a yellow oil. NMR is in 
accordance with the literature.15 α-anomer: 1H NMR (500 MHz, Chloroform-d) δ 8.58 (s, NH, 
1H), 7.37-7.25 (m, Ar, 18H), 7.19-7.14 (m, Ar, 2H), 6.53 (d, J=3.6 Hz, H-1, 1H), 4.96 (d, 
J=10.9 Hz, CH2,1H), 4.86 (d, J=10.6 Hz, CH2,1H), 4.83 (d, J=11.0 Hz, CH2,1H), 4.75 (d, 
J=11.7 Hz, CH2, 1H), 4.68 (d, J=11.7 Hz, CH2,1H), 4.61 (d, J=12.0 Hz, CH2, 1H), 4.53 (d, 
J=10.5 Hz, CH2,1H), 4.47 (d, J=12.1 Hz, CH2,1H), 4.06 (t, J=9.4 Hz, H-3, 1H), 3.99 (dt, 
J=2.56 Hz, J=10.1 Hz, H-5, 1H), 3.81-3.76 (m, H-2, H-4, H-6a, 3H), 3.67 (dd, J=2.0, J=11.0 
Hz, H-6b, 1H) ppm. 
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Synthesis of 2-hydroxyethyl tosylcarbamate (26b) and ethane-1,2-diyl 
bis(tosylcarbamate) (135)  
 
Tosyl isocyanate (2.3 mL, 15.1 mmol) was added slowly to a flask, in an ice bath, containing 
a solution of ethylene glycol (4.2 mL, 75.1 mmol) in acetone (127 mL). The reaction mixture 
was allowed to warm up to RT and stirred overnight. The solvent was removed under reduced 
pressure and the crude product was purified through chromatographic column with the eluent 
DCM: AcOEt 4:1 + 1% of HCOOH to yield 135 as a white solid (Rf = 0.43, 1.0 g, 2.2 mmol, 
15%) up to + 1% of HCOOH up to 1:1 + 1% of HCOOH to yield 26b as a white solid (Rf = 
0.45, 2.2 g, 8.5 mmol, 56%). 
2-hydroxyethyl tosylcarbamate (26b): The desired product was recrystallized with AcOEt. 
1H NMR (500 MHz, Acetone-d6) δ 10.3 (s, NH, 1H), 7.92-7.89 (m, Ar, 2H), 7.44-7.43 (m, 
Ar, 2H), 4.10-4.08 (m, CH2, 2H), 3.66 (t, J= 4.96, CH2,2H), 2.44(s, CH3, 3H) ppm. 
13C NMR 
(126 MHz, Acetone-d6) δ 151.9 (C=O), 145.4 (iCTs), 137.7 (iCTs), 130.3 (m-CH, 2C), 128.9 
(o-CH, 2C), 68.6 (CH2), 60.5 (CH2), 21.5 (CH3). HRMS (MALDI+): Calculated for 
C10H13NO5SNa+ m/z 282.04066; found m/z 282.04060. m.p.= 130-133 °C. 
Ethane-1,2-diyl bis(tosylcarbamate) (135): The product was recrystallized with MeOH. 1H 
NMR (500 MHz, Acetone-d6) δ 10.4 (s, NH, 2H), 7.92-7.88 (m, Ar, 4H), 7.44-7.42 (m, Ar, 
4H), 4.19 (s, CH2, 4H), 2.45-2.44 (m, CH3, 6H). 
13C NMR (126 MHz, Acetone-d6) δ 151.5 
(C=O), 145.6 (iCTs), 137.6 (iCTs), 130.4 (m-CH, 2C), 128.9 (o-CH, 2C), 64.5 (CH2, 4C), 21.5 
(CH3, 2C). HRMS (MALDI+): Calculated for C18H20N2O8S2Na+ m/z 479.05533; found m/z 
479.05215. m.p.= 205-208 °C. 
PROCEDURES AND RESULTS FOR N- and O-GLYCOSYLATION REACTIONS 
 
Procedure A: 2-hydroxyethyl tosylcarbamate (57 mg, 0.220 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) in dry solvent (2 mL). The reaction mixture was stirred for 48h. The solvent 
was removed under reduced pressure. The crude product (colorless oil, 160 mg) was purified 
through chromatographic column (EPT: AcOEt 2:1).  
Procedure B: 2-hydroxyethyl tosylcarbamate (57 mg, 0.220 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
85 
 
mg, 0.146 mmol) in dry solvent (2 mL). The reaction mixture was stirred for 48h. The solvent 
was removed under reduced pressure without any purifications of the crude product (colorless 
oil, 160 mg). 
Procedure C: 2-hydroxyethyl tosylcarbamate (25.7 mg, 0.099 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) in dry solvent (2,00 mL). The reaction mixture was stirred for 48h. The 
solvent was removed under reduced pressure without any purifications of the crude product. 
Procedure D: 2-hydroxyethyl tosylcarbamate (57 mg, 0.220 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) in dry solvent (1 mL). The reaction mixture was stirred for 48h. The solvent 
was removed under reduced pressure without any purifications of the crude product. 
Procedure E: 2-hydroxyethyl tosylcarbamate (57 mg, 0.220 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) in dry solvent (10 mL). The reaction mixture was stirred for 48h. The 
solvent was removed under reduced pressure without any purifications of the crude product. 
Procedure F: 2-hydroxyethyl tosylcarbamate (7.6 mg, 0.0293 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) in dry solvent (2,00 mL). The reaction mixture was stirred for 48h. The 
solvent was removed under reduced pressure without any purifications of the crude product. 
Procedure G: 2-hydroxyethyl tosylcarbamate (191 mg, 0.735 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) in dry solvent (2 mL). The reaction mixture was stirred for 48h. The 
reaction mixture was extracted with NaOH 1M, to remove the excess of carbamate, washed 
with NH4Cl, Brine, dried over Na2SO4, filtered and concentrated under reduced pressure to 
obtain 90 mg of crude product as yellow oil. 
Procedure H: 2-hydroxyethyl tosylcarbamate (47 mg, 0.181 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) in dry solvent (2 mL). The reaction mixture was stirred for 48h. The solvent 
was removed under reduced pressure. The crude product (yellow oil, 160 mg) was purified 
through chromatographic column (EPT: AcOEt 2:1).  
Procedure I: 2-hydroxyethyl tosylcarbamate (57mg, 0,220 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) and TfOLi (4 mg, 20% mol) in dry solvent (2mL). The reaction mixture was 
stirred for 48h. Then, it was extracted with NaOH 1M, washed with NH4Cl, Brine, dried over 
Na2SO4, filtered and concentrated under reduced pressure to obtain 90 mg of crude product as 
yellow oil. 
Procedure J: 2-hydroxyethyl tosylcarbamate (57mg, 0.220 mmol) was added to a vial 
containing a solution of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 
mg, 0.146 mmol) and Tf2NLi (8 mg, 20% mol) in dry solvent (2 mL). The reaction mixture 
was stirred for 48h. Then, it was extracted with NaOH 1M, washed with NH4Cl, Brine, dried 
over Na2SO4, filtered and concentrated under reduced pressure to obtain 99 mg of crude 
product as yellow oil. 
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B 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
Toluene 40 87:13 1:1 / / / 
A 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
DCM RT 46:54 1:1 34 40 / 
B 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
THF RT 56:44 1:1 / / / 
B 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
MeNO2 RT 0:100 1:1 / / 13% 
*The data reported were estimated through 13C(1H)-NMR. **The data reported were determined through 1H-NMR of the crude 
product. 
 


















F 0.073 M (5.0 eq.) 0.0146 M (1.0 
eq.) 
Toluene 40 100:0 / / / 37% 
C 0.073 M (1.5 eq.) 0.049 M (1.0 
eq.) 
Toluene 40 85:15 3:1 / / 14% 
B 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
Toluene 40 87:13 1:1 / / / 
G 0.073M (1.0 eq.) 0.367 M (5.0 
eq.) 
Toluene 40 47:53 3:1 / / 34% 
F 0.073 M (5.0 eq.) 0.0146 M (1.0 
eq.) 
DCM RT 70:30 3:1 / / 30% 
C 0.073 M (1.5 eq.) 0.049 M (1.0 
eq.) 
DCM RT 70:30 1:2 / / / 
H 0.073 M (1.0 eq.) 0.0905 M (1.2 
eq.) 
DCM RT 60:40 1:3 / / / 
A 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
DCM RT 46:54 1:1 34 40 / 
G 0.073M (1.0 eq.) 0.367M (5.0 
eq.) 
DCM RT 14:86 1:1 / / 19% 
*The data reported were estimated through 13C(1H)-NMR. **The data reported were determined through 1H-NMR of the crude 
product. 
 
TABLE C: The use of different concentration 
 








Solvent T (°C) N-Glycosylation: 
O-Glycosylation** 










D 0.146 M (1.0 eq.) 0.220 M (1.5 
eq.) 
Toluene 40 83:17 3:1 / / 7% 
B 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
Toluene 40 87:13 1:1 / / / 
E 0.0146 M (1.0 eq.) 0.022 M (1.5 
eq.) 
Toluene 40 75:25 1:1 / / / 
D 0.146 M (1.0 eq.) 0.220 M (1.5 
eq.) 
DCM RT 27:73 1:1 / / 8% 
A 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
DCM RT 46:54 1:1 34 40 / 
E 0.0146 M (1.0 eq.) 0.022 M (1.5 
eq.) 
DCM RT 56:44 1:3 / / / 
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A 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
DCM RT 46:54 1:1 34 40 / 
I 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
DCM RT 0:100 1:1 / / 15% 
J 0.073 M (1.0 eq.) 0.110 M (1.5 
eq.) 
DCM RT 0:100 1:1 / / 13% 
*The data reported were estimated through 13C(1H)-NMR. **The data reported were determined through 1H-NMR of the crude product. 






Solvent T (°C) N-Glycosylation: 
O-
Glycosylation** 






B 0.073 M (1.0 eq.) 0.110 M (1.5 eq.) Toluene RT 83:17 1:1 / / 
B 0.073 M (1.0 eq.) 0.110 M (1.5 eq.) Toluene 40 87:13 1:1 / / 
*The data reported were estimated through 13C(1H)-NMR. **The data reported were determined through 1H-NMR of the crude product. 
 
2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl 2-hydroxyethyl tosylcarbamate (27b-β) 
The product was isolated as a colorless oil (Rf = 0,37, PE:AcOEt 1:1+2% of MeOH) . 
1H 
NMR (500 MHz, Chloroform-d) δ 7.89-7.85 (m, Ar, 2H), 7.33-7.27 (m, Ar, 18H), 7.16-7.14 
(m, Ar, 2H), 7.11-7.09 (m, Ar, 2H), 5.53 (d, J= 9.22 Hz, H-1, 1H), 4.87 (d, J= 10.9 Hz, H-6, 
1H), 4.89 (d, J= 11.0 Hz, H-6, 1H), 4.85-4.72 (m, CH2
Bn, 3H), 4.58-4.54 (m, CH2
Bn, 1H), 
4.51-4.46 (m, CH2
Bn, 2H), 4.43-4.35 (m, H-3, 1H), 4.32-4.30 (m, CH2
Bn, 1H), 3.89-3.87 (m, 
CH2
Bn, 1H), 3.75 (t, J= 8.95, H-2, 1H), 3.71-3.67 (m, H-4, CH2, 3H), 3.61-3.57 (m, H-5, CH2, 
3H), 2.73 (bs, OH, 1H), 2.37 (s, CH3, 3H) ppm. 
13C NMR (126 MHz, Chloroform-d) δ 
144.68, 138.4  5, 138.12, 137.92, 137.67, 129.44, 128.60, 128.58, 128.56, 128.50, 128.47, 
128.32, 127.99, 127.93, 127.86, 86.77 (C-2), 85.86 (C-1), 77.160 (C-3, C-4, C-5 with 
Chloroform), 75.94, 75.20, 74.57, 73.50, 68.90, 68.32, 60.52, 21.77 ppm. HRMS (MALDI+): 
Calculated for C44H47NO10SNa+ m/z 804.28129; found m/z 804.27668. [α]D
298= -1,65. 
2,3,4,6-Tetra-O-benzyl -D-glucopyranosyl oxy-ethyl tosylcarbamate (31a) 
The product was obtained as a α/β mixture (2:3) and isolated as a colorless oil (Rf = 0.23, 
PE:AcOEt 1:1+2% of MeOH) . 1H NMR (500 MHz, Chloroform-d) δ 8.72 (s, NH, 1H), 7.94 
(m, Ar, 2H), 7.90-7.87 (m, Ar, 2H), 7.84-7.82 (m, Ar, 1H), 7.36-7.27 (m, Ar, 44H), 7.20-7.12 
(m, Ar, 4H), 4.98 (dd, J= 10.9, 4.45 Hz, CH, 1H), 4.92 (dd, J= 10.9, 4.42 Hz, CH, 1H), 4.87-
4.76 (m, 6H), 4.71-4.55 (m, H-1α, CH2
Bn,7H), 4.53-4.46 (m, 2H), 4.33 (d, J= 7.91 Hz, H-1β, 
1H), 4.30-4.27 (m, 2H), 4.25-4.20 (m, 2H), 4.03-3.90 (m, H-6β, H-3α, H-5α, 3H), 3.80 (m, H-
6β, 1H), 3.79-3.71 (m, 4H), 3.67-3.50 (m, H-2α, H-3β, H-6α, CH2, 5H), 3.45-3.33 (m, H-4β, 
H-2β, H-4α, 3H), 2.40 (s, CH3, 3H), 2.39 (s, CH3, 3H) ppm. 
13C NMR (126 MHz, 
Chloroform-d) δ 150.68 (C=O), 150.62 (C=O), 145.03, 144.88, 138.79, 138.61, 138.58, 
138.20, 138.05, 137.94, 137.85, 137.63, 137.76, 135.71, 129.84, 129.71, 129.63, 128.66, 
128.59, 128.57, 128.55, 128.52, 128.51, 128.47, 128.23, 128.20, 128.19, 128.12, 128.11, 
128.05, 128.04, 128.01, 127.97, 127.94, 127.80, 104.08 (C-1β), 97.73 (C-1α), 84.65 (C-2α), 
82.23 (C-2β), 81.87 (C-5α), 80.02 (C-3β), 78.19 (C-4α), 77.81 (C-5β), 75.88, 75.83, 75.36, 
75.15, 74.81, 74.71 (C-4β), 73.65, 73.62, 73.51, 70.72 (C-3α), 69.71 (C-6α), 68.91, 67.93 (C-
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6β), 66.63, 65.69, 65.45, 21.78 ppm. HRMS (MALDI+): Calculated for C44H47NO10SNa+ 
m/z 804.28129; found m/z 804.28935. [α]D
298= +12.7. 
Synthesis of Ethyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside (136)  
 
Procedure K: EtOH (13 µL, 0.223 mmol) was added to a solution of trichloroacetimidate (100 
mg, 0.146 mmol) and TfOLi (4 mg, 20% mol) in dry DCM. The reaction mixture was stirred 
at RT for 48h. The solvent was removed and the crude product was purified through 
chromatographic column (EPT: AcOEt 8:1) to yield the α-anomer (136a) as a colorless oil (24 
mg, 0.043 mmol, 29 %), β-anomer (136b) as a colorless oil (24 mg, 0.043 mmol, 20 %) and 
product 129 (2 mg, 0.0036 mmol, 2 %).  1H-NMR was in accordance with the literature.73,100  
Procedure L: EtOH (13 µL, 0.223 mmol) was added to a solution of trichloroacetimidate (100 
mg, 0.146 mmol) and Tf2NLi (8 mg, 20% mol) in dry DCM. The reaction mixture was stirred 
at RT for 48h. The solvent was removed with any purification of the crude product (60 mg, 
yellow oil). 
TABLE F: Using EtOH as acceptor 
Entry Procedure Trichloroacetimidate 
(25a-α) 
EtOH Solvent T (°C) 136a:136b* 
1 K 0.073 M (1.0 eq.) 0.111 M (1.5 eq.) DCM RT 56:44 
2 L 0.073 M (1.0 eq.) 0.111 M (1.5 eq.) DCM RT 25:75 
*The data reported were determined through 1H-NMR of the crude product. 
Synthesis of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (129) 
 
A mixture of 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl trichloroacetimidate (100 mg, 0.146 
mmol) and TfOLi (4 mg, 20% mol) in dry DCM was stirred at RT for 48h. The solvent was 
removed without any purification of the obtained red oil (115 mg). NMR data of the crude 
product were consistent with the reported in literature.  




K2CO3 (2.05 g, 14,8 mmol), trichloroacetonitrile (1.9 mL, 18.9 mmol) were added to a 
solution of 2,3,4,6-tetra-O-benzyl-D-glucopyranose (2 g, 3,70 mmol) in dry DCM (12 mL). 
The reaction mixture was stirred for 3 h at RT and evaporated under vacuo onto celite. The 
crude product was purified through chromatographic column (EPT: AcOEt 9:1 →7:1 + 0,5% 
of Et3N) to yield the desired product (2.29 g, 3.34 mmol, 90 %) as a mixture of anomers from 
which fractions containing primarily the β-anomer could be isolated (623 mg, 909 mmol). 
NMR of the mixed fractions showed α/β 30:60. From this data it was possible to determinate 
the yield of the desired product (1.52 g, 2.22 mmol, 60%). NMR data of the compound 25a-β 
were consistent with the reported in literature.101 β-anomer: 1H NMR (500 MHz, Chloroform-
d) δ 8.71 (s, NH, 1H), 7.33-7.27 (m, Ar, 20H), 7.18-7.17 (m, Ar, 2H), 5.81 (m, H-1, 1H), 4.95 
(d, CH2, J=10.8 Hz, 1H), 4.91 (d, CH2, J=11.0 Hz, 1H), 4.82 (m, CH2, 2H), 4.76 (d, CH2, 
J=10.9 Hz, 1H), 4.62 (d, CH2, J=12.2 Hz, 1H), 4.58 (d, CH2, J=10.9 Hz, 1H), 4.55 (d, CH2, 








Synthesis of 2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl 2-hydroxyethyl tosylcarbamate 
(27b) and 2,3,4,6-Tetra-O-benzyl-D-glucopyranosyl oxy-ethyl tosylcarbamate (31a) 
 
2-hydroxyethyl tosylcarbamate (57 mg, 0.220 mmol) was added to a vial containing a 
solution of 2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl trichloroacetimidate (100 mg, 0.146 
mmol) in dry DCM (2 mL). The reaction mixture was stirred for 48h. Then, it was extracted 
with NaOH 1M, washed with NH4Cl, Brine, dried over Na2SO4, filtered and concentrated 
under reduced pressure to obtain the crude product as yellow oil. It was purified through 
chromatographic column (EPT: AcOEt 2:1). The desired product (colorless oil, 37 mg, 0.047 
mmol, 33%) was obtained as a mixture of O-glycoside (α/β 3:1) and N-glycoside (α/β 7:3) in 
a 40:60 ratio. 1H NMR (500 MHz, Chloroform-d) δ 8.66 (s, NH, 1H), 7.89-7.82 (m, Ar, 6H), 
7.36-7.27 (m, Ar, 52H), 7.25-7.06 (m, Ar, 15H), 6.43 (d, J= 7.95 Hz, H-1α (41), 1H), 5.53 (d, 
J= 9.25 Hz, H-1β (41), 1H), 4.98-4.75 (m, H-6β (41), CH2
Bn, 12H), 4.74-4.54 (m, H-1α (42), 
CH2
Bn, 12H), 4.52-4.44 (m, H-3α (41), CH2
Bn, 4H), 4.42-4.36 (m, H-3β (41), CH2
Bn, 1H), 
4.32-4.27 (m, H-1β (42), CH2
Bn, 1H), 4.23-4.16 (m, H-5α (41), CH2
Bn, 4H), 4.15-4.09 (m, H-
2α (41), CH2
Bn, 4H), 3.99-3.90 (m, H-6β (42), H-3α (42), H-5α (42), 3H), 3.79-3.69 (m, H-6α 
(41), H-2β (41), H-4β (41), H-6β (42), CH2
Bn, 7H), 3.64-3.49 (m, H-4α (41), H-6α (41), H-5β 
(41), H-2α (42), H-3β (42), H-6α (4), CH2 (42), 10H), 3.45-3.32 (m, H-4β (42), H-2β (42), H-
4α (42), 2H), 2.39 (s, CH3 (42), 3H), 2.37 (s, CH3 (41β), 2H), 2.33 (s, CH3 (41α), 3H). 
13C 
NMR (126 MHz, Chloroform-d) δ 152.88 (C=O), 150.64 (C=O), 144.86, 144.74, 138.78, 
138.76, 138.26, 138.20, 138.14, 137.97, 137.61, 136.96, 136.68, 129.62, 129.42, 128.65, 
128.53, 128.51, 128.49, 128.46, 128.45, 128.26, 128.23, 128.19, 128.10, 128.03, 127.98, 
127.92, 127.84, 127.81, 127.79, 127.71, 104.09 (C-1β (42)), 97.80 (C-1α (42)), 86.74 (C-2β 
(41)), 85.83 (C-1β (41)), 84.65 (C-2α (41)), 82.48 (C-3α (41)), 82.21 (C-2β (42)), 81.88 (C-5α 
(42)), 81.81 (C-1α (41)), 80.01 (C-3β (42)), 79.05 (C-2α (41)), 78.19 (C-4α (42)), 77.92, 
77.160 (C-3β (41), C-4β (41), C-5β (41), C-4α (41), C-6α (41) with Chloroform), 75.87, 
75.32, 75.17, 74.84, 74.58 74.31 (C-5α (41)), 73.85, 73.78, 73.64, 73.60, 73.47, 70.76 (C-3α 
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